<SEC-DOCUMENT>0001213900-23-036445.txt : 20230504
<SEC-HEADER>0001213900-23-036445.hdr.sgml : 20230504
<ACCEPTANCE-DATETIME>20230504165028
ACCESSION NUMBER:		0001213900-23-036445
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20230504
DATE AS OF CHANGE:		20230504

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HeartBeam, Inc.
		CENTRAL INDEX KEY:			0001779372
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				474881450
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-269520
		FILM NUMBER:		23889659

	BUSINESS ADDRESS:	
		STREET 1:		2118 WALSH AVE., SUITE 210
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95050
		BUSINESS PHONE:		408-899-4443

	MAIL ADDRESS:	
		STREET 1:		2118 WALSH AVE., SUITE 210
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95050
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>f424b20523_heartbeaminc.htm
<DESCRIPTION>PROSPECTUS
<TEXT>
<HTML>
<HEAD><TITLE></TITLE></HEAD>
<BODY STYLE="margin:0;padding:0;border-width:0;text-justify-trim: punctuation; margin: 0; padding: 10pt;"><DIV STYLE="margin:0;padding:0;border-width:0;width:600px;margin: 0 auto;">
	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 50.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">

						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Prospectus Supplement</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 33.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:right;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Filed Pursuant to Rule&#x00a0;424(b)(2)</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 50.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">(to Prospectus dated February&#x00a0;10, 2023)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 33.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:right;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Registration No.&#x00a0;333</FONT><FONT CLASS="nobreak"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">-269520</FONT></FONT></P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;font-size:18pt;">HEARTBEAM, INC.</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;font-size:14pt;">1,000,000&#x00a0;Shares of Common Stock</FONT></P>
		<TABLE CLASS="Basic-Table" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="Basic-Table _idGenTableRowColumn-7">
					<TD CLASS="Basic-Table CellOverride-3" STYLE="border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-width:1pt;padding-bottom:12pt;padding-left:0pt;padding-right:0pt;padding-top:12pt;width: 100.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-top: windowtext 1pt none; border-top-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="top">

						<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:12pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:11pt;">We are offering and selling to an investor 1,000,000</FONT><FONT CLASS="nobreak" STYLE="font-size:11pt;"> </FONT><FONT CLASS="CharOverride-3" STYLE="font-size:11pt;">shares of our Common Stock, par value $0.0001, at an offering price of $1.50 pursuant to this prospectus and the accompanying base prospectus.</FONT></P>
						<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;"><FONT CLASS="CharOverride-3" STYLE="font-size:11pt;">The sales of the shares of Common Stock will be made in accordance with a Securities Purchase Agreement, dated as of May&#x00a0;2, 2023, as amended, by and between us and the investor named therein (the &#x201c;Securities Purchase Agreement&#x201d;).</FONT></P>
						<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-bottom:12pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:11pt;">Our common stock and warrants are listed on The NASDAQ Capital Market under the symbol &#x201c;BEAT&#x201d; and &#x201c;BEATW&#x201d;, respectively. On May&#x00a0;3, 2023, the last reported sale price of our common stock on The NASDAQ Capital Market was $2.31 per share.</FONT></P>
					</TD>
				</TR>

		</TABLE>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-12" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;">Per Share<FONT CLASS="Superscript" STYLE="vertical-align:super;font-size:58%;">(1)</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;">Total</P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;">Proceeds,<BR>before expenses,<BR>to us</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Offering price</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">1.50</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">1,500,000</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">1,400,000</P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;font-size:11pt;">Investing in our securities involves a high degree of risk, including that the trading price of our common stock has been subject to volatility. See &#x201c;Risk Factors&#x201d; beginning on page&#x00a0;S</FONT><FONT CLASS="nobreak"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;font-size:11pt;">-11</FONT></FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;font-size:11pt;"> of this prospectus supplement, page&#x00a0;9 of the accompanying base prospectus and under similar headings in the documents incorporated by reference into this prospectus supplement and the accompanying base prospectus</FONT><FONT CLASS="CharOverride-3" STYLE="font-size:11pt;">.</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;font-size:11pt;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:8pt;text-align:center;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;font-size:11pt;">The date of this prospectus supplement is May&#x00a0;4, 2023</FONT></P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">&#x00a0;</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1_TOC" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"><A NAME="TOC001"></A>TABLE OF CONTENTS</FONT></P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;">Page</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5">
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 100.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:center;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Prospectus Supplement</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-top:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9901">ABOUT THIS PROSPECTUS SUPPLEMENT</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">S-ii</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9902">PROSPECTUS SUPPLEMENT SUMMARY</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">S-1</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9903">RISK FACTORS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">S-11</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9904">SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">S-12</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9905">USE OF PROCEEDS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">S-13</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9906">MARKET PRICE OF OUR COMMON STOCK</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">S-13</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9907">DIVIDEND POLICY</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">S-13</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9908">DESCRIPTION OF SECURITIES WE ARE OFFERING</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">S-13</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9909">LEGAL MATTERS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">S-14</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9910">EXPERTS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">S-14</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9911">INCORPORATION BY REFERENCE</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">S-15</P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Prospectus</FONT></P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9912">ABOUT THIS PROSPECTUS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">ii</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9913">THE COMPANY</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">1</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9914">RISK FACTORS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">9</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9915">SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">10</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9916">USE OF PROCEEDS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">11</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9917">DESCRIPTION OF CAPITAL STOCK</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">12</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9918">DESCRIPTION OF DEBT SECURITIES</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">16</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9919">DESCRIPTION OF WARRANTS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">22</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9920">DESCRIPTION OF RIGHTS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">24</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9921">DESCRIPTION OF UNITS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">25</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9922">PLAN OF DISTRIBUTION</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">26</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9923">LEGAL MATTERS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">28</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9924">EXPERTS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">28</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9925">WHERE YOU CAN FIND MORE INFORMATION</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">28</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9926">INCORPORATION BY REFERENCE</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">29</P>
					</TD>
				</TR>

		</TABLE>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">S-i</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9901"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">ABOUT THIS PROSPECTUS SUPPLEMENT</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">This prospectus supplement and the accompanying base prospectus are part of a registration statement that we filed with the U.S.&#x00a0;Securities and Exchange Commission, or SEC, utilizing a &#x201c;shelf&#x201d; registration process. This document is in two parts. The first part is this prospectus supplement, which describes the specific terms of this offering and also adds to and updates information contained in the accompanying base prospectus and the documents incorporated by reference herein. The second part, the accompanying base prospectus, provides more general information. Generally, when we refer to this prospectus, we are referring to both parts of this document combined. To the extent there is a conflict between the information contained in this prospectus supplement and the information contained in the accompanying base prospectus or any document incorporated by reference therein filed prior to the date of this prospectus supplement, you should rely on the information in this prospectus supplement; provided that if any statement in one of these documents is inconsistent with a statement in another document having a later date<FONT CLASS="nobreak">-for</FONT> example, a document incorporated by reference in the accompanying base prospectus<FONT CLASS="nobreak">-the</FONT> statement in the document having the later date modifies or supersedes the earlier statement.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We further note that the representations, warranties and covenants made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference herein were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a representation, warranty or covenant to you. Moreover, such representations, warranties or covenants were accurate only as of the date when made. Accordingly, such representations, warranties and covenants should not be relied on as accurately representing the current state of our affairs.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">You should rely only on the information contained in this prospectus supplement or the accompanying base prospectus or incorporated by reference herein. We have not authorized anyone to provide you with information that is different. The information contained in this prospectus supplement or the accompanying base prospectus, or incorporated by reference herein or therein is accurate only as of the respective dates thereof, regardless of the time of delivery of this prospectus supplement and the accompanying base prospectus or of any sale of our Common Stock. It is important for you to read and consider all information contained in this prospectus supplement and the accompanying base prospectus, including the documents incorporated by reference herein and therein, in making your investment decision. You should also read and consider the information in the documents to which we have referred you in the sections entitled &#x201c;Where You Can Find More Information&#x201d; and &#x201c;Incorporation of Certain Information by Reference&#x201d; in this prospectus supplement and in the accompanying base prospectus, respectively.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We are offering to sell, and seeking offers to buy, the securities offered by this prospectus supplement only in jurisdictions where offers and sales are permitted. The distribution of this prospectus supplement and the accompanying base prospectus and the offering of the securities offered by this prospectus supplement in certain jurisdictions may be restricted by law. Persons outside the United&#x00a0;States who come into possession of this prospectus supplement and the accompanying base prospectus must inform themselves about, and observe any restrictions relating to, the offering of the Common Stock and the distribution of this prospectus supplement and the accompanying base prospectus outside the United&#x00a0;States. This prospectus supplement and the accompanying base prospectus do not constitute, and may not be used in connection with, an offer to sell, or a solicitation of an offer to buy, any securities offered by this prospectus supplement and the accompanying base prospectus by any person in any jurisdiction in which it is unlawful for such person to make such an offer or solicitation.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">When we refer to &#x201c;BEAT,&#x201d; &#x201c;we,&#x201d; &#x201c;our,&#x201d; &#x201c;us&#x201d; and the &#x201c;Company&#x201d; in this prospectus, we mean HeartBeam, Inc., unless otherwise specified. When we refer to &#x201c;you,&#x201d; we mean the holders of the applicable series of securities.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">S-ii</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>





	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9902"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">PROSPECTUS SUPPLEMENT SUMMARY</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">The following information below is only a summary of more detailed information included elsewhere in, or incorporated by reference into, this prospectus supplement and the accompanying base prospectus, and should be read together with the information contained or incorporated by reference in other parts of this prospectus supplement and the accompanying base prospectus. This summary highlights selected information about us and this offering. This summary may not contain all of the information that may be important to you. Before making a decision to invest in our securities, you should read carefully all of the information contained in or incorporated by reference into this prospectus supplement and the accompanying base prospectus, including the information set forth under the caption &#x201c;Risk Factors&#x201d; in this prospectus supplement and the accompanying base prospectus as well as the documents incorporated herein by reference, which are described under &#x201c;Where You Can Find More Information; Incorporation by Reference&#x201d; in this prospectus supplement. Unless otherwise indicated or unless the context requires otherwise, this prospectus includes the accounts of HeartBeam, Inc., a Delaware corporation and its </FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">wholly</FONT><FONT CLASS="nobreak"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">-owned</FONT></FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;"> subsidiaries, collectively referred to as &#x201c;we&#x201d;, &#x201c;us&#x201d;, &#x201c;our&#x201d;, &#x201c;HeartBeam&#x201d; or the &#x201c;Company&#x201d;.</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Overview</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Overview</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Company Overview</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We are a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (&#x201c;ECG&#x201d;) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. Our ability to develop higher resolution ECG solutions is achieved through the development of our proprietary and patented Vector Electrocardiography (&#x201c;VECG&#x201d;) technology platform. Our VECG is capable of developing three<FONT CLASS="nobreak">-dimensional</FONT> (&#x201c;3D&#x201d;) vector images of cardiac electrical activity by displaying the spatial locations of ECG waveforms that demonstrated in early studies to deliver equal or superior diagnostic capability than traditional hospital<FONT CLASS="nobreak">-based</FONT> ECG systems.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;text-align:center;margin-top:8pt;"><IMG ALT="" SRC="timage_001.jpg" STYLE="width:166.4px;max-width:100%;"></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our aim is to deliver innovative, ambulatory cardiac health monitoring technologies that can be used for patients anywhere, especially where critical cardiac care decisions need to be made on a more timely basis. Our products (hereinafter &#x201c;Product&#x201d; or &#x201c;Products&#x201d;) require Food and Drug Administration (&#x201c;FDA&#x201d;) clearance and have not been cleared for marketing.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We believe our Products and services will benefit many stakeholders, including patients, healthcare providers, and healthcare payors. We are developing our telehealth Product (&#x201c;HeartBeam AIMIGo<FONT CLASS="Superscript" STYLE="vertical-align:super;font-size:58%;">TM</FONT>&#x201d;), to address the rapidly growing telehealth market.&#x00a0;HeartBeam AIMIGo is comprised of a credit card sized electrocardiogram device and powerful cloud<FONT CLASS="nobreak">-based</FONT> diagnostic expert software systems. We intend to show that our easy to use device (without external electrodes) provides signals equivalent to a standard 12L device, and therefore will have a number of applications for ambulatory use. We believe that we are uniquely positioned to play a central role in cardiac remote monitoring including high<FONT CLASS="nobreak">-risk</FONT> coronary artery disease patients, because the initial studies have shown that our ischemia detection system may be more accurate than existing ambulatory monitoring solutions. Coronary artery disease (&#x201c;CAD&#x201d;) patients are at increased risk for a heart attack or Myocardial Infarction (&#x201c;MI&#x201d;).</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">S-1</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="Text_flush_Center" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:8pt;"><IMG ALT="" SRC="timage_002.jpg" STYLE="width:323.84px;max-width:100%;"></P>
		<P CLASS="Text_flush_Center" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:8pt;">HeartBeam AIMIGo device in planar and ready position</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We are also applying our software platform to create a tool for detecting heart attacks in the Emergency Department (&#x201c;ED&#x201d;) environment using standard 12<FONT CLASS="nobreak">-lead</FONT> ECG recordings. The software tool, (&#x201c;HeartBeam AIMI<FONT CLASS="Superscript" STYLE="vertical-align:super;font-size:58%;">TM</FONT>&#x201d;) is designed to enable emergency physicians diagnose heart attacks more accurately and quickly than currently available tools. Market clearance of this Product is planned to precede HeartBeam AIMIGo.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">To date, we have developed working prototypes for both HeartBeam AIMIGo and HeartBeam AIMI.&#x00a0;HeartBeam AIMI has been submitted for FDA 510(k)&#x00a0;clearance and we have received questions from the FDA within the statutory 30<FONT CLASS="nobreak">-day</FONT> review deadline, discussed the questions via teleconference with the FDA review team and provided written responses addressing the questions to the primary reviewer.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The custom software and hardware of our Products, we believe, are classified as Class&#x00a0;II medical devices by the FDA, running on an FDA approved Class&#x00a0;I registered software platform. Class&#x00a0;II medical devices are those for which general controls alone are insufficient to provide reasonable assurance of safety and effectiveness and there is sufficient information to establish special controls. Special controls can include performance standards, post<FONT CLASS="nobreak">-market</FONT> surveillance, patient histories and FDA guidance documents. Premarket review and clearance by the FDA for these devices is generally accomplished through the 510(k)&#x00a0;or 510(k)&#x00a0;de<FONT CLASS="nobreak">-novo</FONT> premarket notification process.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">HeartBeam has nine issued U.S.&#x00a0;patents (U.S.&#x00a0;10,433,744, U.S.&#x00a0;10,117,592, U.S.&#x00a0;11,071,490, U.S.&#x00a0;11,419,538, U.S.&#x00a0;11,445,963, U.S.&#x00a0;11,529,085, U.S.&#x00a0;10,980,433, U.S.&#x00a0;11,412,972 and U.S.&#x00a0;11,234,658), and six pending U.S.&#x00a0;applications. Four of the pending applications have been published, the remaining two pending cases are unpublished. Outside of the U.S., HeartBeam has four issued patents in Germany, France, Netherlands and United Kingdom and seven pending applications in Canada, China, the European Union, Japan and Australia. HeartBeam has three pending PCT applications. The issued patents are predicted to expire between April&#x00a0;11, 2036 and April&#x00a0;21, 2042.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Market Overview</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Chronic diseases are the number one burden on the healthcare system, driving up costs each year, and cardiovascular illnesses are one of the top contributors. Regulators, payors, and providers are focused on shifting the diagnosis and management of these conditions to drive better outcomes at lower cost. Connected medical solutions are expanding rapidly and are projected to reach $155&#x00a0;billion by 2026, a compound annual growth rate (&#x201c;CAGR&#x201d;) of 17%. These solutions are socio<FONT CLASS="nobreak">-technical</FONT> models for healthcare management and delivery using technology to provide healthcare services remotely and aim to maximize healthcare resources and provide increased, flexible capabilities for patients to engage with clinicians and better self<FONT CLASS="nobreak">-manage</FONT> their care, using readily available consumer<FONT CLASS="nobreak">-facing</FONT> technologies to deliver patient care outside the hospital or doctor&#x2019;s office.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The market for Remote Patient Monitoring (&#x201c;RPM&#x201d;) is projected to reach $31.3&#x00a0;billion by 2023. In 2019, 1,800&#x00a0;hospitals in the US were using mobile applications to improve risk management and quality of care. The number in 2020 was likely larger as the onset of the COVID<FONT CLASS="nobreak">-19</FONT> pandemic greatly accelerated use and acceptance of telehealth by both patients and healthcare providers.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">S-2</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Cardiovascular disease is the number one cost to the healthcare system and is estimated to be responsible for 1 in every 6 healthcare dollars spent in the US.&#x00a0;As cardiovascular disease is the leading cause of death worldwide, early detection, diagnosis, and management of chronic cardiac conditions are necessary to relieve the increasing burden on the healthcare infrastructure. Diagnostic tests such as ECGs are used to detect, diagnose, and track numerous cardiovascular conditions. With advances in mobile communications, diagnostic monitoring of cardiac conditions is increasingly occurring outside the hospital.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;text-align:center;margin-top:8pt;"><IMG ALT="" SRC="timage_003.jpg" STYLE="width:467.2px;max-width:100%;"></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We intend to show that our easy to use device (without external electrodes) provides signals equivalent to a standard 12L device, and therefore will have a number of applications for ambulatory use. Our initial telemedicine technology Product HeartBeam AIMIGo will first address the heart attack detection market as well as the market to monitor CAD patients who are typically at high risk for a heart attack. Additionally, we expect to cater to patients across different risk profiles interested in our cardiac monitoring solutions for different heart conditions. Currently there are no products on the market that are user friendly, easy to carry, and always with the patient to provide physicians and patients with timely and highly accurate information about all heart conditions that could be detected with a 12L ECG, including potential ischemic events. A tool that is always with the patient, that decreases time to intervention, and that decreases the number of unnecessary ED visits by chest pain patients would have a significant effect on saving lives and healthcare dollars. We believe our technology will address this problem and will provide a convenient, cost<FONT CLASS="nobreak">-effective</FONT>, integrated telehealth solution, including software and hardware for physicians and their patients. There are approximately 20&#x00a0;million people in the US who are considered at high risk for a heart attack, including 8&#x00a0;million who already have had prior intervention for MI&#x2019;s and are therefore considered to be at extreme risk.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">In the US, mobile cardiac tests are primarily conducted through outsourced Independent Diagnostic Testing Facilities (&#x201c;IDTFs&#x201d;) or as part of an RPM/telehealth system. Reimbursement rates vary depending on the use case and generally are based on the value a technology offers to patients and healthcare providers. Actual reimbursed pricing is set by the Centers for Medicare&#x00a0;&amp; Medicaid Services (&#x201c;CMS&#x201d;). Reimbursement rates for private insurers typically provide for similar or higher reimbursement rates when compared to those set by the government for Medicare and Medicaid.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">In the ED environment, early and accurate diagnosis of a chest pain patient who is potentially having a heart attack is of immense importance. Guidelines state that every chest pain patient in an ED must receive an ECG within 10&#x00a0;minutes of presentation. The accuracy of these initial ECGs, interpreted by physicians, is only approximately 75%. The need for increased ECG accuracy in detecting a heart attack in the ED is well defined, and an improved solution could result in saved lives and healthcare dollars. A 510(k)&#x00a0;for our ED Product, HeartBeam AIMI, was submitted for review on August&#x00a0;15, 2022 to the FDA.&#x00a0;We believe this Product will offer an increase in the accuracy of heart attack detection in EDs. There are approximately 5,000&#x00a0;Emergency Departments in the US.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">S-3</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Products and Technology</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The foundation of our novel technology is the concept of VECG, a technology that has long been seen as superior to ECGs in detecting MIs but is no longer used clinically because of the difficulty experienced by physicians interpreting the output. We solved the crucial problem of recording three orthogonal (x, y and z) projections of the heart vector with a device that is sized like a credit card. The thickness of our credit card sized ECG signal collection device is about 1/8 inch (4 mm), and it weighs about 1 ounce (28 grams). The core technology consists of a series of patented inventions and associated algorithms. In addition to using VECG to get a more complete 3D characterization of cardiac activity, we use the concept of a baseline. Our MI marker is a differential marker that measures the change in cardiac parameters between an asymptomatic (baseline) recording and the symptomatic recording. It is personalized for every patient as every patient has a unique baseline. Our increase in diagnostic performance in detecting MIs, when compared to a panel of cardiologists, is attributed to a richer cardiac information set offered by VECG&#x00a0;and the fact that our MI marker compares the baseline and symptomatic recordings and does that in the 3D space of VECG.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">This novel technology has resulted in two key Products to date: a telehealth Product for cardiovascular patients (HeartBeam AIMIGo) and a powerful cloud<FONT CLASS="nobreak">-based</FONT> ECG interpretation based on a quantitative comparison of the patients 3D VECG baseline and symptomatic recordings for EDs (HeartBeam AIMI). Our telehealth ECG collection device is the size of a credit card and records cardiac signals with integrated electrodes rather than wires or self<FONT CLASS="nobreak">-adhesive</FONT> electrodes. Unlike a standard 12<FONT CLASS="nobreak">-lead</FONT> ECG machine that records signals in empirically determined locations on a human body, our approach is focused on recording three projections of the heart vector. The successful recording of the projections of the heart vector enables the synthesis, via a patented method, of a 12<FONT CLASS="nobreak">-lead</FONT> signal set and internal algorithmic diagnostic work in the space of 3D heart vectors.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">There are obvious ease of use advantages when comparing our handheld device that fits in a wallet and can be instantly self<FONT CLASS="nobreak">-applied</FONT> versus the current 12<FONT CLASS="nobreak">-lead</FONT> ECG machine that requires a trained professional to apply. In addition, there are diagnostic performance advantages, including, based on our initial study, increased accuracy in diagnosing MIs. The system is used by patients at home or elsewhere, and collected data is sent to a physician to assess whether the patient&#x2019;s chest pain is truly the result of an MI.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our telehealth HeartBeam AIMIGo system will be a prescription<FONT CLASS="nobreak">-only</FONT> mobile health system intended for individuals with known or suspected heart disease, especially CAD.&#x00a0;It helps guide physicians in choosing the best course of action for their patients who experience chest pain outside of a medical facility. HeartBeam AIMIGo will bring a medical grade ECG to patients and will enable them to receive a plan of action from a physician in a timely manner. At the time of onboarding and at regularly scheduled time intervals, patients record a baseline 30 second cardiac reading using our device. When a patient experiences symptoms, such as irregular heartbeats or chest pain, the patient can simply open the smartphone application and press the credit card sized device against the chest to collect signals that can be converted to a synthesized 12<FONT CLASS="nobreak">-lead</FONT> ECG.&#x00a0;This synthesized 12<FONT CLASS="nobreak">-lead</FONT> ECG is sent to the physician overlayed with the patient&#x2019;s synthesized baseline ECG recording. In addition, the patient provides input on their symptoms that is sent, along with the ECG data, to the cloud for interpretation by a physician. A cloud<FONT CLASS="nobreak">-based</FONT> algorithm processes the signals and displays the symptom description and patient history to a physician to analyze and prescribe an action plan. From start to finish, the process takes just a few minutes.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The telehealth HeartBeam AIMIGo system consists of a number of capabilities that will be productized in an incremental fashion. These are:</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;">1.<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>A credit card sized cardiac electrical signal collection device. The device captures cardiac signals that represent x, y and z projections of the heart vector and transmits them via Bluetooth connection to a smartphone. It is always with the patient as it easily fits in a wallet. It is easy to use as all that is required of the patient is that the device be pressed against the chest.</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;">2.<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>A smartphone application that receives the cardiac signals from the HeartBeam signal collection device. The application has several functions: guiding the patient through the signal collection, asking about symptoms, displaying the status of the data collection including real time signal quality check, and notifying the patient of the plan of action as determined by a physician. In addition, the application will contain HIPAA<FONT CLASS="nobreak">-compliant</FONT> video conferencing or text capabilities for the healthcare provider to communicate directly with the patient.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">S-4</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;">3.<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>A cloud<FONT CLASS="nobreak">-based</FONT> software system that serves four basic functions: (1)&#x00a0;Performing a final check of the ECG signal quality, (2)&#x00a0;Synthesizing a 12<FONT CLASS="nobreak">-lead</FONT> ECG from the measured (recorded) 3 vector leads, (3)&#x00a0;Creating a diagnostic suggestion based on 3D VECG interpretation, risk factors and symptoms and (4)&#x00a0;Preparing a summary report for the physician. These software functions will be introduced to the HeartBeam AIMIGo product in a sequential manner. To facilitate a more accurate physician interpretation of the data, the software overlays the patient&#x2019;s synthesized baseline 12 lead ECG waveform on the synthesized 12 lead ECG waveform from the current event. To ensure high signal quality, the system checks for noise levels in the recorded signals. Those signals that can be effectively filtered are accepted and those that have a noise level above an empirically established threshold are rejected. If a recorded signal is rejected, the user is asked to repeat the recording.</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;">4.<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>A web<FONT CLASS="nobreak">-based</FONT> physician portal capable of displaying the following relevant information for the physician to analyze: diagnostic suggestion, patient history, symptoms, baseline and current, synthesized 12<FONT CLASS="nobreak">-lead</FONT> ECG, and recorded 3 vector leads. Our physician portal assists physicians with their diagnostic interpretation by providing both the baseline 12<FONT CLASS="nobreak">-lead</FONT> synthesized ECG and the 12<FONT CLASS="nobreak">-lead</FONT> synthesized ECG that is under evaluation.</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;">5.<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>A dedicated ECG monitoring and reading team of medical professionals to offer 24/7/365 services in order to assist symptomatic patients when making a decision of whether they should go to the Emergency Department. This capability will be developed in<FONT CLASS="nobreak">-house</FONT> or outsourced through a contracted third<FONT CLASS="nobreak">-party</FONT> organization.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The market release of our telehealth Product will be in multiple versions.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The initial Product will have a limited feature set and introduce a 3<FONT CLASS="nobreak">-lead</FONT> 3D VECG credit card<FONT CLASS="nobreak">-sized</FONT> device, the HeartBeam AIMIGo 3L, that records the&#x00a0;X,Y,Z cardiac activity and displays the signals for clinician review, providing the regulatory foundation for subsequent products in our product portfolio. The 510(k)&#x00a0;submission to the FDA is planned for early 2023.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Following this we will offer to the physician a pair of baseline and symptomatic 12<FONT CLASS="nobreak">-lead</FONT> ECGs, both synthesized from 3<FONT CLASS="nobreak">-lead</FONT> 3D VECG signals recorded by the HeartBeam AIMIGo device, and a symptoms report. It leverages recently issued patents for a personalized system for synthesizing 12<FONT CLASS="nobreak">-lead</FONT> ECG waveforms. The 510(k)&#x00a0;submission to the FDA is planned for late 2023.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Future versions may include our proprietary ECG interpretation MI marker and our overall MI diagnostic suggestion in addition to all features of the earlier Products and may as well offer an automated atrial fibrillation detection algorithm.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The same core technology built into the telehealth Product HeartBeam AIMIGo is used in the ED Product HeartBeam AIMI.&#x00a0;In this application, the increased accuracy of detecting MIs by the ECG is of utmost importance. An ECG is the first diagnostic test a chest pain patient receives in the ED and it has a major impact on the patient&#x2019;s subsequent clinical path. The ED Product has no hardware and introduces minimal change to the standard of care chest pain diagnostic path. It uses a baseline standard 12<FONT CLASS="nobreak">-lead</FONT> ECG from the patient&#x2019;s Electronic Medical Record (&#x201c;EMR&#x201d;) and the standard 12<FONT CLASS="nobreak">-lead</FONT> ECG that is being evaluated. It converts the two ECGs to a VECG representation and utilizes our proprietary 3D VECG differential marker to generate an ECG interpretation suggestion to be used by the ED physician. The importance of increased accuracy of the first ECG interpretation for a chest pain patient presenting to an ED is significant, potentially leading to faster intervention or avoiding unnecessary activation of the cardiac catheterization lab.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">FDA Regulatory Path</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We have defined the FDA 510(k)&#x00a0;clearance paths for both Products and have contracted with regulatory consultants to help us clear both products with the FDA.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The initial Product will have a limited feature set and introduce a 3<FONT CLASS="nobreak">-lead</FONT> 3D VECG credit card<FONT CLASS="nobreak">-sized</FONT> device, the HeartBeam AIMIGo 3L, that records the&#x00a0;X, Y, Z cardiac activity and displays the signals for clinician review, providing the regulatory foundation for subsequent products in our product portfolio.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">S-5</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The 510(k)&#x00a0;submission to the FDA is planned for early Q2 2023. We are planning a subsequent 510(k)&#x00a0;submission, in Q4 2023, for the Product, which will include the ability to generate synthesized 12L ECG recordings. The submission is planned to contain results of a validation study comparing our synthesized 12<FONT CLASS="nobreak">-lead</FONT> ECG recordings to standard 12<FONT CLASS="nobreak">-lead</FONT> ECG recordings.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">HeartBeam&#x2019;s ED software product, HeartBeam AIMI, is hosted on LIVMOR&#x2019;s Class&#x00a0;I registered software platform and a predicate device for the cloud<FONT CLASS="nobreak">-based</FONT> diagnostic engine for the ED product was identified. The predicate device is widely used as part of a software package produced by a leading ECG machine manufacturer. The predicate device software makes a diagnostic suggestion regarding a potential MI diagnosis. HeartBeam AIMI will also make a diagnostic suggestion to the ED physician. In the HIDES pilot study, we showed improved performance in detecting ischemia over a panel of cardiologists.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">For the FDA 510(k)&#x00a0;regulatory submission, a retrospective study was performed comparing patients&#x2019; baseline and asymptomatic ECG recordings and providing a diagnostic suggestion from the HeartBeam AIMI software. The diagnostic suggestion of the predicate device software, that was already recorded in the patient&#x2019;s EMR, was compared to the diagnostic suggestion of our Product. The 510(k)&#x00a0;regulatory submission for market clearance was filed with the FDA on August&#x00a0;15, 2022.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Market Opportunity</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">ECGs are key diagnostic tests utilized in the diagnosis and monitoring of cardiovascular disease, the number one cause of death worldwide. In the US in 2016, there were approximately 120&#x00a0;million adults living with cardiovascular disease and approximately 20&#x00a0;million adults with diagnosed coronary artery disease. The prevalence of these cardiac conditions and thus the market size is increasing, due to an aging population and lifestyle choices.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Every 40 seconds someone in the US has a heart attack, or MI.&#x00a0;Unfortunately, there is no way for patients to tell whether the symptoms they are experiencing are due to an MI, or some other more benign condition such as indigestion. As a result, patients often ignore symptoms and delay seeking care, which leads to worse outcomes and increased mortality. On the other hand, many patients who go to the ED with chest pain are not experiencing an MI.&#x00a0;Chest pain is the second most common reason for an ED visit in patients over&#x00a0;45, yet fewer than 20% of chest pain ED visits result in a diagnosis of a life<FONT CLASS="nobreak">-threatening</FONT> condition. These unnecessary ED visits lead to well over $10&#x00a0;billion in unnecessary healthcare expenditures.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Most ECGs are conducted in a healthcare facility setting using a 12<FONT CLASS="nobreak">-lead</FONT> ECG machine, the gold standard. ECGs taken outside of healthcare facilities are expected to grow more quickly than in<FONT CLASS="nobreak">-hospital</FONT> ECGs. Monitoring cardiac patients outside of a hospital is a fast<FONT CLASS="nobreak">-growing</FONT> trend, as it is less expensive and provides a better patient experience. However, while ambulatory cardiac monitoring devices are often much easier for patients to use, they have fewer leads than the gold standard and therefore cannot offer as comprehensive a picture of cardiac health.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">While a standard 12<FONT CLASS="nobreak">-lead</FONT> ECG readout is of great medical value, it is simply impractical to have a standard 12<FONT CLASS="nobreak">-lead</FONT> machine next to patients when they experience symptoms outside the clinical setting, since recording the event requires attaching multiple electrodes to the patient&#x2019;s body with professional assistance. While existing technologies use predominantly single lead ECG devices to monitor arrhythmias, these technologies do not provide information to the physician on the presence of life<FONT CLASS="nobreak">-threatening</FONT> conditions of acute coronary syndrome (&#x201c;ACS&#x201d;) or heart attacks.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We believe our telehealth technology addresses these market needs and has several key attributes that make it a good fit for these patients. Our telehealth Product is generally used when symptoms occur and offers the potential for lifelong patient usage. The device is practically always near the patient and ready to be used for recording a cardiac event. It enables very nearly real<FONT CLASS="nobreak">-time</FONT> cardiac data transmission during a telemedicine visit. It offers a recorded 3 vector lead set of signals and a synthesized 12<FONT CLASS="nobreak">-lead</FONT> ECG set of signals. We believe physicians will typically prescribe our solution to chronic cardiovascular patients for long term monitoring, thereby enabling prolonged data collection and delivering a more complete picture for diagnosis. This will also enable the use of artificial intelligence on our future database that will have a unique set of longitudinal synthesized 12<FONT CLASS="nobreak">-lead</FONT> ECGs for patients.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">As our VECG platform demonstrates 12<FONT CLASS="nobreak">-Lead</FONT> equivalence and clinical&#x00a0;&amp; cost<FONT CLASS="nobreak">-effectiveness</FONT> advantages, coupled with a patent protected technology, we believe this might open multiple licensing and/or partnering opportunities with players in the ECG, cardiac monitoring patch and smart watch verticals.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">S-6</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Market Strategy</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our goal is to establish our products as key solutions for cardiology practices and&#x00a0;hospital EDs. Our efforts to enter the market involve establishing clinical evidence and demonstrating the cost<FONT CLASS="nobreak">-effectiveness</FONT> of adopting our products. For both the telehealth (HeartBeam AIMIGo) and the ED Products (HeartBeam AIMI), the initial geographic market is the United&#x00a0;States.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We believe that both the telehealth and ED Products will be subject to the US FDA&#x2019;s 510(k)&#x00a0;review process. A 510(k)&#x00a0;for our HeartBeam AIMI was submitted to the FDA on August&#x00a0;15, 2022, for review and we are in the process of preparing a 510(k)&#x00a0;submission for HeartBeam AIMIGo.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">For HeartBeam AIMIGo, the primary customers are cardiology practices and the cardiology departments of&#x00a0;hospitals. Healthcare insurers are another important customer, as they will potentially benefit from the reduced costs to the healthcare system. We are working to develop new clinical studies and publish results of completed clinical studies and plan to demonstrate real world cost<FONT CLASS="nobreak">-effectiveness</FONT> of the use of the solution.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our initial targets for HeartBeam AIMIGo are market segments that see value in an easy<FONT CLASS="nobreak">-to</FONT><FONT CLASS="nobreak">-use</FONT> device that can generate synthesized 12L ECG recordings. These will be segments in which payment for the device will be outside of the established reimbursement system. These target segments include concierge practices, hospital<FONT CLASS="nobreak">-at</FONT><FONT CLASS="nobreak">-home</FONT> segment and clinical trials. As we establish clinical data on the clinical and cost<FONT CLASS="nobreak">-effectiveness</FONT> of HeartBeam AIMIGo, we will target at<FONT CLASS="nobreak">-risk</FONT> cardiology practices, including high risk patients being discharged from hospitals after experiencing an MI.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our long<FONT CLASS="nobreak">-term</FONT> strategy is to generate sufficient evidence of clinical efficacy and cost<FONT CLASS="nobreak">-effectiveness</FONT> to generate reimbursement coverage and payment specifically for the HeartBeam AIMIGo solution. We expect to be able to demonstrate significant clinical benefits for patients and savings to the healthcare system, justifying appropriate reimbursement levels.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">For the telehealth Product, our primary marketing strategy will focus on the medical community with continued validation of clinical efficacy and cost<FONT CLASS="nobreak">-effectiveness</FONT> and the establishment of reference sites. We will also create educational materials and provide other support to help educate our customers&#x2019; patients.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We will explore other business models. For example, hospitals face CMS penalties if their 30<FONT CLASS="nobreak">-day</FONT> readmission rates for patients who are discharged after an MI exceed certain thresholds. These CMS penalties are levied on all hospital CMS payments, so the impact can be significant. Our telehealth Product can be a tool to help hospitals manage these patients after discharge. We will explore models in which hospitals pay for the device and for the initial 30&#x00a0;days of service. In addition, we will explore models for value<FONT CLASS="nobreak">-based</FONT> care, in which the use of the telehealth Product reduces overall costs.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We are currently speaking with hospitals in large healthcare systems to educate them about our first two products. These are sophisticated customers, and we plan to use technical presentations, peer reviewed clinical data, and demonstration projects to achieve penetration of this market. We plan to continue to expand our medical advisory board, conduct clinical trials with leading cardiologists to increase the body of evidence, and establish reference sites among these customers.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">For the ED Product, the primary customers are acute care facilities. As with the telehealth Product, we plan to publish clinical studies on the effectiveness of the Product. In addition, we plan to develop financial models demonstrating the cost<FONT CLASS="nobreak">-effectiveness</FONT> of the approach and establish reference sites who are using the Product. We do not expect to obtain specific reimbursement for the ED Product but intend to demonstrate that the purchase of the software would result in clinical and economic benefits and potentially reduced malpractice legal exposure for ED provider institutions.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We expect our value proposition will be progressively increased as we gradually add additional functionality to our monitoring solutions and drive down the cost of continuous monitoring by increasing scale and automation. We expect our HeartBeam AIMIGo device and AIMI software to gradually incorporate internally developed algorithms with the capabilities of detecting heart conditions that can be exposed via a standard 12<FONT CLASS="nobreak">-L</FONT> ECG device. Additionally, as we collect rich longitudinal data sets from our patients, we expect to train AI and ML algorithms that could potentially have predictive capabilities regarding different heart conditions. Over time and with scale we expect our costs to decrease and provide more and better services to our patients by improving our capabilities.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We plan to establish a direct sales network with relationships and experience selling to our target markets.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">S-7</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Clinical Data</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">HeartBeam has performed three initial clinical studies to assess performance of our technologies.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">In the first study (HeartBeam Ischemia Detection Study&#x00a0;&#x2014;&#x00a0;HIDES), we simultaneously collected traditional 12<FONT CLASS="nobreak">-lead</FONT> ECG and vector&#x00a0;X,Y and Z signals on patients whose coronary arteries were occluded during a Percutaneous Coronary Intervention (PCI). Our VECG<FONT CLASS="nobreak">-based</FONT> signal interpretation system had significantly (21%) higher accuracy in detecting ischemia.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">In a second study (B Score), the HeartBeam diagnostic engine, using ECG, symptoms, and history, matched the diagnostic performance of expert cardiologists in detecting the presence of MIs in patients presenting to an ED with chest pain. This result indicates that the quality of the diagnostic advice produced by our expert system will be extremely valuable to the physician who is assessing the condition of a patient in a telehealth environment.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The third study, ISPEC, which assessed the false positive rate for non<FONT CLASS="nobreak">-symptomatic</FONT> patients, is relevant in a telehealth situation. It is important that the system have a low false positive rate when patients are conducting baseline recordings, which are required on at least a monthly basis. The study yielded no false positives.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">All three studies are being prepared for peer<FONT CLASS="nobreak">-reviewed</FONT> publication.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Intellectual Property</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We believe our intellectual property (&#x201c;IP&#x201d;) protects our innovations, and our goal is to become a leader in the ambulatory VECG sector. For some aspects of our proprietary technology, we rely on trade secret protection. It is our view that the combination of these two methods of IP protection maximizes our chances for success.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">HeartBeam has nine issued U.S.&#x00a0;patents (U.S.&#x00a0;10,433,744, U.S.&#x00a0;10,117,592, U.S.&#x00a0;11,071,490, U.S.&#x00a0;11,419,538, U.S.&#x00a0;11,445,963, U.S.&#x00a0;11,529,085, U.S.&#x00a0;10,980,433, U.S.&#x00a0;11,412,972 and U.S.&#x00a0;11,234,658), and six pending U.S applications. Four of the pending applications have been published, the remaining two pending cases are unpublished. Outside of the U.S., HeartBeam has four issued patents in Germany, France, Netherlands, and United Kingdom and seven pending applications in Canada, China, the European Union (&#x201c;EU&#x201d;), Japan and Australia. HeartBeam has three pending PCT applications. The issued patents are predicted to expire between April&#x00a0;11, 2036 and April&#x00a0;21, 2042.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our issued and pending U.S.&#x00a0;patent applications cover compact VECG systems for remote detection and/or diagnosis of acute myocardial infarction (&#x201c;AMI&#x201d;). Outside of the U.S., the pending EU, Australian (&#x201c;AU&#x201d;), Japanese (&#x201c;JP&#x201d;) and Chinese (&#x201c;CN&#x201d;) patent applications correspond to the pending and issued US cases. The pending PCT applications cover methods and apparatuses for automatic cardiac diagnosis as well as compact systems including retractable electrodes.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Research and Development</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The primary objective of our research and development program is to provide innovative, user<FONT CLASS="nobreak">-friendly</FONT>, ambulatory VECG solutions with high medical value. To date, we have been highly successful in developing our initial products. The emphasis has been on developing a user<FONT CLASS="nobreak">-friendly</FONT> solution that is always with the patient and assists physicians in diagnosing heart attacks in chest pain patients.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our Research team is largely based in Belgrade, Serbia as well as in California, USA.&#x00a0;We have assembled a highly capable Belgrade team currently consisting of seven PhD level contributors who are credited with developing our key inventions and patents. The diverse group includes:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>Two nuclear physicists.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>Two Biomedical Engineers experienced in developed digital health applications.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>Two highly experienced Healthcare IT development professionals.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>Two Electrical Engineers (M.S.E.E) with strong signal processing and ECG analysis algorithm expertise from the medical device industry.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">S-8</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>An Electrical Engineer (M.S.E.E) with exceptional implantable medical device development and&#x00a0;power optimization expertise.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>A Software Engineer, (PhD Computer Science), with deep expertise in developing mobile applications for medical devices.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Future research and development efforts will focus on the application of signal processing and artificial intelligence to address a range of cardiac conditions.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">During 2022 we also added 3 development engineers led by our recently hired Chief Technology Officer Kenneth Persen. This is an experienced development team that worked together previously and was successful in delivering FDA cleared products.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Future Products</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our core technology&#x00a0;&#x2014;&#x00a0;the heart vector approach adopted and invented by our research team&#x00a0;&#x2014;&#x00a0;is a platform technology that can provide diagnostic solutions to a variety of cardiovascular patients. Our plans call for expanding solutions that diagnose all major cardiac conditions that are diagnosed by ECGs.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our future plans include the development of a VECG<FONT CLASS="nobreak">-based</FONT>, synthesized 12<FONT CLASS="nobreak">-lead</FONT> capable patch ECG monitor that will provide advantages over existing single<FONT CLASS="nobreak">-lead</FONT> ECG patch products such as the Zio<FONT CLASS="nobreak">-XT</FONT> from iRhythm Technologies, Inc. Our approach will offer a synthesized 12<FONT CLASS="nobreak">-lead</FONT> ECG with a patch that is very similar, in dimensions and look and feel, to the currently available single lead ECG patches. We believe providing standard of care 12<FONT CLASS="nobreak">-lead</FONT> ECG capabilities will have significant diagnostic advantages over a single lead patch.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We also plan to integrate a synthesized 12<FONT CLASS="nobreak">-lead</FONT> ECG smartwatch<FONT CLASS="nobreak">-based</FONT> monitor intended for detection of heart attacks and complex cardiac arrhythmias. This invention eliminates the need for a dedicated ECG device while offering a synthesized 12<FONT CLASS="nobreak">-lead</FONT> ECG capability enabling heart attack and complex arrhythmia detection.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">While our initial telehealth Product is powered by a software expert system that serves as a diagnostic aid to a physician, we will develop an AI based diagnostic system that will supplement our diagnostic expert system.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We are committed to continue advancing the full potential inherent in our synthesized 12<FONT CLASS="nobreak">-lead</FONT> 3D VECG technology as demonstrated in recently issued and allowed patents with potentially disruptive market impacts.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Corporate Information</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">HeartBeam was incorporated as a C corporation under the laws of the State of Delaware on June&#x00a0;11, 2015. We do not own any subsidiaries. Our corporate offices are located at 2118 Walsh Avenue, Suite 210, Santa Clara, CA&#x00a0;95050. Our telephone number is (408)&#x00a0;899<FONT CLASS="nobreak">-4443</FONT>. The address of our website is <FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">https:</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">//</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">www.heartbeam</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">/</FONT>. The inclusion of our website address in this prospectus does not include or incorporate by reference the information on our website into this prospectus.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">S-9</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">OFFERING SUMMARY</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">This summary highlights certain information about this offering and selected information contained elsewhere in or incorporated by reference into this prospectus supplement. This summary is not complete and does not contain all of the information that you should consider before deciding whether to invest in securities. For a more complete understanding of our company and this offering, we encourage you to read and consider carefully the more detailed information in this prospectus supplement and the accompanying base prospectus, including the information incorporated by reference into this prospectus supplement and the accompanying base prospectus, and the information referred to under the heading &#x201c;RISK FACTORS&#x201d; in this prospectus supplement on page&#x00a0;S</FONT><FONT CLASS="nobreak"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">-11</FONT></FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;"> and on page&#x00a0;9 of the accompanying base prospectus, and in the documents incorporated by reference into this prospectus supplement and the accompanying base prospectus.</FONT></P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 3pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 41.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">

						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Issuer</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 57.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">HeartBeam, Inc.</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 41.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Common stock offered by us</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 57.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:8pt;">1,000,000<FONT CLASS="nobreak"> </FONT>shares</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 41.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Common stock outstanding prior to the offering</FONT><FONT CLASS="Superscript" STYLE="vertical-align:super;font-size:58%;">(1)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 57.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:8pt;"><BR>24,676,409<FONT CLASS="nobreak"> </FONT>shares</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 41.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Common stock to be outstanding after this offering</FONT><FONT CLASS="Superscript" STYLE="vertical-align:super;font-size:58%;">(1)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 57.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:8pt;"><BR>25,676,409<FONT CLASS="nobreak"> </FONT>shares</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 41.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Common Stock Trading symbol</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 57.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:8pt;">Our Common Stock is traded on Nasdaq Capital Market under the symbol &#x201c;BEAT&#x201d;.</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 41.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Use of proceeds</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 57.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:8pt;">We intend to use the net proceeds from the offering for working capital and general corporate purposes. See &#x201c;Use of Proceeds.&#x201d;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 41.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Risk factors</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 57.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:8pt;">This investment involves a high degree of risk. See &#x201c;Risk Factors&#x201d; and other information included or incorporated by reference in this prospectus supplement beginning on page&#x00a0;S<FONT CLASS="nobreak">-11</FONT> and the accompanying base prospectus beginning on page&#x00a0;9 for a discussion of certain factors you should carefully consider before deciding to invest in shares of our common stock.</P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="Tablefootnotef" STYLE="margin-top: 0in;  border: none; margin-right: 0in; margin-bottom: -5pt; margin-left: 24.0pt; text-align: justify; text-justify: inter-ideograph; text-indent: -24.0pt; padding: 0in; font-size: 9.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">____________</P><P CLASS="Tablefootnote_f" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:10pt;">(1)<FONT STYLE="width: 18px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The number of shares of Common Stock outstanding is based on shares of Common Stock issued and outstanding as of December&#x00a0;31, 2022 plus the 16,666,666 shares of Common Stock issued on May&#x00a0;2, 2023 and excludes the following:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT><FONT CLASS="CharOverride-1" STYLE="font-size:9pt;">2,196,798&#x00a0;shares of Common Stock issuable upon the exercise of outstanding stock options having a weighted average exercise price of $1.76 per share;</FONT></P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT><FONT CLASS="CharOverride-1" STYLE="font-size:9pt;">253,970&#x00a0;shares of Common Stock issuable upon vesting of RSUs;</FONT></P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT><FONT CLASS="CharOverride-1" STYLE="font-size:9pt;">3,908,276&#x00a0;shares of Common Stock issuable upon the exercise of outstanding warrants having a weighted average exercise price of $5.42 per share;</FONT></P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT><FONT CLASS="CharOverride-1" STYLE="font-size:9pt;">747,364&#x00a0;shares of Common Stock reserved for future issuance under the Company&#x2019;s 2022 Equity Incentive Plan.</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-left:24pt;margin-top:8pt;"><FONT CLASS="CharOverride-1" STYLE="font-size:9pt;">Except as otherwise indicated herein, all information in this prospectus reflects or assumes:</FONT></P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT><FONT CLASS="CharOverride-1" STYLE="font-size:9pt;">no exercise of the outstanding options described above;</FONT></P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">S-10</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9903"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">RISK FACTORS</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Investment in any securities offered pursuant to this prospectus and the applicable prospectus supplement involves risks. You should carefully consider the risk factors incorporated by reference to our most recent Annual Report on Form&#x00a0;10<FONT CLASS="nobreak">-K</FONT> and any subsequent Quarterly Reports on Form&#x00a0;10<FONT CLASS="nobreak">-Q</FONT> or Current Reports on Form&#x00a0;8<FONT CLASS="nobreak">-K</FONT> we file after the date of this prospectus, and all other information contained or incorporated by reference into this prospectus, as updated by our subsequent filings under the Securities Exchange&#x00a0;Act&#x00a0;of&#x00a0;1934, as amended (the &#x201c;Exchange&#x00a0;Act&#x201d;), and the risk factors and other information contained in the applicable prospectus supplement before acquiring any of such securities. The occurrence of any of these risks might cause you to lose all or part of your investment in the offered securities.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Risks Relating to this Offering</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We may allocate the net proceeds from this offering in ways that you or other stockholders may not approve.</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We currently intend to use the net proceeds of this offering, if any, for working capital and general corporate purposes, which may include capital expenditures, research and development expenditures, regulatory affairs expenditures, clinical trial expenditures, acquisitions of new technologies and investments, and the financing of possible acquisitions or business expansions. This expected use of the net proceeds from this offering represents our intentions based upon our current plans and business conditions. The amounts and timing of our actual expenditures may vary significantly depending on numerous factors, including the progress of our development efforts, the status of and results from clinical trials, as well as any third<FONT CLASS="nobreak">-party</FONT> intellectual property or other assets that we may opportunistically identify and seek to license or acquire or any collaborations that we may enter into with third parties for our product candidates, and any unforeseen cash needs. Because the number and variability of factors that will determine our use of the proceeds from this offering, their ultimate use may vary substantially from their currently intended use. As a result, our management will retain broad discretion over the allocation of the net proceeds from this offering and could spend the proceeds in ways that do not necessarily improve our operating results or enhance the value of our common stock. See &#x201c;Use of Proceeds.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Sales of our common stock in this offering, or the perception that such sales may occur, could cause a drop in the market price of our common stock.</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We may issue and sell shares of our common stock for aggregate gross proceeds of up to $13&#x00a0;million from time to time in connection with this offering. The issuance and sale from time to time of these new shares of common stock, or our ability to issue these new shares of common stock in this offering could have the effect of depressing the market price of our common stock.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We may sell additional shares of our common stock to fund our operations, which sales may occur during or immediately after sales pursuant to this offering are commenced, which would result in dilution to our shareholders.</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">In order to raise additional funds to support our operations, we may sell additional shares of our common stock, which would result in dilution to all of our shareholders that may adversely impact our business. See &#x201c;Dilution.&#x201d; In particular, at any time, including during the pendency of this offering, we may sell additional shares of our common stock, other than pursuant to this offering, in amounts that may be material to us, which may be in amounts that are equal to or greater than the size of this offering, including, without limitation, through underwritten public offerings, privately negotiated transactions, block trades, or any combination of the above, subject, in certain circumstances, to the consent of the Agent. We cannot assure you that we will be able to sell shares or other securities in any other offering at a price per share that is equal to or greater than the price per share paid by investors in this offering, and investors purchasing shares or other securities in the future could have rights superior to existing shareholders. The price per share at which we sell additional shares of our common stock or other securities convertible into or exchangeable for our common stock in future transactions may be higher or lower than the price per share in this offering.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">S-11</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9904"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">SPECIAL NOTICE REGARDING </FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">FORWARD-LOOKING</FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"> STATEMENTS</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">This prospectus contains forward<FONT CLASS="nobreak">-looking</FONT> statements that involve risks and uncertainties, principally in the sections entitled &#x201c;Risk Factors.&#x201d; All statements other than statements of historical fact contained in this prospectus, including statements regarding future events, our future financial performance, business strategy and plans and objectives of management for future operations, are forward<FONT CLASS="nobreak">-looking</FONT> statements. We have attempted to identify forward<FONT CLASS="nobreak">-looking</FONT> statements by terminology including &#x201c;anticipates,&#x201d; &#x201c;believes,&#x201d; &#x201c;can,&#x201d; &#x201c;continue,&#x201d; &#x201c;could,&#x201d; &#x201c;estimates,&#x201d; &#x201c;expects,&#x201d; &#x201c;intends,&#x201d; &#x201c;may,&#x201d; &#x201c;plans,&#x201d; &#x201c;potential,&#x201d; &#x201c;predicts,&#x201d; &#x201c;should,&#x201d; or &#x201c;will&#x201d; or the negative of these terms or other comparable terminology. Although we do not make forward looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks outlined under &#x201c;Risk Factors&#x201d; or elsewhere in this prospectus, which may cause our or our industry&#x2019;s actual results, levels of activity, performance or achievements expressed or implied by these forward<FONT CLASS="nobreak">-looking</FONT> statements.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Forward<FONT CLASS="nobreak">-looking</FONT> statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by which, that performance or those results will be achieved. Forward<FONT CLASS="nobreak">-looking</FONT> statements are based on information available at the time they are made and/or management&#x2019;s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from what is expressed in or suggested by the forward<FONT CLASS="nobreak">-looking</FONT> statements.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Forward<FONT CLASS="nobreak">-looking</FONT> statements speak only as of the date they are made. You should not put undue reliance on any forward<FONT CLASS="nobreak">-looking</FONT> statements. We assume no obligation to update forward<FONT CLASS="nobreak">-looking</FONT> statements to reflect actual results, changes in assumptions or changes in other factors affecting forward<FONT CLASS="nobreak">-looking</FONT> information, except to the extent required by applicable securities laws. If we do update one or more forward<FONT CLASS="nobreak">-looking</FONT> statements, no inference should be drawn that we will make additional updates with respect to those or other forward<FONT CLASS="nobreak">-looking</FONT> statements.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">S-12</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9905"></A><FONT CLASS="Bold-AllCaps" STYLE="font-style:normal;font-variant:normal;font-weight:bold;text-transform:uppercase;">USE OF PROCEEDS</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We currently intend to use the net proceeds from this offering, if any, for working capital and general corporate purposes.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The timing and amount of our actual expenditures will be based on many factors, including cash flows from operations and the anticipated growth of our business. As of the date of this prospectus, we cannot specify with certainty all of the particular uses for the net proceeds to us from this offering. As a result, our management will have broad discretion regarding the timing and application of the net proceeds from this offering. Pending their ultimate use, we intend to invest the net proceeds in short<FONT CLASS="nobreak">-term</FONT>, investment<FONT CLASS="nobreak">-grade</FONT>, interest<FONT CLASS="nobreak">-bearing</FONT> instruments.</P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9906"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">MARKET PRICE OF OUR COMMON STOCK</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our common stock is presently listed on The NASDAQ Global Market under the symbol &#x201c;BEAT&#x201d;. On May&#x00a0;3 2023, the last reported sale price of our common stock was $2.31.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Holders</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">As of May&#x00a0;3, 2023 we had 50 registered holders of record of our common stock. A substantially greater number of holders of our common stock are &#x201c;street name&#x201d; or beneficial holders, whose shares of record are held through banks, brokers, other financial institutions and registered clearing agencies.</P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9907"></A><FONT CLASS="Bold-AllCaps" STYLE="font-style:normal;font-variant:normal;font-weight:bold;text-transform:uppercase;">DIVIDEND POLICY</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We have never declared or paid cash dividends on our capital stock. We currently intend to retain our future earnings, if any, for use in our business and therefore do not anticipate paying cash dividends in the foreseeable future. Payment of future dividends, if any, will be at the discretion of our board of directors after taking into account various factors, including our financial condition, operating results, current and anticipated cash needs and plans for expansion.</P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9908"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">DESCRIPTION OF SECURITIES WE ARE OFFERING</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">In this offering, we are offering a 1,000,000 maximum of shares of our Common at public offering price of $1.50 per share.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The material terms and provisions of our Common Stock are described under the caption &#x201c;Description of Capital Stock&#x201d; starting on page 12 of the accompanying base prospectus.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Transfer Agent</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The transfer agent and registrar for our common stock is VStock Transfer, LLC with an address at 18 Lafayette Pl, Woodmere, NY&#x00a0;11598.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">S-13</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9909"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">LEGAL MATTERS</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The validity of the shares of common stock offered hereby will be passed upon for us by Lucosky Brookman LLP.</P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9910"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">EXPERTS</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The financial statements as of and for the year ended December&#x00a0;31, 2022 incorporated by reference in this registration statement have been audited by Marcum LLP, an independent registered public accounting firm, as stated in their report (the report on the financial statements contains an explanatory paragraph regarding the Company&#x2019;s ability to continue as a going concern). Such financial statements are incorporated by reference in reliance upon the report of such firm given upon their authority as experts in accounting and auditing.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The financial statements as of and for the year ended December&#x00a0;31, 2021 incorporated by reference in this registration statement have been audited by Friedman LLP, an independent registered public accounting firm, as stated in their report. Such financial statements are incorporated by reference in reliance upon the report of such firm given upon their authority as experts in accounting and auditing.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">S-14</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9911"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">INCORPORATION BY REFERENCE</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The SEC&#x2019;s rules allow us to &#x201c;incorporate by reference&#x201d; information into this prospectus, which means that we can disclose important information to you by referring you to another document filed separately with the SEC.&#x00a0;The information incorporated by reference is deemed to be part of this prospectus, and subsequent information that we file with the SEC will automatically update and supersede that information. Any statement contained in a previously filed document incorporated by reference will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus modifies or replaces that statement.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We incorporate by reference our documents listed below and any future filings made by us with the SEC under Sections 13(a), 13(c), 14 or 15(d)&#x00a0;of the Securities Exchange&#x00a0;Act&#x00a0;of&#x00a0;1934, as amended, which we refer to as the &#x201c;Exchange&#x00a0;Act&#x201d; in this prospectus, between the date of this prospectus and the termination of the offering of the securities described in this prospectus. We are not, however, incorporating by reference any documents or portions thereof, whether specifically listed below or filed in the future, that are not deemed &#x201c;filed&#x201d; with the SEC, including any information furnished pursuant to Items 2.02 or 7.01 of Form&#x00a0;8<FONT CLASS="nobreak">-K</FONT> or related exhibits furnished pursuant to Item&#x00a0;9.01 of Form&#x00a0;8<FONT CLASS="nobreak">-K</FONT>.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">This prospectus supplement incorporates by reference the documents listed below, other than those documents or the portions of those documents deemed to be furnished and not filed in accordance with SEC rules:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>our Annual Report on&#x00a0;<A HREF="http://www.sec.gov/Archives/edgar/data/1779372/000177937223000006/beat-20221231.htm">Form&#x00a0;10<FONT CLASS="nobreak">-K</FONT></A>&#x00a0;for the fiscal year ended December<FONT CLASS="nobreak">&#x00a0;</FONT>31, 2022, filed with the SEC on&#x00a0;March<FONT CLASS="nobreak">&#x00a0;</FONT>16, 2023;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>our Current Reports on Form&#x00a0;8<FONT CLASS="nobreak">-K</FONT>&#x00a0;filed with the SEC on&#x00a0;<A HREF="http://www.sec.gov/Archives/edgar/data/1779372/000177937223000001/beat-20230118.htm">January<FONT CLASS="nobreak">&#x00a0;</FONT>24, 2023</A>,&#x00a0;<A HREF="http://www.sec.gov/Archives/edgar/data/1779372/000121390023006955/ea172546-8k_heartbeam.htm">February<FONT CLASS="nobreak">&#x00a0;</FONT>2, 2023</A>,&#x00a0;<A HREF="http://www.sec.gov/Archives/edgar/data/1779372/000177937223000004/beat-20230228.htm">March<FONT CLASS="nobreak">&#x00a0;</FONT>3, 2023</A>,&#x00a0;<A HREF="http://www.sec.gov/Archives/edgar/data/1779372/000177937223000005/beat-20230308.htm">March<FONT CLASS="nobreak">&#x00a0;</FONT>8, 2023</A>,&#x00a0;<A HREF="http://www.sec.gov/Archives/edgar/data/1779372/000121390023018655/ea174893-8k_heartbeam.htm">March<FONT CLASS="nobreak">&#x00a0;</FONT>9, 2023</A>,&#x00a0;<A HREF="http://www.sec.gov/Archives/edgar/data/1779372/000121390023019312/ea174926-8k_heartbeam.htm">March<FONT CLASS="nobreak">&#x00a0;</FONT>13, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1779372/000177937223000007/beat-20230320.htm">March<FONT CLASS="nobreak">&#x00a0;</FONT>24, 2023</A>, and <A HREF="http://www.sec.gov/Archives/edgar/data/1779372/000177937223000009/beat-20230502.htm">May<FONT CLASS="nobreak">&#x00a0;</FONT>3, 2023</A>; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>our 2022 equity incentive plan on <A HREF="http://www.sec.gov/Archives/edgar/data/1779372/000177937222000027/forms-8x07122022.htm">Form&#x00a0;S<FONT CLASS="nobreak">-8</FONT></A>&#x00a0;filed with the SEC&#x00a0;July<FONT CLASS="nobreak">&#x00a0;</FONT>13, 2022;</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">All reports and other documents we subsequently file pursuant to Section&#x00a0;13(a), 13(c), 14 or 15(d)&#x00a0;of the Exchange&#x00a0;Act prior to the termination of this offering, including all such documents we may file with the SEC after the date of the initial registration statement and prior to the effectiveness of the registration statement, but excluding any information furnished to, rather than filed with, the SEC, will also be incorporated by reference into this prospectus and deemed to be part of this prospectus from the date of the filing of such reports and documents.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">You may request a free copy of any of the documents incorporated by reference in this prospectus (other than exhibits, unless they are specifically incorporated by reference in the documents) by writing or telephoning us at the following address:</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Branislav Vajdic<BR>Chief Executive Officer<BR>2118 Walsh Avenue, Suite 210<BR>Santa Clara, CA&#x00a0;95050<BR>Telephone:&#x00a0;408-899-4443</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Exhibits to the filings will not be sent, however, unless those exhibits have specifically been incorporated by reference in this prospectus and any accompanying prospectus supplement.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">S-15</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;text-align:left;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">PROSPECTUS</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;font-size:18pt;">HeartBeam, Inc.</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;font-size:14pt;">$100,000,000</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;font-size:14pt;">Common Stock</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:0pt;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;font-size:14pt;">Preferred Stock</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:0pt;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;font-size:14pt;">Debt Securities</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:0pt;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;font-size:14pt;">Warrants</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:0pt;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;font-size:14pt;">Rights</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:0pt;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;font-size:14pt;">Units</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We may offer and sell up to $100,000,000 in the aggregate of the securities identified above from time to time in one or more offerings. This prospectus provides you with a general description of the securities.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Each time we offer and sell securities, we will provide a supplement to this prospectus that contains specific information about the offering and the amounts, prices and terms of the securities. The supplement may also add, update or change information contained in this prospectus with respect to that offering. You should carefully read this prospectus and the applicable prospectus supplement before you invest in any of our securities.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We may offer and sell the securities described in this prospectus and any prospectus supplement to or through one or more underwriters, dealers and agents, or directly to purchasers, or through a combination of these methods. If any underwriters, dealers or agents are involved in the sale of any of the securities, their names and any applicable purchase price, fee, commission or discount arrangement between or among them will be set forth, or will be calculable from the information set forth, in the applicable prospectus supplement. See the sections of this prospectus entitled &#x201c;About this Prospectus&#x201d; and &#x201c;Plan of Distribution&#x201d; for more information. No securities may be sold without delivery of this prospectus and the applicable prospectus supplement describing the method and terms of the offering of such securities.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">INVESTING IN OUR SECURITIES INVOLVES RISKS.&#x00a0;SEE THE &#x201c;</FONT><FONT CLASS="CharOverride-3" STYLE="font-style:normal;font-weight:bold;text-decoration:underline;">RISK FACTORS</FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">&#x201d; ON PAGE 9 OF THIS PROSPECTUS AND ANY SIMILAR SECTION CONTAINED IN THE APPLICABLE PROSPECTUS SUPPLEMENT CONCERNING FACTORS YOU SHOULD CONSIDER BEFORE INVESTING IN OUR SECURITIES.</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our common stock and warrants are listed on The NASDAQ Capital Market under the symbol &#x201c;BEAT&#x201d; and &#x201c;BEATW&#x201d;, respectively. On March&#x00a0;7, 2023, the last reported sale price of our common stock on The NASDAQ Capital Market was $3.39 per share.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:8pt;text-align:center;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">The date of this prospectus is February&#x00a0;10, 2023.</FONT></P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">&#x00a0;</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">TABLE OF CONTENTS</FONT></P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;">Page</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9912">ABOUT THIS PROSPECTUS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">ii</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9913">THE COMPANY</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">1</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9914">RISK FACTORS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">9</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9915">SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">10</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9916">USE OF PROCEEDS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">11</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9917">DESCRIPTION OF CAPITAL STOCK</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">12</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9918">DESCRIPTION OF DEBT SECURITIES</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">16</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9919">DESCRIPTION OF WARRANTS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">22</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9920">DESCRIPTION OF RIGHTS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">24</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9921">DESCRIPTION OF UNITS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">25</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9922">PLAN OF DISTRIBUTION</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">26</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9923">LEGAL MATTERS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">28</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9924">EXPERTS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">28</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9925">WHERE YOU CAN FIND MORE INFORMATION</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">28</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TOC_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9926">INCORPORATION BY REFERENCE</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">29</P>
					</TD>
				</TR>

		</TABLE>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">i</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9912"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">ABOUT THIS PROSPECTUS</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">This prospectus is part of a registration statement that we filed with the U.S.&#x00a0;Securities and Exchange Commission (the &#x201c;SEC&#x201d;), using a &#x201c;shelf&#x201d; registration process. By using a shelf registration statement, we may sell securities from time to time and in one or more offerings up to a total dollar amount of $100,000,000 as described in this prospectus. Each time that we offer and sell securities, we will provide a prospectus supplement to this prospectus that contains specific information about the securities being offered and sold and the specific terms of that offering. The prospectus supplement may also add, update or change information contained in this prospectus with respect to that offering. If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement, you should rely on the prospectus supplement. Before purchasing any securities, you should carefully read both this prospectus and the applicable prospectus supplement, together with the additional information described under the headings &#x201c;Where You Can Find More Information&#x201d; and &#x201c;Incorporation by Reference.&#x201d;</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We have not authorized any other person to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. We will not make an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus and the applicable prospectus supplement to this prospectus is accurate as of the date on its respective cover, and that any information incorporated by reference is accurate only as of the date of the document incorporated by reference, unless we indicate otherwise. Our business, financial condition, results of operations and prospects may have changed since those dates.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">When we refer to &#x201c;BEAT,&#x201d; &#x201c;we,&#x201d; &#x201c;our,&#x201d; &#x201c;us&#x201d; and the &#x201c;Company&#x201d; in this prospectus, we mean HeartBeam, Inc., unless otherwise specified. When we refer to &#x201c;you,&#x201d; we mean the holders of the applicable series of securities.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">ii</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>





	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9913"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">THE COMPANY</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Corporate History and Information</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">HeartBeam was incorporated as a C corporation under the laws of the State of Delaware on June&#x00a0;11, 2015. We do not own any subsidiaries.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Company Overview</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We are a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (&#x201c;ECG&#x201d;) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. Our ability to develop higher resolution ECG solutions is achieved through the development of our proprietary and patented Vector Electrocardiography (&#x201c;VECG&#x201d;) technology platform. Our vector electrocardiography technology is capable of developing three<FONT CLASS="nobreak">-dimensional</FONT> (3D) images of cardiac electrical activity by displaying the spatial locations of ECG waveforms that has demonstrated in early studies to deliver equal or superior diagnostic capability than traditional hospital based ECG systems.</P>
		<P CLASS="ParaOverride-1" STYLE="margin:0;padding:0;border-width:0;margin-top:10pt;text-align:center;margin-top:10pt;"><IMG ALT="" SRC="timage_001.jpg" STYLE="width:217.6px;max-width:100%;"></P>
		<P CLASS="Text_flush_Center" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:8pt;">3D projections of cardiac vectors</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our aim is to deliver innovative, remote patient monitoring (&#x201c;RPM&#x201d;) technologies that can be used for patients anywhere where critical cardiac care decisions can be made on a more timely basis. Our products require Food and Drug Administration (&#x201c;FDA&#x201d;) clearance and have not been cleared for marketing (hereinafter &#x201c;Product&#x201d; or &#x201c;Products&#x201d;.)</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We believe our Products and services will benefit many stakeholders, including patients, healthcare providers, and healthcare payors. We are developing Generation 1 of our telehealth product (&#x201c;HeartBeam AIMIGo<FONT CLASS="Superscript" STYLE="vertical-align:super;font-size:58%;">TM</FONT>&#x201d;) to address the rapidly growing field of RPM.&#x00a0;HeartBeam AIMIGo is comprised of a credit card sized electrocardiogram device and a powerful cloud<FONT CLASS="nobreak">-based</FONT> diagnostic expert software system. We believe that we are uniquely positioned to play a central role in remote monitoring of high<FONT CLASS="nobreak">-risk</FONT> coronary artery disease patients, because the initial studies have shown that our ischemia detection system may be more accurate than existing RPM solutions.</P>
		<P CLASS="ParaOverride-1" STYLE="margin:0;padding:0;border-width:0;margin-top:10pt;text-align:center;margin-top:10pt;"><IMG ALT="" SRC="timage_002.jpg" STYLE="width:316.16px;max-width:100%;"></P>
		<P CLASS="Text_flush_Center" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:8pt;">Photographs of version 1 HeartBeam AIMIGo devices in planer and ready to use position.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">1</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We are also applying our software platform to create a tool for detecting heart attacks in the emergency room environment using traditional ECG devices. The software tool, (&#x201c;HeartBeam AIMI<FONT CLASS="Superscript" STYLE="vertical-align:super;font-size:58%;">(TM)</FONT>&#x201d;) is designed to enable emergency physicians to more accurately and quickly diagnose heart attacks than currently available. Market release of this Product will precede that of HeartBeam AIMIGo.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">To date, we have developed working prototypes for both HeartBeam AIMIGo and HeartBeam AIMI.&#x00a0;HeartBeam AIMI has been submitted for FDA 510(k)&#x00a0;clearance and we have received questions from the FDA within the statutory 30<FONT CLASS="nobreak">-day</FONT> review deadline, discussed the questions via teleconference with the FDA review team and provided written responses addressing the questions to the primary reviewer. We believe we are on track for FDA clearance this quarter.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The custom software and hardware of our Products, we believe, are classified as Class&#x00a0;II medical devices by the FDA, running on an FDA approved Class&#x00a0;I registered platform. Class&#x00a0;II medical devices are those for which general controls alone are insufficient to provide reasonable assurance of safety and effectiveness and there is sufficient information to establish special controls. Special controls can include performance standards, post<FONT CLASS="nobreak">-market</FONT> surveillance, patient histories and FDA guidance documents. Premarket review and clearance by the FDA for these devices is generally accomplished through the 510(k)&#x00a0;or 510(k)&#x00a0;de<FONT CLASS="nobreak">-novo</FONT> premarket notification process.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Recent Developments not Incorporated by Reference</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">In September&#x00a0;2022, we were granted two patents;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>We were granted a 12<FONT CLASS="nobreak">-lead</FONT> ECG patch monitor intended for detection of acute coronary syndrome (&#x201c;ACS&#x201d;) and cardiac arrhythmia by the United&#x00a0;States Patent and Trademark Office. The innovation builds on our growing intellectual property portfolio enabling synthesized 12<FONT CLASS="nobreak">-lead</FONT> ECG diagnostics outside of a medical setting.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>We were also granted a patent that enables generation of a synthesized 12<FONT CLASS="nobreak">-lead</FONT> ECG by the HeartBeam AIMIGo credit card<FONT CLASS="nobreak">-sized</FONT> device by the United&#x00a0;States Patent and Trademark Office. The innovation opens the pathway for a patient to record a set of signals using HeartBeam AIMIGo outside of a medical setting with a diagnostic synthesized 12<FONT CLASS="nobreak">-lead</FONT> ECG immediately transmitted to a physician for review and diagnosis. Unlike single<FONT CLASS="nobreak">-lead</FONT> ECG products currently in the marketplace, such as other credit card sized devices or smartwatches, our technology is intended to quickly and accurately help a physician identify a heart attack (&#x201c;Myocardial Infarction&#x201d; or &#x201c;MI&#x201d;).</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">In October&#x00a0;2022, we announced the expansion of our product pipeline with smartwatch connectivity enablement for 24/7 heart monitoring capability. The product pipeline advancement allows for the addition of arrhythmia detection capabilities to address the multibillion<FONT CLASS="nobreak">-dollar</FONT> global market for atrial fibrillation and other arrhythmia monitoring. This capability builds on our recently issued patents. This broader product portfolio enables the following:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>Introducing a 3<FONT CLASS="nobreak">-lead</FONT> 3D vector electrocardiogram credit card<FONT CLASS="nobreak">-sized</FONT> device, the HeartBeam AIMIGo&#x00a0;3L, that records the&#x00a0;X,Y,Z cardiac activity and displays the signals for clinician review, providing the regulatory foundation for subsequent products in our product portfolio. The 510(K)&#x00a0;submission to the FDA is planned for Q4 2022.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>Leveraging recently issued patents to incorporate both synthesized baseline and symptomatic 12<FONT CLASS="nobreak">-lead</FONT> signals for enhanced diagnostic accuracy as well as the addition of atrial fibrillation detection capability in the HeartBeam AIMIGo 12L device for FDA 510(K)&#x00a0;submission in Q2 2023.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>Broadening of the product portfolio profile to enable smartwatch connectivity to our platform in future products as an optional monitoring solution for the clinician and the patient.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">In October&#x00a0;2022, we announced the appointment of Peter J.&#x00a0;Fitzgerald, MD, Ph. D, as Chief Medical Officer. Dr.&#x00a0;Fitzgerald is the Director of the Center for Cardiovascular Technology and Director of the Cardiovascular Core Analysis Laboratory at Stanford University Medical School. In addition to his world<FONT CLASS="nobreak">-renowned</FONT> expertise in interventional cardiology, Dr.&#x00a0;Fitzgerald is an accomplished inventor, entrepreneur, and investment fund founder.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">In November&#x00a0;2022, we announced that our patent for a 12<FONT CLASS="nobreak">-lead</FONT> ECG smartwatch<FONT CLASS="nobreak">-based</FONT> monitor intended for detection of heart attacks and complex cardiac arrhythmias was allowed by the United&#x00a0;States Patent and Trademark Office. The innovation builds on our growing intellectual property portfolio enabling 12<FONT CLASS="nobreak">-lead</FONT> ECG diagnostics outside of a medical setting.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">2</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Market Overview</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Chronic diseases are the number one burden on the healthcare system, driving up costs each year, and cardiovascular illnesses are one of the top contributors. Regulators, payors and providers are focused on shifting the diagnosis and management of these conditions to drive better outcomes at lower cost. Connected medical solutions are expanding rapidly and are projected to reach $155&#x00a0;billion by 2026, a compound annual growth rate (&#x201c;CAGR&#x201d;) of 17%. These solutions are socio<FONT CLASS="nobreak">-technical</FONT> models for healthcare management and delivery using technology to provide healthcare services remotely and aim to maximize healthcare resources and provide increased, flexible opportunities for consumers to engage with clinicians and better self<FONT CLASS="nobreak">-manage</FONT> their care, using readily available consumer technologies to deliver patient care outside of the hospital or doctor&#x2019;s office. The types of companies that make up this market include Accenture, IBM, SAP, GE Healthcare, Oracle, Microsoft, Airstrip Technology, Medtronic, Allscripts, Boston Scientific, Athenahealth, Cerner, Philips, Agamatrix, Qualcomm, and AliveCor.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The market for RPM, is projected to reach $31.3&#x00a0;billion by the end of 2023. In 2019, 1,800&#x00a0;hospitals in the US were using mobile applications to improve risk management and quality of care. The number in 2020 was likely larger as the onset of the COVID<FONT CLASS="nobreak">-19</FONT> pandemic greatly accelerated use and acceptance of telehealth by both patients and healthcare providers.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Cardiovascular disease is the number one cost to the healthcare system and is estimated to be responsible for 1 in every 6 healthcare dollars spent in the US.&#x00a0;As cardiovascular disease is the leading cause of death worldwide, early detection, diagnosis, and management of chronic cardiac conditions are necessary to relieve the increasing burden on the healthcare infrastructure. Diagnostic tests such as ECGs are used to detect, diagnose and track numerous cardiovascular conditions. With advances in mobile communications, diagnostic monitoring of cardiac conditions is increasingly occurring outside the hospital.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our initial telemedicine technology Product will address the heart attack detection market as well as the market to monitor coronary artery disease (&#x201c;CAD&#x201d;) patients who are typically at high risk for a heart attack. Currently there are no products on the market that are user friendly, easy to carry, and always with the patient in order to provide physicians and patients with timely and highly accurate information about potential ACS and MI events. A tool that is always with the patient, that decreases time to intervention, and that decreases the number of unnecessary ED visits by chest pain patients would have a significant effect on saving lives and healthcare dollars. We believe our technology will address this problem and will provide a convenient, cost<FONT CLASS="nobreak">-effective</FONT>, integrated telehealth solution, including software and hardware for physicians and their patients. There are approximately 18&#x00a0;million people in the US who are considered at high risk for a heart attack, including 8&#x00a0;million who already have had prior intervention for MI&#x2019;s and are therefore considered to be at extreme risk.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">In the US, mobile cardiac tests are primarily conducted through outsourced Independent Diagnostic Testing Facilities (&#x201c;IDTFs&#x201d;) or as part of an RPM system. Reimbursement rates vary depending on the use case and generally are based on the value a technology offers to patients and healthcare providers. Actual reimbursed pricing is set by the Centers for Medicare&#x00a0;&amp; Medicaid Services (&#x201c;CMS&#x201d;). Reimbursement rates for private insurers typically provide for similar or better reimbursement rates when compared to those set by the Government for Medicare and Medicaid.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">In the ED environment, early and accurate diagnosis of a chest pain patient who is potentially having a heart attack is of immense importance. Guidelines state that every chest pain patient in an ED must receive an ECG within 10&#x00a0;minutes of presentation. The accuracy of these initial ECGs is only approximately 75%. The need for increased ECG accuracy in detecting a heart attack in the ED is well defined, and an improved solution could result in saved lives and healthcare dollars. A 510(K)&#x00a0;for our ED Product was submitted for review on August&#x00a0;15, 2022 to the FDA.&#x00a0;We believe this Product will offer a marked increase in the accuracy of heart attack detection in EDs. There are approximately 5,000&#x00a0;ED departments in the US.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Products and Technology</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The foundation of our novel technology is the concept of VECG, a technology that has long been seen as superior to ECGs in detecting MIs but is no longer used clinically because of the difficulty experienced by physicians interpreting the output. We solved the crucial problem of recording three orthogonal (x, y and z) projections of the heart vector with a device that is sized like a credit card. The thickness of our credit card sized ECG signal collection device is about 1/8 inch (3 mm), and it weighs about 1 ounce (28 grams). The core technology consists of a series of patented inventions and associated algorithms. In addition to using VECG to get a more complete 3D characterization of </P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">3</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">cardiac activity, we use the concept of a baseline. Our MI marker is a differential marker that measures the change in cardiac parameters between an asymptomatic (baseline) recording and the symptomatic recording. It is personalized for every patient as every patient has a unique baseline. Our increase in diagnostic performance in detecting MIs, when compared to a panel of cardiologists, is attributed to a richer cardiac information set offered by VECG&#x00a0;and the fact that our MI marker compares the baseline and symptomatic recordings and does that in the 3D space of VECG.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">This novel technology has resulted in two key Products to date: a telehealth Product for high<FONT CLASS="nobreak">-risk</FONT> cardiovascular patients (HeartBeam AIMIGo) and a powerful cloud<FONT CLASS="nobreak">-based</FONT> diagnostic expert and MI detection system for EDs (HeartBeam AIMI). Our telehealth ECG collection device is the size of a credit card and records cardiac signals with integrated electrodes rather than wires or self<FONT CLASS="nobreak">-adhesive</FONT> electrodes. Unlike a standard 12<FONT CLASS="nobreak">-lead</FONT> ECG machine that records signals in empirically determined locations on a human body, our approach is focused on recording three projections of the heart vector. The successful recording of the projections of the heart vector enables the synthesis of a 12<FONT CLASS="nobreak">-lead</FONT> signal set and internal algorithmic diagnostic work in the space of 3D heart vectors.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">There are obvious ease of use advantages when comparing our handheld device that fits in a wallet and can be instantly self<FONT CLASS="nobreak">-applied</FONT> versus the current 12<FONT CLASS="nobreak">-lead</FONT> ECG machine that requires a trained professional to apply. In addition, there are diagnostic performance advantages, including, based on our initial study, increased accuracy in diagnosing MIs. The system is used by patients at home or elsewhere, with help from their physicians, to assess whether their chest pain is truly the result of an MI.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our telehealth HeartBeam AIMIGo system will be a prescription<FONT CLASS="nobreak">-only</FONT> mobile health system intended for individuals with known or suspected heart disease, especially CAD.&#x00a0;It helps guide physicians in choosing the best course of action for their patients who experience chest pain outside of a medical facility. HeartBeam AIMIGo will bring a medical grade ECG to patients and will enable them to receive a plan of action from a physician in a timely manner. At the time of onboarding and at regularly scheduled time intervals, patients record a baseline 30 second cardiac reading using our device. When a patient experiences symptoms, such as irregular heartbeats or chest pain, the patient can simply open the smartphone app and press the credit card sized device against the chest to collect signals that can be converted to a synthesized 12<FONT CLASS="nobreak">-lead</FONT> ECG.&#x00a0;This synthesized 12<FONT CLASS="nobreak">-lead</FONT> ECG is sent to the physician overlayed with the patient&#x2019;s derived baseline ECG recording. In addition, the patient provides input on their symptoms that are sent, along with the ECG data, to the cloud for interpretation by a physician. A cloud<FONT CLASS="nobreak">-based</FONT> algorithm processes the signals and displays the symptom description and patient history to a physician to analyze and prescribe an action plan. From start to finish, the process takes just a few minutes.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The telehealth HeartBeam AIMIGo system consists of:</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;">1.<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>A credit card sized cardiac electrical signal collection device. The device captures cardiac signals that represent x, y and z projections of the heart vector and transmits them via Bluetooth connection to a smartphone. It is always with the patient as it easily fits in a wallet. It is easy to use as all that is required of the patient is that the device be pressed against the chest.</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;">2.<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>A smartphone application that receives the cardiac signals from the HeartBeam signal collection device. The app has several functions: guiding the patient through the signal collection, asking about symptoms, displaying the status of the data collection, and notifying the patient of the plan of action as determined by a physician. In addition, the app will contain HIPAA<FONT CLASS="nobreak">-compliant</FONT> video conferencing or text capabilities for the healthcare provider to communicate directly with the patient.</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;">3.<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>A cloud<FONT CLASS="nobreak">-based</FONT> software system that serves four basic functions: (1)&#x00a0;Performing a final check of the ECG signal quality, (2)&#x00a0;Synthesizing a 12<FONT CLASS="nobreak">-lead</FONT> ECG from the measured (recorded) 3 vector leads, (3)&#x00a0;A diagnostic suggestion based on 3D VECG interpretation, risk factors and symptoms and (4)&#x00a0;Preparing a summary report for the physician. These software functions will be introduced to the HeartBeam AIMIGo product in a sequential manner. In order to facilitate a more accurate physician interpretation of the data, the software overlays the patient&#x2019;s synthesized baseline 12 lead ECG waveform on the synthesized 12 lead ECG waveform from the current event. To ensure high signal quality, the system checks for noise levels in the recorded signals. Those signals that can be effectively filtered are accepted and those that have a noise level above an empirically established threshold are rejected. If a recorded signal is rejected, the user is asked to repeat the recording.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">4</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;">4.<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>A web<FONT CLASS="nobreak">-based</FONT> physician portal capable of displaying the relevant information for the physician to analyze: diagnostic suggestion, patient history, symptoms, baseline and current readings, synthesized 12<FONT CLASS="nobreak">-lead</FONT> ECG, and recorded 3 vector leads. Our physician portal assists physicians with their diagnostic interpretation by providing both the baseline 12<FONT CLASS="nobreak">-lead</FONT> synthesized ECG and the 12<FONT CLASS="nobreak">-lead</FONT> synthesized ECG that is under evaluation.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The market release of our telehealth Product will be in multiple generations.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The generation 1 Product will have a limited feature set and introduce a 3<FONT CLASS="nobreak">-lead</FONT> 3D VECG credit card<FONT CLASS="nobreak">-sized</FONT> device, the HeartBeam AIMIGo 3L, that records the&#x00a0;X,Y,Z cardiac activity and displays the signals for clinician review, providing the regulatory foundation for subsequent products in our product portfolio. The 510(K)&#x00a0;submission to the FDA is planned for the fourth quarter of 2022.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The generation 2 Product will offer to the physician a pair of baseline and symptomatic 12<FONT CLASS="nobreak">-lead</FONT> ECGs both synthesized from 3<FONT CLASS="nobreak">-lead</FONT> 3D VECG signals recorded by the HeartBeam AIMIGo device and a symptoms report. It leverages recently issued patents for enhanced diagnostic accuracy of the synthesized 12<FONT CLASS="nobreak">-lead</FONT> ECG waveforms. The generation 2 Product is planned to offer an automated atrial fibrillation detection algorithm. This product is an excellent match for existing CPT RPM reimbursement codes. The 510(K)&#x00a0;submission to the FDA is planned for the second quarter of 2023.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The generation 3&#x00a0;Product will feature our proprietary MI marker as well as our diagnostic suggestion in addition to all features of the earlier generation Products.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We plan to seek a unique reimbursement code for HeartBeam AIMIGo.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The same core technology is used in the ED Product (HeartBeam AIMI). In this application, the increased accuracy of detecting MIs by the ECG is of utmost importance. An ECG is the first diagnostic test a chest pain patient receives in the ED and it has a major impact on the patient&#x2019;s subsequent clinical path. The ED Product has no hardware and introduces minimal change to the standard of care chest pain diagnostic path. It uses a baseline standard 12<FONT CLASS="nobreak">-lead</FONT> ECG from the patient&#x2019;s Electronic Medical Record (&#x201c;EMR&#x201d;) and the chest pain ECG that is being evaluated. It converts them to a VECG representation and utilizes our proprietary 3D VECG differential marker. An initial clinical study indicates that the ED software Product offers considerable improvement in the accuracy of MI detection compared to a panel of experienced cardiologists interpreting a standard 12 lead ECG.&#x00a0;The importance of increased accuracy of the first ECG interpretation for a chest pain patient presenting to an ED is significant, potentially leading to faster intervention or avoiding unnecessary activation of the cardiac catheterization lab.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Market Opportunity</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">ECGs are key diagnostic tests utilized in the diagnosis and monitoring of cardiovascular disease, the number one cause of death worldwide. In the US in 2016, there were 121.5&#x00a0;million adults living with cardiovascular disease and 18.3&#x00a0;million adults with diagnosed coronary artery disease. The market size is increasing, due to an aging population and lifestyle choices.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Every 40 seconds someone in the US has a heart attack (&#x201c;MI&#x201d;).&#x00a0;Unfortunately, there is no way for patients to tell whether the symptoms they are experiencing are due to an MI, or some other more benign condition such as indigestion. As a result, patients often ignore symptoms and delay seeking care, which leads to worse outcomes and increased mortality. On the other hand, many patients who go to the Emergency Room with chest pain are not experiencing an MI.&#x00a0;Chest pain is the second most common reason for an ED visit, yet fewer than 20% of chest pain ED visits result in a diagnosis of a life<FONT CLASS="nobreak">-threatening</FONT> condition. These unnecessary ED visits lead to well over $10&#x00a0;billion in unnecessary healthcare expenditures.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Most ECGs are conducted in a healthcare facility setting using a 12<FONT CLASS="nobreak">-lead</FONT> ECG machine, the gold standard. ECGs taken outside of healthcare facilities are expected to grow more quickly than in<FONT CLASS="nobreak">-hospital</FONT> ECGs. Monitoring cardiac patients outside of a hospital is a fast<FONT CLASS="nobreak">-growing</FONT> trend, as it is less expensive and provides a better patient experience. However, while ambulatory cardiac monitoring devices are often much easier for patients to use, they have fewer leads than the gold standard and therefore cannot offer as comprehensive a picture of cardiac health.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">5</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">While a standard 12<FONT CLASS="nobreak">-lead</FONT> ECG readout is of great medical value, it is simply impractical to have a machine next to patients when they experience symptoms outside the clinical setting, since recording the event requires attaching multiple electrodes to the patient&#x2019;s body with professional assistance. While existing technologies use predominantly single lead ECG devices to monitor arrhythmias, these technologies do not provide information to the physician on the presence of life<FONT CLASS="nobreak">-threatening</FONT> conditions of ACS or heart attacks.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We believe our telehealth technology addresses these market needs and has several key attributes that make it a good fit for these patients. Our telehealth Product is generally used when symptoms occur and offers the potential for lifelong patient usage. The device is always near the patient and ready to be used for recording a cardiac event. It enables real<FONT CLASS="nobreak">-time</FONT> cardiac data transmission during a telemedicine visit. It offers a recorded 3 vector lead set of signals and a synthesized 12<FONT CLASS="nobreak">-lead</FONT> ECG set of signals. We believe physicians will typically prescribe our solution to chronic cardiovascular patients for long term monitoring, thereby enabling prolonged data collection and delivering a more complete picture for diagnosis. This will also enable the use of artificial intelligence on our future database that will have a unique set of longitudinal synthesized 12<FONT CLASS="nobreak">-lead</FONT> ECGs for patients.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Market Strategy</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our goal is to establish our products as key solutions for cardiology practices and&#x00a0;hospital EDs. Our efforts to enter the market involve establishing clinical evidence and demonstrating the cost<FONT CLASS="nobreak">-effectiveness</FONT> of adopting our products. For both the telehealth (HeartBeam AIMIGo) and the ED Products (HeartBeam AIMI), the initial geographic market is the United&#x00a0;States.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We believe that both the telehealth and ED Products will be subject to the US FDA&#x2019;s 510(k)&#x00a0;review process. A 510(K)&#x00a0;for our HeartBeam AIMI was submitted to the FDA on August&#x00a0;15, 2022 for review and we are in the process of preparing a 510(K)&#x00a0;submission for HeartBeam AIMIGo.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">For HeartBeam AIMIGo, the primary customers are cardiology practices and the cardiology departments of&#x00a0;hospitals. Healthcare insurers are another important customer, as they will potentially benefit from the reduced costs to the healthcare system. We are working to develop new clinical studies and publish results of completed clinical studies and plan to demonstrate real world cost<FONT CLASS="nobreak">-effectiveness</FONT> of the use of the solution.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our long<FONT CLASS="nobreak">-term</FONT> strategy is to generate sufficient evidence of clinical efficacy and cost<FONT CLASS="nobreak">-effectiveness</FONT> to generate reimbursement coverage and payment specifically for the HeartBeam telehealth Generation 2 solution. We expect to be able to demonstrate significant clinical benefits for patients and savings to the health care system, justifying reimbursement levels well in excess of the amount paid through the RPM pathway.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">For the telehealth Product, our primary marketing strategy will focus on the medical community with continued validation of clinical efficacy and cost<FONT CLASS="nobreak">-effectiveness</FONT> and the establishment of reference sites. We will also create educational materials and provide other support to help educate our customers&#x2019; patients.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Clinical Data</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">HeartBeam has performed three clinical studies to assess performance of our technologies.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">In the first study (HeartBeam Ischemia Detection Study&#x00a0;&#x2014;&#x00a0;HIDES), we collected electrical signal data on patients whose coronary arteries were occluded during a Percutaneous Coronary Intervention (PCI), using simultaneously a traditional 12<FONT CLASS="nobreak">-lead</FONT> ECG and our vector signal based device. Our VECG<FONT CLASS="nobreak">-based</FONT> signal interpretation system had significantly (21%) higher accuracy in detecting ischemia as more fully discussed in the Business Section.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">In a second study (B Score), the HeartBeam diagnostic engine, using ECG, symptoms, and history, matched the diagnostic performance of expert cardiologists in detecting the presence of MIs in patients presenting to an ED with chest pain. This result indicates that the quality of the diagnostic advice produced by our expert system will be extremely valuable to the physician who is assessing the condition of a patient in a telehealth environment.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The third study, ISPEC, which assessed the false positive rate for non<FONT CLASS="nobreak">-symptomatic</FONT> patients, is relevant in a telehealth situation. It is important that the system have a low false positive rate when patients are conducting baseline recordings, which are required on at least a monthly basis. The study yielded no false positives.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">All three studies are being prepared for peer<FONT CLASS="nobreak">-reviewed</FONT> publication.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">6</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Intellectual Property</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We believe our innovations are protected with our patent portfolio and our goal is to become a leader in the ambulatory VECG sector. For a limited number of aspects of our proprietary technology we rely on trade secret protection. It is our view that the combination of these two methods of intellectual property protection maximizes our chances for success.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The issued and pending U.S.&#x00a0;patent applications cover compact VECG systems for remote detection and/or diagnosis of AMI.&#x00a0;The pending EU and CN patent applications correspond to the pending and issued US cases. The pending PCT applications cover methods and apparatuses for automatic cardiac diagnosis as well as compact systems including retractable electrodes.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">HeartBeam has five issued U.S.&#x00a0;patents (U.S.10,433,744, U.S.10,117,592, U.S.11,071,490, U.S.11,419,538 and U.S.&#x00a0;11,445,963), and seven pending U.S applications. Five of the pending applications have been published, the remaining two pending cases are unpublished. Outside of the U.S., HeartBeam has four issued patents in Germany, France, Netherlands and United Kingdom and seven pending applications in Canada, China, the European Union (&#x201c;EU&#x201d;), Japan and Australia. HeartBeam has two pending PCT applications. The issued patents are predicted to expire between April&#x00a0;11, 2036 and October&#x00a0;5, 2041.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Research and Development</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The primary objective of our research and development program is to provide innovative ambulatory VECG, user friendly solutions with high medical value. To date, we have been highly successful in developing our initial products. The emphasis has been on developing a user<FONT CLASS="nobreak">-friendly</FONT> solution that is always with the patient and that provides assistance to physicians in diagnosing heart attacks in chest pain patients.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our Research team is largely based in Belgrade, Serbia as well as in California, USA.&#x00a0;We have assembled a highly capable Belgrade team currently consisting of seven PhD level contributors who are credited with developing our key inventions and patents. The diverse group includes:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>Two nuclear physicists.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>Two Biomedical Engineers experienced in developed digital health applications.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>Two highly experienced Healthcare IT development professionals.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>Two Electrical Engineers (M.S.E.E) with strong signal processing and ECG analysis algorithm expertise from the medical device industry.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>An Electrical Engineer (M.S.E.E) with exceptional implantable medical device development and&#x00a0;power optimization expertise.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>A Software Engineer, (PhD Computer Science), with deep expertise in developing mobile applications for medical devices.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Future research and development efforts will focus on the application of signal processing and artificial intelligence to address a range of cardiac conditions.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">In the third quarter of 2022 we added 3 development engineers led by our recently hired Chief Technology Officer Ken Persen. This is an experienced development team that worked together previously and was successful in delivering FDA cleared products.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Future Products</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our core technology&#x00a0;&#x2014;&#x00a0;the heart vector approach adopted and invented by our research team&#x00a0;&#x2014;&#x00a0;is a platform technology that can provide diagnostic solutions to a variety of cardiovascular patients. Our plans call for expanding solutions that diagnose all major cardiac conditions that are diagnosed by ECGs.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">7</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our future plans include the development of a VECG that is a synthesized 12<FONT CLASS="nobreak">-lead</FONT> capable patch ECG monitor that will provide advantages over existing single<FONT CLASS="nobreak">-lead</FONT> ECG patch products such as the Zio<FONT CLASS="nobreak">-XT</FONT> from iRhythm Technologies, Inc. Our approach will offer a synthesized 12<FONT CLASS="nobreak">-lead</FONT> ECG with a patch that is very similar, in dimensions and look and feel, to the currently available single lead ECG patches. We believe providing standard of care 12<FONT CLASS="nobreak">-lead</FONT> ECG capabilities will have significant diagnostic advantages over a single lead patch.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We also plan to integrate a synthesized 12<FONT CLASS="nobreak">-lead</FONT> ECG smartwatch<FONT CLASS="nobreak">-based</FONT> monitor intended for detection of heart attacks and complex cardiac arrhythmias. This invention eliminates the need for a dedicated ECG device while offering a synthesized 12<FONT CLASS="nobreak">-lead</FONT> ECG capability enabling heart attack and complex arrhythmia detection.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">While our initial telehealth Product is powered by a software expert system that serves as a diagnostic aid to a physician, we will develop an AI based diagnostic system that will supplement our diagnostic expert system.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We are committed to continue advancing the full potential inherent in our synthesized 12<FONT CLASS="nobreak">-lead</FONT> 3D VECG technology as demonstrated in recently issued and allowed patents with potentially enormous market impacts.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Corporate Information</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our corporate offices are located at 2118 Walsh Avenue, Suite 210, Santa Clara, CA&#x00a0;95050. Our telephone number is (408)&#x00a0;899<FONT CLASS="nobreak">-4443</FONT>. The address of our website is <FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">https:</FONT>//<FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">www.heartbeam</FONT>/. The inclusion of our website address in this prospectus does not include or incorporate by reference the information on our website into this prospectus.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">8</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9914"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">RISK FACTORS</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Investment in any securities offered pursuant to this prospectus and the applicable prospectus supplement involves risks. You should carefully consider the risk factors incorporated by reference to our most recent Annual Report on Form&#x00a0;10<FONT CLASS="nobreak">-K</FONT> and any subsequent Quarterly Reports on Form&#x00a0;10<FONT CLASS="nobreak">-Q</FONT> or Current Reports on Form&#x00a0;8<FONT CLASS="nobreak">-K</FONT> we file after the date of this prospectus, and all other information contained or incorporated by reference into this prospectus, as updated by our subsequent filings under the Exchange&#x00a0;Act, and the risk factors and other information contained in the applicable prospectus supplement before acquiring any of such securities. The occurrence of any of these risks might cause you to lose all or part of your investment in the offered securities.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">9</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9915"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">SPECIAL NOTICE REGARDING </FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">FORWARD-LOOKING</FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"> STATEMENTS</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">This prospectus contains forward<FONT CLASS="nobreak">-looking</FONT> statements that involve risks and uncertainties, principally in the sections entitled &#x201c;Risk Factors.&#x201d; All statements other than statements of historical fact contained in this prospectus, including statements regarding future events, our future financial performance, business strategy and plans and objectives of management for future operations, are forward<FONT CLASS="nobreak">-looking</FONT> statements. We have attempted to identify forward<FONT CLASS="nobreak">-looking</FONT> statements by terminology including &#x201c;anticipates,&#x201d; &#x201c;believes,&#x201d; &#x201c;can,&#x201d; &#x201c;continue,&#x201d; &#x201c;could,&#x201d; &#x201c;estimates,&#x201d; &#x201c;expects,&#x201d; &#x201c;intends,&#x201d; &#x201c;may,&#x201d; &#x201c;plans,&#x201d; &#x201c;potential,&#x201d; &#x201c;predicts,&#x201d; &#x201c;should,&#x201d; or &#x201c;will&#x201d; or the negative of these terms or other comparable terminology. Although we do not make forward looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks outlined under &#x201c;Risk Factors&#x201d; or elsewhere in this prospectus, which may cause our or our industry&#x2019;s actual results, levels of activity, performance or achievements expressed or implied by these forward<FONT CLASS="nobreak">-looking</FONT> statements.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Forward<FONT CLASS="nobreak">-looking</FONT> statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by which, that performance or those results will be achieved. Forward<FONT CLASS="nobreak">-looking</FONT> statements are based on information available at the time they are made and/or management&#x2019;s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from what is expressed in or suggested by the forward<FONT CLASS="nobreak">-looking</FONT> statements.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Forward<FONT CLASS="nobreak">-looking</FONT> statements speak only as of the date they are made. You should not put undue reliance on any forward<FONT CLASS="nobreak">-looking</FONT> statements. We assume no obligation to update forward<FONT CLASS="nobreak">-looking</FONT> statements to reflect actual results, changes in assumptions or changes in other factors affecting forward<FONT CLASS="nobreak">-looking</FONT> information, except to the extent required by applicable securities laws. If we do update one or more forward<FONT CLASS="nobreak">-looking</FONT> statements, no inference should be drawn that we will make additional updates with respect to those or other forward<FONT CLASS="nobreak">-looking</FONT> statements.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">10</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9916"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">USE OF PROCEEDS</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We intend to use the net proceeds from the sale of the securities as set forth in the applicable prospectus supplement.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">11</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9917"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">DESCRIPTION OF CAPITAL STOCK</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The following description of the Company&#x2019;s capital stock and provisions of its Certificate of Incorporation and Bylaws are summaries and are qualified by reference to the Company&#x2019;s Certificate of Incorporation and Bylaws, which have been publicly filed with the SEC.&#x00a0;See &#x201c;Where You Can Find More Information&#x201d; and &#x201c;Incorporation by Reference.&#x201d;</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Authorized and Outstanding Capital Stock</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The Company is authorized to issue 110,000,000<FONT CLASS="nobreak"> </FONT>shares of capital stock, consisting of 100,000,000<FONT CLASS="nobreak"> </FONT>shares of Common Stock, par value $0.0001 per share and 10,000,000<FONT CLASS="nobreak"> </FONT>shares of Preferred Stock, par value $0.0001 per share.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">As of December&#x00a0;31, 2022, the Company had 8,009,743 outstanding shares of Common Stock held by approximately 50<FONT CLASS="nobreak"> </FONT>shareholders of record. As of the date thereof, there were no shares of preferred stock issued and outstanding.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Common Stock</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The holders of our Common Stock are entitled to one vote per share. In addition, the holders of our Common Stock will be entitled to receive dividends ratably, if any, declared by our board of directors out of legally available funds; however, the current policy of the board of directors is to retain earnings, if any, for operations and growth. Upon liquidation, dissolution or winding<FONT CLASS="nobreak">-up</FONT>, the holders of our Common Stock are entitled to share ratably in all assets that are legally available for distribution. The holders of our Common Stock have no pre<FONT CLASS="nobreak">-emptive</FONT>, subscription, redemption or conversion rights. The rights, preferences and privileges of holders of the our Common Stock are subject to, and may be adversely affected by, the rights of the holders of any series of preferred stock, which may be designated solely by action of the board of directors and issued in the future.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Preferred Stock</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our Board of Directors will have the authority, without further action by our stockholders, to issue up to 10,000,000<FONT CLASS="nobreak"> </FONT>shares of preferred stock in one or more series and to fix the rights, preferences, privileges and restrictions thereof. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences, sinking fund terms and the number of shares constituting, or the designation of, such series, any or all of which may be greater than the rights of Common Stock. The issuance of our preferred stock could adversely affect the voting power of holders of Common Stock and the likelihood that such holders will receive dividend payments and payments upon our liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deferring or preventing a change in control of our company or other corporate action.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Warrants</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The following summary of certain terms and provisions of the warrants (the &#x201c;Warrants&#x201d;) is not complete and is subject to, and qualified in its entirety by, the provisions of the warrant agency agreement between us and VStock Transfer, LLC (the &#x201c;Warrant Agent&#x201d;), and the form of warrant, which have been publicly filed with the SEC.&#x00a0;See &#x201c;Where You Can Find More Information&#x201d; and &#x201c;Incorporation by Reference.&#x201d; As of December&#x00a0;31, 2022, there were 3,162,500 Warrants issued and outstanding trading under BEATW.&#x00a0;The exercise price of the Warrants is $6 per share. Each Warrant is exercisable for one share of our Common Stock, subject to adjustment in the event of stock dividends, stock splits, stock combinations, reclassifications, reorganizations or similar events affecting our common stock as described herein. A holder may not exercise any portion of a warrant to the extent that the holder, together with its affiliates and any other person or entity acting as a group, would own more than 4.99% of the outstanding Common Stock after exercise, as such percentage ownership is determined in accordance with the terms of the Warrants, except that upon notice from the holder to us, the holder may waive such limitation up to a percentage, not in excess of 9.99%. Each warrant will be exercisable immediately upon issuance and will expire five (5)&#x00a0;years after the initial issuance date.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">12</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">In addition to the warrants mentioned above, the Company has issued the following:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>On February<FONT CLASS="nobreak">&#x00a0;</FONT>18, 2022, the Company issued 58,000&#x00a0;warrants to purchase 58,000<FONT CLASS="nobreak"> </FONT>shares of common stock at an exercise price of $6.00 per share, with an expiration date of five&#x00a0;years from the date thereof.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>On January<FONT CLASS="nobreak">&#x00a0;</FONT>14, 2022, the Company issued 72,727&#x00a0;warrants based on performance metrics achieved in 2021 to purchase 72,727<FONT CLASS="nobreak"> </FONT>shares of common stock at an exercise price of $5.50 per share, with an expiration of five&#x00a0;years from the date of issuance.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>In connection with the short<FONT CLASS="nobreak">-term</FONT> notes issued in 2019, the Board of Directors approved the issuance of 15,277 fully vested warrants as an incentive to investors with the rights to convert into a fixed number of shares of the Company&#x2019;s common stock for an above market fixed price of $2.75 per share, exercisable, in whole or in part, for a period of 4&#x00a0;years from the date of issuance.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>During the course of 2019, the Company issued milestone warrants totaling 407,272&#x00a0;units (&#x201c;Penny Warrants&#x201d;). These were valued with an exercise price of $0.0003 and will vest upon meeting certain milestones. The warrant may be exercised, in whole or in part upon the earliest to occur of: (i)&#x00a0;following the Company&#x2019;s initial public offering, the date on which the Company has a market capitalization of at least $50,000,000 for five consecutive&#x00a0;business days; (ii)&#x00a0;the closing of a Change of Control transaction with net proceeds to Company equity holders of at least $50,000,000; (iii)&#x00a0;the date on which the Company receives a bona fide pre<FONT CLASS="nobreak">-money</FONT> valuation from a third party investor of at least $50,000,000; (iv)&#x00a0;the date on which the Holder&#x2019;s continuous status as a Service Provider is terminated by the Company without Cause upon or within 12&#x00a0;months after a Change of Control; and (v)&#x00a0;the date on which the Holder terminates his continuous status as a Service Provider for Good Reason within 12&#x00a0;months after a Change of Control.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>On November<FONT CLASS="nobreak">&#x00a0;</FONT>15, 2022, the Company issued warrants to the lead underwriter, as portion of the underwriting compensation payable in connection with the Company&#x2019;s initial public offering (&#x201c;IPO&#x201d;). The warrants accounted for 7% of the number of common stock sold in the IPO, which was 192,50&#x00a0;warrants, exercisable at a per share exercise price equal to $7.50 per share and expire five&#x00a0;years from the date of issuance. The warrants are subject to a 180<FONT CLASS="nobreak">-day</FONT> lock<FONT CLASS="nobreak">-up</FONT> period.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">2022 Equity Incentive Plan</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">On June&#x00a0;15, 2022, the our Board of Directors approved the 2022 Equity Incentive Plan (&#x201c;2022 Equity Plan&#x201d;), to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to employees, directors, and consultants, and to promote the success of the Company&#x2019;s business. The 2022 Equity Plan provides for the grant of stock options and restricted stock awards (&#x201c;RSUs&#x201d;) to purchase common stock. The Board of Directors approved 1,900,000<FONT CLASS="nobreak"> </FONT>shares of Common Stock issuance under the 2022 Equity Plan.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">As of December&#x00a0;31, 2022, there were 747,364<FONT CLASS="nobreak"> </FONT>shares available for issuance under the 2022 Equity Plan. The number of shares available for issuance under the 2022 Equity Plan will be increased on the first&#x00a0;day of each fiscal year beginning with the 2023 fiscal year, in an amount equal to the&#x00a0;<FONT CLASS="CharOverride-1" STYLE="text-decoration:underline;">least</FONT>&#x00a0;of 3,800,000&#x00a0;Shares, five percent (5%) of the total number of shares of all classes of common stock of the Company outstanding on the last&#x00a0;day of the immediately preceding fiscal year, and a lesser number of Shares determined by the Administrator.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Eligible recipients of option awards are employees, officers, consultants, attorneys, advisors or directors (including non<FONT CLASS="nobreak">-employee</FONT> directors) of the Company or of any parent, subsidiary or affiliate of the Company. The Board of Directors has the authority to grant to any eligible recipient any options, restricted stock or other awards valued in whole or in part by reference to, or otherwise based on, the Company&#x2019;s Common Stock; provided, however, that Incentive Options may only be granted to employees of the Company or its subsidiaries.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The provisions of each option granted need not be the same with respect to each option recipient. Option recipients have entered into award agreements with the Company, in such form as the full Board of Directors has determined. The 2022 Equity Plan is administered by the Board of Directors.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">13</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Anti-Takeover</FONT><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;"> Provisions</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The following is a summary of certain provisions of Delaware law, our Certificate of Incorporation and our bylaws. This summary does not purport to be complete and is qualified in its entirety by reference to the corporate law of Delaware and our Certificate of Incorporation and bylaws.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Amended Certificate of Incorporation and Amended and Restated Bylaws</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our charter documents include provisions that may have the effect of discouraging, delaying or preventing a change in control or an unsolicited acquisition proposal that a stockholder might consider favorable, including a proposal that might result in the payment of a premium over the market price for the shares held by our stockholders. Certain provisions are summarized in the following paragraphs.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Effects of authorized but unissued common stock.<FONT STYLE="width: 13px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>One of the effects of the existence of authorized but unissued common stock may be to enable our board of directors to make more difficult or to discourage an attempt to obtain control of our Company by means of a merger, tender offer, proxy contest or otherwise, and thereby to protect the continuity of management. If, in the due exercise of its fiduciary obligations, the board of directors were to determine that a takeover proposal was not in our best interest, such shares could be issued by the board of directors without stockholder approval in one or more transactions that might prevent or render more difficult or costly the completion of the takeover transaction by diluting the voting or other rights of the proposed acquirer or insurgent stockholder group, by putting a substantial voting block in institutional or other hands that might undertake to support the position of the incumbent board of directors, by effecting an acquisition that might complicate or preclude the takeover, or otherwise.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Special Meeting of Stockholders and Stockholder Action by Written Consent.<FONT STYLE="width: 13px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>A special meeting of the stockholders may be called at any time by the Board, Chairperson of the Board, Chief Executive Officer or President (in the absence of a Chief Executive Officer) or by one or more stockholders holding shares in the aggregate entitled to cast not less than 10% of the votes at that meeting.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Section&#x00a0;203 of the Delaware General Corporation Law</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We are subject to Section&#x00a0;203 of the DGCL, which prohibits a Delaware corporation from engaging in any business combination with any interested stockholder for a period of three&#x00a0;years after the date that such stockholder became an interested stockholder, with the following exceptions:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>before such date, our board of directors approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>upon closing of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares owned by (i)&#x00a0;persons who are directors and also officers and (ii)&#x00a0;employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or on or after such date, the business combination is approved by our board of directors and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least&#x00a0;66-&#x2154;% of the outstanding voting stock that is not owned by the interested stockholder.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">In general, Section&#x00a0;203 defines business combination to include the following:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>any merger or consolidation involving the corporation and the interested stockholder;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">14</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>any transaction involving the corporation that has the effect of increasing the proportionate share of the stock or any class or series of the corporation beneficially owned by the interested stockholder; or</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>The receipt by the interested stockholder of the benefit of any loss, advances, guarantees, pledges or other financial benefits by or through the corporation.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">In general, Section&#x00a0;203 defines an &#x201c;interested stockholder&#x201d; as an entity or person who, together with the person&#x2019;s affiliates and associates, beneficially owns, or within three&#x00a0;years prior to the time of determination of interested stockholder status did own, 15% or more of the outstanding voting stock of the corporation.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">The NASDAQ Capital Market Listing</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our common stock and warrants are listed on the NASDAQ, under the symbol &#x201c;BEAT&#x201d; and &#x201c;BEATW&#x201d;, respectively.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Transfer Agent and Warrant Agent</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The transfer agent, warrant agent and registrar for our common stock is VStock Transfer with an address of 18 Lafayette Place Woodmere, New&#x00a0;York 11598.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">15</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9918"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">DESCRIPTION OF DEBT SECURITIES</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">General</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The debt securities that we may offer by this prospectus consist of notes, debentures, or other evidences of indebtedness. The debt securities may constitute either senior or subordinated debt securities, and in either case may be either secured or unsecured. Any debt securities that we offer and sell will be our direct obligations. Debt securities may be issued in one or more series. All debt securities of any one series need not be issued at the same time, and unless otherwise provided, a series of debt securities may be reopened, with the required consent of the holders of outstanding debt securities, for issuance of additional debt securities of that series or to establish additional terms of that series of debt securities (with such additional terms applicable only to unissued or additional debt securities of that series). The form of indenture has been filed as an exhibit to the registration statement of which this prospectus is a part and is subject to any amendments or supplements that we may enter into with the trustee(s), however, we may issue debt securities not subject to the indenture provided such terms of debt securities are not otherwise required to be set forth in the indenture. The material terms of the indenture are summarized below and we refer you to the indenture for a detailed description of these material terms. Additional or different provisions that are applicable to a particular series of debt securities will, if material, be described in a prospectus supplement relating to the offering of debt securities of that series. These provisions may include, among other things and to the extent applicable, the following:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the title of the debt securities, including, as applicable, whether the debt securities will be issued as senior debt securities, senior subordinated debt securities or subordinated debt securities, any subordination provisions particular to the series of debt securities;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>any limit on the aggregate principal amount of the debt securities;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>whether the debt securities are senior debt securities or subordinated debt securities and applicable subordination provisions, if any;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>whether the debt securities will be secured or unsecured;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>if other than 100% of the aggregate principal amount, the percentage of the aggregate principal amount at which we will sell the debt securities, such as an original issuance discount;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the date or dates, whether fixed or extendable, on which the principal of the debt securities will be payable;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the rate or rates, which may be fixed or variable, at which the debt securities will bear interest, if any, the date or dates from which any such interest will accrue, the interest payment dates on which we will pay any such interest, the basis upon which interest will be calculated if other than that of a 360<FONT CLASS="nobreak">-day</FONT> year consisting of twelve 30<FONT CLASS="nobreak">-day</FONT>&#x00a0;months, and, in the case of registered securities, the record dates for the determination of holders to whom interest is payable;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the place or places where the principal of and any premium or interest on the debt securities will be payable and where the debt securities may be surrendered for conversion or exchange;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>whether we may, at our option, redeem the debt securities, and if so, the price or prices at which, the period or periods within which, and the terms and conditions upon which, we may redeem the debt securities, in whole or in part, pursuant to any sinking fund or otherwise;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>if other than 100% of the aggregate principal amount thereof, the portion of the principal amount of the debt securities which will be payable upon declaration of acceleration of the maturity date thereof or provable in bankruptcy, or, if applicable, which is convertible or exchangeable;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>any obligation we may have to redeem, purchase or repay the debt securities pursuant to any sinking fund or analogous provisions or at the option of a holder of debt securities, and the price or prices at which, the currency in which and the period or periods within which, and the terms and conditions upon which, the debt securities will be redeemed, purchased or repaid, in whole or in part, pursuant to any such obligation, and any provision for the remarketing of the debt securities;</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">16</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the issuance of debt securities as registered securities or unregistered securities or both, and the rights of the holders of the debt securities to exchange unregistered securities for registered securities, or vice versa, and the circumstances under which any such exchanges, if permitted, may be made;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the denominations, which may be in United&#x00a0;States Dollars or in any foreign currency, in which the debt securities will be issued, if other than denominations of $1,000 and any integral multiple thereof;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>whether the debt securities will be issued in the form of certificated debt securities, and if so, the form of the debt securities (or forms thereof if unregistered and registered securities are issuable in that series), including the legends required by law or as we deem necessary or appropriate, the form of any coupons or temporary global security which may be issued and the forms of any other certificates which may be required under the indenture or which we may require in connection with the offering, sale, delivery or exchange of the debt securities;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>if other than United&#x00a0;States Dollars, the currency or currencies in which payments of principal, interest and other amounts payable with respect to the debt securities will be denominated, payable, redeemable or repurchasable, as the case may be;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>whether the debt securities may be issuable in tranches;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the obligations, if any, we may have to permit the conversion or exchange of the debt securities into common stock, preferred stock or other capital stock or property, or a combination thereof, and the terms and conditions upon which such conversion or exchange will be effected (including conversion price or exchange ratio), and any limitations on the ownership or transferability of the securities or property into which the debt securities may be converted or exchanged;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>if other than the trustee under the indenture, any trustees, authenticating or paying agents, transfer agents or registrars or any other agents with respect to the debt securities;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>any deletions from, modifications of or additions to the events of default with respect to the debt securities or the right of the Trustee or the holders of the debt securities in connection with events of default;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>any deletions from, modifications of or additions to the covenants with respect to the debt securities;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>if the amount of payments of principal of, and make<FONT CLASS="nobreak">-whole</FONT> amount, if any, and interest on the debt securities may be determined with reference to an index, the manner in which such amount will be determined;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>whether the debt securities will be issued in whole or in part in the global form of one or more debt securities and, if so, the depositary for such debt securities, the circumstances under which any such debt security may be exchanged for debt securities registered in the name of, and under which any transfer of debt securities may be registered in the name of, any person other than such depositary or its nominee, and any other provisions regarding such debt securities;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>whether, under what circumstances and the currency in which, we will pay additional amounts on the debt securities to any holder of the debt securities who is not a United&#x00a0;States person in respect of any tax, assessment or governmental charge and, if so, whether we will have the option to redeem such debt securities rather than pay such additional amounts, and the terms of any such option;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>whether the debt securities will be secured by any collateral and, if so, a general description of the collateral and the terms of any related security, pledge or other agreements;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the persons to whom any interest on the debt securities will be payable, if other than the registered holders thereof on the regular record date therefore; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>any other material terms or conditions upon which the debt securities will be issued.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Unless otherwise indicated in the applicable prospectus supplement, we will issue debt securities in fully registered form without coupons and in denominations of $1,000 and in integral multiples of $1,000, and interest will be computed on the basis of a 360<FONT CLASS="nobreak">-day</FONT> year of twelve 30<FONT CLASS="nobreak">-day</FONT>&#x00a0;months. If any interest payment date or the maturity date falls on a&#x00a0;day that is not a business&#x00a0;day, then the payment will be made on the next business&#x00a0;day without additional interest and with </P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">17</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">the same effect as if it were made on the originally scheduled date. &#x201c;Business&#x00a0;day&#x201d; means any calendar&#x00a0;day that is not a Saturday, Sunday or legal holiday in New&#x00a0;York, New&#x00a0;York, and on which the trustee and commercial banks are open for business in New&#x00a0;York, New&#x00a0;York.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Unless we inform you otherwise in a prospectus supplement, each series of our senior debt securities will rank equally in right of payment with all of our other unsubordinated debt. The subordinated debt securities will rank junior in right of payment and be subordinate to all of our unsubordinated debt.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Unless otherwise indicated in the applicable prospectus supplement, the trustee will act as paying agent and registrar for the debt securities under the indenture. We may act as paying agent under the indenture.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The prospectus supplement will contain a description of United&#x00a0;States federal income tax consequences relating to the debt securities, to the extent applicable.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Covenants</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The applicable prospectus supplement will describe any covenants, such as restrictive covenants restricting us or our subsidiaries, if any, from incurring, issuing, assuming or guarantying any indebtedness or restricting us or our subsidiaries, if any, from paying dividends or acquiring any of our or its capital stock.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Consolidation, Merger and Transfer of Assets</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The indenture permits a consolidation or merger between us and another entity and/or the sale, conveyance or lease by us of all or substantially all of our property and assets, provided that:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the resulting or acquiring entity, if other than us, is organized and existing under the laws of a United&#x00a0;States jurisdiction and assumes all of our responsibilities and liabilities under the indenture, including the payment of all amounts due on the debt securities and performance of the covenants in the indenture;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>immediately after the transaction, and giving effect to the transaction, no event of default under the indenture exists; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>we have delivered to the trustee an officers&#x2019; certificate stating that the transaction and, if a supplemental indenture is required in connection with the transaction, the supplemental indenture comply with the indenture and that all conditions precedent to the transaction contained in the indenture have been satisfied.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">If we consolidate or merge with or into any other entity, or sell or lease all or substantially all of our assets in compliance with the terms and conditions of the indenture, the resulting or acquiring entity will be substituted for us in the indenture and the debt securities with the same effect as if it had been an original party to the indenture and the debt securities. As a result, such successor entity may exercise our rights and powers under the indenture and the debt securities, in our name and, except in the case of a lease, we will be released from all our liabilities and obligations under the indenture and under the debt securities.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Notwithstanding the foregoing, we may transfer all of our property and assets to another entity if, immediately after giving effect to the transfer, such entity is our wholly owned subsidiary. The term &#x201c;wholly owned subsidiary&#x201d; means any subsidiary in which we and/or our other wholly owned subsidiaries, if any, own all of the outstanding capital stock.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Modification and Waiver</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Under the indenture, some of our rights and obligations and some of the rights of the holders of the debt securities may be modified or amended with the consent of the holders of not less than a majority in aggregate principal amount of the outstanding debt securities affected by the modification or amendment. However, the following modifications and amendments will not be effective against any holder without its consent:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>a change in the stated maturity date of any payment of principal or interest;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>a reduction in the principal amount of or interest on any debt securities;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>an alteration or impairment of any right to convert at the rate or upon the terms provided in the indenture;</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">18</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>a change in the currency in which any payment on the debt securities is payable;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>an impairment of a holder&#x2019;s right to sue us for the enforcement of payments due on the debt securities; or</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>a reduction in the percentage of outstanding debt securities required to consent to a modification or amendment of the indenture or required to consent to a waiver of compliance with certain provisions of the indenture or certain defaults under the indenture.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Under the indenture, the holders of not less than a majority in aggregate principal amount of the outstanding debt securities may, on behalf of all holders of the debt securities:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>waive compliance by us with certain restrictive provisions of the indenture; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>waive any past default under the indenture in accordance with the applicable provisions of the indenture, except a default in the payment of the principal of or interest on any series of debt securities.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Events of Default</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Unless we indicate otherwise in the applicable prospectus supplement, &#x201c;event of default&#x201d; under the indenture will mean, with respect to any series of debt securities, any of the following:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>failure to pay interest on any debt security for 30&#x00a0;days after the payment is due;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>failure to pay the principal of any debt security when due, either at maturity, upon redemption, by declaration or otherwise;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>failure on our part to observe or perform any other covenant or agreement in the indenture that applies to the debt securities for 90&#x00a0;days after we have received written notice of the failure to perform in the manner specified in the indenture; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>certain events of bankruptcy, insolvency or reorganization.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Remedies Upon an Event of Default</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">If an event of default occurs and continues, the trustee or the holders of not less than 25% in aggregate principal amount of the outstanding debt securities of such series may declare the entire principal of all the debt securities to be due and payable immediately, except that, if the event of default is caused by certain events in bankruptcy, insolvency or reorganization, the entire principal of all of the debt securities of such series will become due and payable immediately without any act on the part of the trustee or holders of the debt securities. If such a declaration occurs, the holders of a majority of the aggregate principal amount of the outstanding debt securities of such series can, subject to conditions, rescind the declaration.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The indenture requires us to furnish to the trustee not less often than annually, a certificate from our principal executive officer, principal financial officer or principal accounting officer, as the case may be, as to such officer&#x2019;s knowledge of our compliance with all conditions and covenants under the indenture. The trustee may withhold notice to the holders of debt securities of any default, except defaults in the payment of principal of or interest on any debt securities if the trustee in good faith determines that the withholding of notice is in the best interests of the holders. For purposes of this paragraph, &#x201c;default&#x201d; means any event which is, or after notice or lapse of time or both would become, an event of default under the indenture.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The trustee is not obligated to exercise any of its rights or powers under the indenture at the request, order or direction of any holders of debt securities, unless the holders offer the trustee satisfactory security or indemnity. If satisfactory security or indemnity is provided, then, subject to other rights of the trustee, the holders of a majority in aggregate principal amount of the outstanding debt securities may direct the time, method and place of:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>conducting any proceeding for any remedy available to the trustee; or</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>exercising any trust or power conferred upon the trustee.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">19</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The holder of a debt security will have the right to begin any proceeding with respect to the indenture or for any remedy only if:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the holder has previously given the trustee written notice of a continuing event of default;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the holders of not less than a majority in aggregate principal amount of the outstanding debt securities have made a written request of, and offered reasonable indemnity to, the trustee to begin such proceeding;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the trustee has not started such proceeding within 60&#x00a0;days after receiving the request; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>no direction inconsistent with such written request has been given to the trustee under the indenture.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">However, the holder of any debt security will have an absolute right to receive payment of principal of and interest on the debt security when due and to institute suit to enforce this payment.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Satisfaction and Discharge; Defeasance</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Satisfaction and Discharge of Indenture.<FONT STYLE="width: 13px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>Unless otherwise indicated in the applicable prospectus supplement, if at any time,</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>we have paid the principal of and interest on all the debt securities of any series, except for debt securities which have been destroyed, lost or stolen and which have been replaced or paid in accordance with the indenture, as and when the same shall have become due and payable, or</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>we have delivered to the trustee for cancellation all debt securities of any series theretofore authenticated, except for debt securities of such series which have been destroyed, lost or stolen and which have been replaced or paid as provided in the indenture, or</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>all the debt securities of such series not theretofore delivered to the trustee for cancellation have become due and payable, or are by their terms are to become due and payable within one year or are to be called for redemption within one year, and we have deposited with the trustee, in trust, sufficient money or government obligations, or a combination thereof, to pay the principal, any interest and any other sums due on the debt securities, on the dates the payments are due or become due under the indenture and the terms of the debt securities,</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">then the indenture shall cease to be of further effect with respect to the debt securities of such series, except for:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>rights of registration of transfer and exchange, and our right of optional redemption;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>substitution of mutilated, defaced, destroyed, lost or stolen debt securities;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>rights of holders to receive payments of principal thereof and interest thereon upon the original stated due dates therefor (but not upon acceleration) and remaining rights of the holders to receive mandatory sinking fund payments, if any;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the rights, obligations and immunities of the trustee under the indenture; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the rights of the holders of such series of debt securities as beneficiaries thereof with respect to the property so deposited with the trustee payable to all or any of them.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Defeasance and Covenant Defeasance.<FONT STYLE="width: 13px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>Unless otherwise indicated in the applicable prospectus supplement, we may elect with respect to any debt securities of any series either:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>to defease and be discharged from all of our obligations with respect to such debt securities (&#x201c;defeasance&#x201d;), with certain exceptions described below; or</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>to be released from our obligations with respect to such debt securities under such covenants as may be specified in the applicable prospectus supplement, and any omission to comply with those obligations will not constitute a default or an event of default with respect to such debt securities (&#x201c;covenant defeasance&#x201d;).</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">20</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We must comply with the following conditions before the defeasance or covenant defeasance can be effected:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>we must irrevocably deposit with the indenture trustee or other qualifying trustee, under the terms of an irrevocable trust agreement in form and substance satisfactory to the trustee, trust funds in trust solely for the benefit of the holders of such debt securities, sufficient money or government obligations, or a combination thereof, to pay the principal, any interest and any other sums on the due dates for those payments; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>we must deliver to the trustee an opinion of counsel to the effect that the holders of such debt securities will not recognize income, gain or loss for federal income tax purposes as a result of defeasance or covenant defeasance, as the case may be, to be effected with respect to such debt securities and will be subject to federal income tax on the same amount, in the same manner and at the same times as would be the case if such defeasance or covenant defeasance, as the case may be, had not occurred.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">In connection with defeasance, any irrevocable trust agreement contemplated by the indenture must include, among other things, provision for:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>payment of the principal of and interest on such debt securities, if any, appertaining thereto when due (by redemption, sinking fund payments or otherwise),</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the payment of the expenses of the trustee incurred or to be incurred in connection with carrying out such trust provisions,</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>rights of registration, transfer, substitution and exchange of such debt securities in accordance with the terms stated in the indenture, and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>continuation of the rights, obligations and immunities of the trustee as against the holders of such debt securities as stated in the indenture.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The accompanying prospectus supplement may further describe any provisions permitting or restricting defeasance or covenant defeasance with respect to the debt securities of a particular series.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Global Securities</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Unless otherwise indicated in the applicable prospectus supplement, each debt security offered by this prospectus will be issued in the form of one or more global debt securities representing all or part of that series of debt securities. This means that we will not issue certificates for that series of debt securities to the holders. Instead, a global debt security representing that series will be deposited with, or on behalf of, a securities depositary and registered in the name of the depositary or a nominee of the depositary. Any such depositary must be a clearing agency registered under the Exchange&#x00a0;Act. We will describe the specific terms of the depositary arrangement with respect to a series of debt securities to be represented by a global security in the applicable prospectus supplement.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Notices</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We will give notices to holders of the debt securities by mail at the addresses listed in the security register. In the case of notice in respect of unregistered securities or coupon securities, we may give notice by publication in a newspaper of general circulation in New&#x00a0;York, New&#x00a0;York.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Governing Law</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The particular terms of a series of debt securities will be described in a prospectus supplement relating to such series of debt securities. Any indentures will be subject to and governed by the Trust Indenture Act&#x00a0;of&#x00a0;1939, as amended, and may be supplemented or amended from time to time following their execution. Unless otherwise stated in the applicable prospectus supplement, we will not be limited in the amount of debt securities that we may issue, and neither the senior debt securities nor the subordinated debt securities will be secured by any of our property or assets. Thus, by owning debt securities, you are one of our unsecured creditors.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Regarding the Trustee</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">From time to time, we may maintain deposit accounts and conduct other banking transactions with the trustee to be appointed under the indenture or its affiliates in the ordinary course of business.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">21</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9919"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">DESCRIPTION OF WARRANTS</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We may offer to sell warrants from time to time. If we do so, we will describe the specific terms of the warrants in a prospectus supplement. In particular, we may issue warrants for the purchase of common stock, preferred stock and/or debt securities in one or more series. We may also issue warrants independently or together with other securities and the warrants may be attached to or separate from those securities.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We will evidence each series of warrants by warrant certificates that we will issue under a separate agreement. We will enter into the warrant agreement with a warrant agent. We will indicate the name and address of the warrant agent in the applicable prospectus supplement relating to a particular series of warrants.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We will describe in the applicable prospectus supplement the terms of the series of warrants, including:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the offering price and aggregate number of warrants offered;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the currency for which the warrants may be purchased;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each such security or each principal amount of such security;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>if applicable, the date on and after which the warrants and the related securities will be separately transferable;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>in the case of warrants to purchase debt securities, the principal amount of debt securities purchasable upon exercise of one warrant and the price at, and currency in which, this principal amount of debt securities may be purchased upon such exercise;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>in the case of warrants to purchase common stock or preferred stock, the number of shares of common stock or preferred stock, as the case may be, purchasable upon the exercise of one warrant and the price at which these shares may be purchased upon such exercise;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the effect of any merger, consolidation, sale or other disposition of our business on the warrant agreement and the warrants;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the terms of any rights to redeem or call the warrants;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise of the warrants;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the dates on which the right to exercise the warrants will commence and expire;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the manner in which the warrant agreement and warrants may be modified;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>certain United&#x00a0;States federal income tax consequences of holding or exercising the warrants;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the terms of the securities issuable upon exercise of the warrants; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>any other specific material terms, preferences, rights or limitations of or restrictions on the warrants.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Holders may exercise the warrants by delivering the warrant certificate representing the warrants to be exercised together with other requested information, and paying the required amount to the warrant agent in immediately available funds, as provided in the applicable prospectus supplement. We will set forth in the applicable prospectus supplement the information that the holder of the warrant will be required to deliver to the warrant agent.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Upon receipt of the required payment and the warrant certificate properly completed and duly executed at the office of the warrant agent or any other office indicated in the applicable prospectus supplement, we will issue and deliver the securities purchasable upon such exercise. If a holder exercises fewer than all of the warrants represented by the warrant certificate, then we will issue a new warrant certificate for the remaining amount of warrants.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">22</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Holder will not have any of the rights of the holders of the securities purchasable upon the exercise of warrants until you exercise them. Accordingly, holder will not be entitled to, among other things, vote or receive dividend payments or similar distributions on the securities you can purchase upon exercise of the warrants.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The information provided above is only a summary of the terms under which we may offer warrants for sale. Accordingly, investors must carefully review the applicable warrant agreement for more information about the specific terms and conditions of these warrants before investing in us. In addition, please carefully review the information provided in the applicable prospectus supplement, which contains additional information that is important for you to consider in evaluating an investment in our securities.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">23</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9920"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">DESCRIPTION OF RIGHTS</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We may issue rights to our stockholders to purchase shares of our common stock or preferred stock described in this prospectus. We may offer rights separately or together with one or more additional rights, preferred stock, common stock, warrants or any combination of those securities in the form of units, as described in the applicable prospectus supplement. Each series of rights will be issued under a separate rights agreement to be entered into between us and a bank or trust company, as rights agent. The rights agent for any rights we offer will be set forth in the applicable prospectus supplement. The rights agent will act solely as our agent in connection with the certificates relating to the rights of the series of certificates and will not assume any obligation or relationship of agency or trust for or with any holders of rights certificates or beneficial owners of rights. The following description sets forth certain general terms and provisions of the rights to which any prospectus supplement may relate. The particular terms of the rights to which any prospectus supplement may relate and the extent, if any, to which the general provisions may apply to the rights so offered will be described in the applicable prospectus supplement. To the extent that any particular terms of the rights, rights agreement or rights certificates described in a prospectus supplement differ from any of the terms described below, then the terms described below will be deemed to have been superseded by that prospectus supplement. We encourage you to read the applicable rights agreement and rights certificate for additional information before you decide whether to purchase any of our rights.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The prospectus supplement relating to any rights that we offer will include specific terms relating to the offering, including, among other matters:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the date of determining the stockholders entitled to the rights distribution;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the aggregate number of shares of common stock, preferred stock or other securities purchasable upon exercise of the rights;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the exercise price;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the aggregate number of rights issued;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>whether the rights are transferrable and the date, if any, on and after which the rights may be separately transferred;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the date on which the right to exercise the rights will commence, and the date on which the right to exercise the rights will expire;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the method by which holders of rights will be entitled to exercise;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the conditions to the completion of the offering;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the withdrawal, termination and cancellation rights;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>whether there are any backstop or standby purchaser or purchasers and the terms of their commitment;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>whether stockholders are entitled to oversubscription right;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>any U.S.&#x00a0;federal income tax considerations; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>any other terms of the rights, including terms, procedures and limitations relating to the distribution, exchange and exercise of the rights.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">If less than all of the rights issued in any rights offering are exercised, we may offer any unsubscribed securities directly to persons other than stockholders, to or through agents, underwriters or dealers or through a combination of such methods, including pursuant to standby arrangements, as described in the applicable prospectus supplement. In connection with any rights offering, we may enter into a standby underwriting or other arrangement with one or more underwriters or other persons pursuant to which such underwriters or other persons would purchase any offered securities remaining unsubscribed for after such rights offering.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">24</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9921"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">DESCRIPTION OF UNITS</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We may issue units consisting of any combination of the other types of securities offered under this prospectus in one or more series. We may evidence each series of units by unit certificates that we will issue under a separate agreement. We may enter into unit agreements with a unit agent. We will indicate the name and address of the unit agent in the applicable prospectus supplement relating to a particular series of units.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The following description, together with the additional information included in any applicable prospectus supplement, summarizes the general features of the units that we may offer under this prospectus. You should read any prospectus supplement and any free writing prospectus that we may authorize to be provided to you related to the series of units being offered, as well as the complete unit agreements that contain the terms of the units. Specific unit agreements will contain additional important terms and provisions and we will file as an exhibit to the registration statement of which this prospectus is a part, or will incorporate by reference from another report that we file with the SEC, the form of each unit agreement relating to units offered under this prospectus.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">If we offer any units, certain terms of that series of units will be described in the applicable prospectus supplement, including, without limitation, the following, as applicable:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the title of the series of units;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>identification and description of the separate constituent securities comprising the units;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the price or prices at which the units will be issued;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>the date, if any, on and after which the constituent securities comprising the units will be separately transferable;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>a discussion of certain United&#x00a0;States federal income tax considerations applicable to the units; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>any other terms of the units and their constituent securities.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">25</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9922"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">PLAN OF DISTRIBUTION</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We may sell our securities from time to time pursuant to underwritten public offerings, negotiated transactions, block trades or a combination of these methods or through underwriters or dealers, through agents and/or directly to one or more purchasers. Our securities may be distributed from time to time in one or more transactions:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>at a fixed price or prices, which may be changed;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>at market prices prevailing at the time of sale;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>at prices related to such prevailing market prices; or</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>at negotiated prices.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Each time that we sell securities covered by this prospectus, we will provide a prospectus supplement or supplements that will describe the method of distribution and set forth the terms and conditions of the offering of such securities, including the offering price of the securities and the proceeds to us, if applicable.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Offers to purchase the securities being offered by this prospectus may be solicited directly. Agents may also be designated to solicit offers to purchase the securities from time to time. Any agent involved in the offer or sale of our securities will be identified in a prospectus supplement.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">If a dealer is utilized in the sale of the securities being offered by this prospectus, the securities will be sold to the dealer, as principal. The dealer may then resell the securities to the public at varying prices to be determined by the dealer at the time of resale.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">If an underwriter is utilized in the sale of the securities being offered by this prospectus, an underwriting agreement will be executed with the underwriter at the time of sale and the name of any underwriter will be provided in the prospectus supplement that the underwriter will use to make resales of the securities to the public. In connection with the sale of the securities, we or the purchasers of securities for whom the underwriter may act as agent, may compensate the underwriter in the form of underwriting discounts or commissions. The underwriter may sell the securities to or through dealers, and those dealers may receive compensation in the form of discounts, concessions or commissions from the underwriters and/or commissions from the purchasers for which they may act as agent. Unless otherwise indicated in a prospectus supplement, an agent will be acting on a best efforts basis and a dealer will purchase securities as a principal, and may then resell the securities at varying prices to be determined by the dealer.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Any compensation paid to underwriters, dealers or agents in connection with the offering of the securities, and any discounts, concessions or commissions allowed by underwriters to participating dealers will be provided in the applicable prospectus supplement. Underwriters, dealers and agents participating in the distribution of the securities may be deemed to be underwriters within the meaning of the Securities Act&#x00a0;of&#x00a0;1933, as amended, and any discounts and commissions received by them and any profit realized by them on resale of the securities may be deemed to be underwriting discounts and commissions. We may enter into agreements to indemnify underwriters, dealers and agents against civil liabilities, including liabilities under the Securities Act, or to contribute to payments they may be required to make in respect thereof and to reimburse those persons for certain expenses.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Any common stock will be listed on the Nasdaq Capital Market, but any other securities may or may not be listed on a national securities exchange. To facilitate the offering of securities, certain persons participating in the offering may engage in transactions that stabilize, maintain or otherwise affect the price of the securities. This may include over<FONT CLASS="nobreak">-allotments</FONT> or short sales of the securities, which involve the sale by persons participating in the offering of more securities than were sold to them. In these circumstances, these persons would cover such over<FONT CLASS="nobreak">-allotments</FONT> or short positions by making purchases in the open market or by exercising their over<FONT CLASS="nobreak">-allotment</FONT> option, if any. In addition, these persons may stabilize or maintain the price of the securities by bidding for or purchasing securities in the open market or by imposing penalty bids, whereby selling concessions allowed to dealers participating in the offering may be reclaimed if securities sold by them are repurchased in connection with stabilization transactions. The effect of these transactions may be to stabilize or maintain the market price of the securities at a level above that which might otherwise prevail in the open market. These transactions may be discontinued at any time.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We may engage in at the market offerings into an existing trading market in accordance with Rule&#x00a0;415(a)(4)&#x00a0;under the Securities Act.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">26</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">In addition, we may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. If the applicable prospectus supplement so indicates, in connection with those derivatives, the third parties may sell securities covered by this prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third party may use securities pledged by us or borrowed from us or others to settle those sales or to close out any related open borrowings of stock, and may use securities received from us in settlement of those derivatives to close out any related open borrowings of stock. The third party in such sale transactions will be an underwriter and, if not identified in this prospectus, will be named in the applicable prospectus supplement (or a post<FONT CLASS="nobreak">-effective</FONT> amendment). In addition, we may otherwise loan or pledge securities to a financial institution or other third party that in turn may sell the securities short using this prospectus and an applicable prospectus supplement. Such financial institution or other third party may transfer its economic short position to investors in our securities or in connection with a concurrent offering of other securities.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We do not make any representation or prediction as to the direction or magnitude of any effect that the transactions described above might have on the price of the securities. In addition, we do not make any representation that underwriters will engage in such transactions or that such transactions, once commenced, will not be discontinued without notice.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The specific terms of any lock<FONT CLASS="nobreak">-up</FONT> provisions in respect of any given offering will be described in the applicable prospectus supplement.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">To comply with applicable state securities laws, the securities offered by this prospectus will be sold, if necessary, in such jurisdictions only through registered or licensed brokers or dealers. In addition, securities may not be sold in some states unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The underwriters, dealers and agents may engage in transactions with us, or perform services for us, in the ordinary course of business for which they receive compensation.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">27</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9923"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">LEGAL MATTERS</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Lucosky Brookman LLP will pass upon certain legal matters relating to the issuance and sale of the securities offered hereby on behalf of HeartBeam, Inc. Additional legal matters may be passed upon for us or any underwriters, dealers or agents, by counsel that we will name in the applicable prospectus supplement.</P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9924"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">EXPERTS</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The financial statements of HeartBeam, Inc. as of December&#x00a0;31, 2021 and 2020, and for each of the&#x00a0;years in the two year period ended December&#x00a0;31, 2021, incorporated by reference in this Registration Statement, have been included in reliance upon the reports of Friedman LLP, an independent registered public accounting firm, appearing elsewhere herein, and upon the authority of said firm as experts in accounting and auditing.</P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9925"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">WHERE YOU CAN FIND MORE INFORMATION</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The SEC maintains a web site that contains reports, proxy and information statements and other information about issuers, such as us, who file electronically with the SEC.&#x00a0;The address of that website is <FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">http:</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">//</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">www.sec.gov</FONT>.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Our website address is <FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">https:</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">//</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">www.heartbeam.com</FONT>. The information on our website, however, is not, and should not be deemed to be, a part of this prospectus.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">This prospectus and any prospectus supplement are part of a registration statement that we filed with the SEC and do not contain all of the information in the registration statement. The full registration statement may be obtained from the SEC or us, as provided below. Forms of the documents establishing the terms of the offered securities are or may be filed as exhibits to the registration statement. Statements in this prospectus or any prospectus supplement about these documents are summaries and each statement is qualified in all respects by reference to the document to which it refers. You should refer to the actual documents for a more complete description of the relevant matters. You may inspect a copy of the registration statement through the SEC&#x2019;s website, as provided above.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">28</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9926"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">INCORPORATION BY REFERENCE</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">The SEC&#x2019;s rules allow us to &#x201c;incorporate by reference&#x201d; information into this prospectus, which means that we can disclose important information to you by referring you to another document filed separately with the SEC.&#x00a0;The information incorporated by reference is deemed to be part of this prospectus, and subsequent information that we file with the SEC will automatically update and supersede that information. Any statement contained in a previously filed document incorporated by reference will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus modifies or replaces that statement.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">We incorporate by reference our documents listed below and any future filings made by us with the SEC under Sections 13(a), 13(c), 14 or 15(d)&#x00a0;of the Securities Exchange&#x00a0;Act&#x00a0;of&#x00a0;1934, as amended, which we refer to as the &#x201c;Exchange&#x00a0;Act&#x201d; in this prospectus, between the date of this prospectus and the termination of the offering of the securities described in this prospectus. We are not, however, incorporating by reference any documents or portions thereof, whether specifically listed below or filed in the future, that are not deemed &#x201c;filed&#x201d; with the SEC, including any information furnished pursuant to Items 2.02 or 7.01 of Form&#x00a0;8<FONT CLASS="nobreak">-K</FONT> or related exhibits furnished pursuant to Item&#x00a0;9.01 of Form&#x00a0;8<FONT CLASS="nobreak">-K</FONT>.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">This prospectus and any accompanying prospectus supplement incorporate by reference the documents set forth below that have previously been filed with the SEC:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>Our Annual Report on <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1779372/000177937222000011/beat-20211231.htm">Form&#x00a0;10<FONT CLASS="nobreak">-K</FONT></A> for the year ended December<FONT CLASS="nobreak">&#x00a0;</FONT>31, 2021, filed with the SEC on March<FONT CLASS="nobreak">&#x00a0;</FONT>24, 2022.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>Our Quarterly Report on Form&#x00a0;10<FONT CLASS="nobreak">-Q</FONT> for the quarter ended <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1779372/000177937222000017/beat-20220331.htm">March<FONT CLASS="nobreak">&#x00a0;</FONT>31, 2022</A>, <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1779372/000177937222000034/beat-20220630.htm">June<FONT CLASS="nobreak">&#x00a0;</FONT>30, 2022</A> and <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1779372/000177937222000047/beat-20220930.htm">September<FONT CLASS="nobreak">&#x00a0;</FONT>30</A>, filed with the SEC on May<FONT CLASS="nobreak">&#x00a0;</FONT>12, 2022, August<FONT CLASS="nobreak">&#x00a0;</FONT>11, 2022 and November<FONT CLASS="nobreak">&#x00a0;</FONT>10, 2022 respectively.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>Our Current Reports on Form&#x00a0;8<FONT CLASS="nobreak">-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1779372/000177937222000005/beat-20220131.htm">February<FONT CLASS="nobreak">&#x00a0;</FONT>2, 2022</A>, <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1779372/000177937222000007/beat-20220218.htm">February<FONT CLASS="nobreak">&#x00a0;</FONT>22, 2022</A>, <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1779372/000177937222000010/beat-20220307.htm">March<FONT CLASS="nobreak">&#x00a0;</FONT>10, 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1779372/000177937222000019/form8-kx06162022.htm">June<FONT CLASS="nobreak">&#x00a0;</FONT>16, 2022</A>, <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1779372/000177937222000033/beat-20220802.htm">August<FONT CLASS="nobreak">&#x00a0;</FONT>8, 2022</A>, <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1779372/000177937222000035/beat-20220811.htm">August<FONT CLASS="nobreak">&#x00a0;</FONT>12, 2022</A>, <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1779372/000177937222000039/beat-20220919.htm">September<FONT CLASS="nobreak">&#x00a0;</FONT>21, 2022</A>, <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1779372/000177937222000048/beat-20221114.htm">November<FONT CLASS="nobreak">&#x00a0;</FONT>17, 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1779372/000177937223000001/beat-20230118.htm">January<FONT CLASS="nobreak">&#x00a0;</FONT>24, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1779372/000177937223000004/beat-20230228.htm">March<FONT CLASS="nobreak">&#x00a0;</FONT>3, 2023</A>, and <A HREF="http://www.sec.gov/Archives/edgar/data/1779372/000177937223000005/beat-20230308.htm">March<FONT CLASS="nobreak">&#x00a0;</FONT>8, 2023</A>.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>The information specifically incorporated by reference into our Annual Report on Form&#x00a0;10<FONT CLASS="nobreak">-K</FONT> for the year ended December<FONT CLASS="nobreak">&#x00a0;</FONT>31, 2021 from our definitive <A HREF="http://www.sec.gov/Archives/edgar/data/1779372/000177937222000015/heartbeaminc-proxystatemen.htm">proxy statement</A> for the annual meeting of stockholders held on June<FONT CLASS="nobreak">&#x00a0;</FONT>15, 2022, filed with the SEC on&#x00a0;May<FONT CLASS="nobreak">&#x00a0;</FONT>2, 2022.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>Our <A HREF="http://www.sec.gov/Archives/edgar/data/1779372/000177937222000044/heartbeaminc-proxystatemen.htm">proxy statement</A> for the special meeting of stockholders was held on November<FONT CLASS="nobreak">&#x00a0;</FONT>14, 2022, filed with the SEC on&#x00a0;October<FONT CLASS="nobreak">&#x00a0;</FONT>11, 2022.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;<FONT STYLE="width: 27px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></FONT>The description of our securities contained in our Registration Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1779372/000121390021058171/ea150371-8a12b_heartbeaminc.htm">Form&#x00a0;8<FONT CLASS="nobreak">-A</FONT></A> filed with the SEC on November<FONT CLASS="nobreak">&#x00a0;</FONT>10, 2021, including any amendment or report filed for the purpose of updating such description.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">All reports and other documents we subsequently file pursuant to Section&#x00a0;13(a), 13(c), 14 or 15(d)&#x00a0;of the Exchange&#x00a0;Act prior to the termination of this offering, including all such documents we may file with the SEC after the date of the initial registration statement and prior to the effectiveness of the registration statement, but excluding any information furnished to, rather than filed with, the SEC, will also be incorporated by reference into this prospectus and deemed to be part of this prospectus from the date of the filing of such reports and documents.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">You may request a free copy of any of the documents incorporated by reference in this prospectus (other than exhibits, unless they are specifically incorporated by reference in the documents) by writing or telephoning us at the following address:</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Branislav Vajdic<BR>Chief Executive Officer<BR>2118 Walsh Avenue, Suite 210<BR>Santa Clara, CA&#x00a0;95050<BR>Telephone:&#x00a0;408-899-4443</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:8pt;">Exhibits to the filings will not be sent, however, unless those exhibits have specifically been incorporated by reference in this prospectus and any accompanying prospectus supplement.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">29</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<DIV STYLE="border: none; border-bottom: double windowtext 6.0pt; padding: 0in 0in 4.0pt 0in; margin-left: 0in; margin-right: 0.0pt;"></DIV>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:48pt;margin-top:48pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;font-size:14pt;"> 1,000,000<BR>Shares of Common Stock</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:48pt;text-align:center;margin-top:48pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;font-size:18pt;">HeartBeam, Inc.</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:48pt;margin-top:48pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">____________________________</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Prospectus Supplement</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:2pt;margin-top:2pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">____________________________</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-bottom:36pt;margin-top:48pt;margin-top:48pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">May&#x00a0;4, 2023</FONT></P>
		<DIV STYLE="border: none; border-bottom: double windowtext 6.0pt; padding: 0in 0in 4.0pt 0in; margin-left: 0in; margin-right: 0.0pt;"></DIV>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">&#x00a0;</P>


</DIV></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>timage_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 timage_001.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &0      04  DE$_]L
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MI'3U7I*J"OT:YY]VZU7UX>75=Q0@!OP??NM]>*,%U?B]O\??NO=<A&[*7%K
M$GGFPO?C_8>_=>ZQ@7X'OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z,O\,9_MOES\9J@F
MP@[UZMF)-K 1[RP[G]7'X_/OW6CPSU]@3X\5AJ_C7T!7:@RGKG%,"--K,BH.
M5NONK9HOKUOCT+R$$%@18@CZ\^VLJ3Z]>ZQ1 B-0WUYO^/[1_P!;\>]M\1Z]
MUD]UZ]U)HXDFJ85<@ 2QMR;7(D46^HY-_=DXG/7NE=EJ>-*ZI"LI!T']5_\
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MHRH.#Y$!!O\ 7^A]^Z]U(-34.AAOKC%E]" \+8CD"_U'OW7NHTAC)'C5E&D
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M4^RF^@'+1UE_TBWX]ML0 1ZYZV>/5C\J@VN.!8_D<B_N@KY=:ZZ+!C<<@_\
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MD:2K@-5#O?<^$@#U.,I,3J9<9DX1I2CHHQP/P3]23[V"#P'#K=?7K7?^4O\
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M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NN05B"P'"_4_P!/?NO=2/ CJ/#+Y)+
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MMS[]U8$T]1Z]13 ZBYX _P!;_BOOW6PP. >N'C_Q_P!X_P"-^_=6Z]X_\?\
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M]UCD0N!8VTL'/-N%Y_V/NRBI/V=>Z5>"A%/%+EO&6$B*]]&OB!I$X%ASZ?\
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M,K\G^R:W%U^_JFMV'BJ['-43-OSK'L;;E/1S3XB"O@@GJX:FG(F$TIA XU2
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MI(XY )'U^NH6_/OQU:J?AZ*YZ "G"O3E7)_N(J@5/*)J^H_W<IY_I[N8T !
MR>/2^X/^Z9JG\!_X]TD^E26Q^\2?[.\*]5_P7Q4]A_C;WM%%:>70<V$GP+PU
MSXQ'\AT-L9+(">2;_P"]GWKH0=<)E+1R*K",D"SM]!R/Z\>]FE%KD>G53^+R
M^?37BX9XS,6J8YHO-+Z%11:X2W(%^/?CPQ\/55XU_;T\_P!H\'_7_K[W^$9_
M+JWXCC\^N_=>K=>]^Z]U[W[KW7B+\'WL&F1UHBN#UA>%'-R.;6^I_P ?\?\
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M ?7J?D$)Q%9].44C_83 ^]C.>E-QC:67S"?Y>D)TES0[R7\G>.0/^'^:I_\
MBGO:')/D.B'8<P7@\S,W^ =#>BE5"GZB_P!/\23[UT(>NG4.K*WZ3;Z&Q_K]
M3Q]?>QY4X]5(J""<=-F-BI29Y:=ICHJ)8V#LI779=1 7\6(M?GWMC6E.''\^
MM*/V].O-_P 6_P!Y]ZQ3Y]6S7Y==^]=;Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NN!0'GG_??[#W<.1CJA0'/7M _Q_P!X_P"*>_:SU[0/
MGUT4_I_O/_(O>P_KUHIZ=09X3ZB"/K<W_J6YMQ].??J4.ORZ;.,=,L\.@'FX
MOQ_6^F_/ ]V/<M>O=-TJ%]-K<7^M_P V_P #_3VSU8$ $'IOEB9GX*\>D_7Z
M@G_#W[JP(7'Y]-S+;G\?[S[]TYU'>.X:_P!#_M_KQ[]U[J!(7IP9%"L"P6S*
M7]+'ZVL.;#W[KW6:G(,C&1;TQ %." 9/+<7\H^F@M?Z?CW[KW0(;L@^SS58R
MK9JVJJ)([#T (REK\#3PWXO[J:4->O=:F_\ PJ'^*[=@]!X'N?;M% <]!N/K
M/8LTLFM0N/H(>T=Q5)\=)A:NHMKD%F,^FYL4'ZO>^%.M&O'R&>OG9FUU<%M)
M/J _58?7CZ?CWOK?7!P ;@\-R/Z@'\'\7]^Z]UP]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U-IRT=//,D#M)&T>FJ%RE/J.DA
ME(*$R V%_P"OOW7NAMZ0^./;7R'W'1;9ZKV7N?>&4JZA?-2;:P57G:REHEK<
M?15>2:CI")I*>CER<0>UN7 O<^_<.M9K0=;<'P-_X2];IS\6*WE\FZVEIZ"6
M:EJ9-H[PV3V%L_+TT=!N'+4==!)+B]VXN1'R.-IH95/&B)T8<F_O5:=;H*9X
M];-G0?\ )]^ /QSAPLNV.EL8^Z,=0P0U6:H^P^X'CGK5Q#X>NG7'Y3L3(T<0
MJHI9+(([(&X (!&B?D>O?X.K)\)A<5MFG%%M2F7%T0B,1@26>M'B=8TD376R
MU,GJ6)!>]Q;_ !]UJU2!Z=>Z=XZ5R>>/Z$C_ %_\?>@A-">'7NG6&D55&K_8
MWU"_ Y^O'/MP #AU[K,^E/TCC_7_ #SSS>_O?7NO(38'\\_\3[]U[J'6,"C7
M(!N!R1SZO=6) J.O=,[M?@?[?VSU[KA[]U[KF%'^J'^^_P!C[]U[KVD?ZH?[
MQ_Q7W[KW71 'T-_?NO=<??NO==$V!/\ 0$_[;WX9QU[KI)$-OR3^+\C^OT]V
M*D?9U[KF;?@6_P!C?W7KW6)RQ*K8A+^IK"VD_J_Q]W%=(_EU[KDRTZ:3&5>2
MUP%9KW/#"Q-CQ[VU:"OY]>Z7*R5#8B-)$<0_=!E8J NOQ$ 7 !OI_P ?=Q\N
MO=0/>^O=>]^Z]U+HA9K?[[ZK[UZ]>Z5= I*BP/U'_0S>]]>Z6%$E@H/UTB__
M "2..#^/>B,U!STI@^%OMZ6-*IN#_K_]##G_ %O?JCHJN 2HKQU<.G*O6V(J
MC?\ W4.+?UE'OPX8X=/W)_W6./Z/^7H/.D?^ F\/_#PR'_6F'WM/AD^WHCV#
M^RN?^:[?X!T.7OW0AZZ90P*L+@_4?\B]^Z]TT8B.-8JL(FD??3W]3&YTQ\\G
MC_6][#$<#U0*" 3D].]A>_Y/OU32GEU:@K7SZ[]ZZWU[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=8)%!N#R#S_3\_\
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M6%,/S^-)'_)P][&>(ST53FH4_/IPR0_W#UEAP(D_WF1??EX#IZ[(&W$?T?\
M*.@XZ1_X";P_\/#(?]:8?>T^&3[>B38/[*Y_YKM_@'0Y>_="'KBQ8*2HNWX'
MTO\ [U[]U[[.FG$M(T55>-5(KIP0".;+'<_7ZGW8!<U/38+>61T\>Z].=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO==6!^H'O=2.!ZU0'B.H%3&!=N?Z6-O\ 4\$?[;W?^%O,GIEA0D=,\Z7
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M?['W[KW2;J8WB,X9[ (/25%QZ0;GGW2BAJ#CU[K'2?;2R0!Y4+!6')M;T'\
M@>]4[B*=IZ]TO,@M,OC$+HS^.(D+<FUFO]2?S;W84KCKW39[MU[KWOW7NE)1
M#U6 _P!]=?=5% .O=+'&I=P/I8K^/^#G^ONW7NE93(#P>0./Z?C_  _UO=U
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MX/TO<_CWI14G..O=/\0$:*% X Y(Y^@'U%OZ>W>O=<CS^3_K@\^_=>Z\./\
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M-^I%_P"5NF'/'Y]Z/7N@)N'=)@VD*52R@A;AM5K?7\_ZWMNI6HI\^O=:L_\
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M[\.)]/+KW4B1U.M3%XY?*[<M<Z+G\6 M?WL&IQU[K#<#ZFWO?7NI=+^?]?\
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MOW7NN?OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K@[%
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MV60?1:^I6W'%I#_2P]WZUTQ^_=>Z][]U[KWOW7NO>_=>Z][]U[KD 3P/]?\
MXCW[KW6=I4-/#%8ZD=F?Z<@D_3F][>_=>ZW+?^$K/Q*J-P=F;B^0&YL=60T?
M7&XMHYG 5$JY>AAJJ#>O7O9F(+0^3'#&Y$*RK=C,J+J&DL2![U7B#P^?6J9U
M?EUO@))*T\WW".KK)*(+H4'VH;]K@VU'Z\\@^Z-5A@8ZM2E.L,;!I*@C@-&
M-7']FW/NP[0 >/6NLZ\*H^ME'(^GT_'MH\3U[KOWKKW7$J6*D?V3<_7WOUZ]
MUD+%0+D 6'UMQ^.;CWKKW7!3K!(_QX_)M^!:]R?>Z9IY]>Z)W\S/G5TM\'>O
MZ?>W;=5)-+D*+/U6!P&.S.T\=G<C+MT8J3(4])0[FS^#^\G$>9@8+$7L#=M(
M*WN%(I7\NM_:>@A^ _\ -G^,_P \\_)M'8 RFU]WFKK*7&XO>&?V!%5Y"+'[
M>EW%7ST>-P.[<S7U4,%%32:F2)M#"[64$BV3BM.O4!!(/5J8QE?&IO%(.3]8
MI;G\WYCY!][U</V=:ZPF*>,^I']/U]!OR/\ %1_7WNO7NNRX*_0W-O\ ??7W
M[KW7#W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UTS!?'
M:Y);D#DVO_2_O77NI.%HH9SDI6FACM5 E9)=#7;5^/Q;WH YSU[K )B5: *V
M@2,XDM^V;&VD/^6_/^M[\.(SU[KP^H_UQ[MU[I[HDU:5(X/];CZ(3]?K[JOG
M]O7NEC0KJ?2/]Y_UT'NW7NEK0H&/J!X9!;Z?5F]^ZJQ(I3Y]*JC0%K_A>+7/
M^I-O=Q\##I1:UTL?GTJ7%E ']?\ BOOR<>DS\/SZ:<W_ ,6:M_Y9#_K:GNDO
MXND]S_N))_J\^@NZ6_X!;R_\/+)?]:J?VW'Y]%>P?V=]_P US_@'0U>W.C_K
MBX<CT$ _X_3_ 'H^]XH?7K1KBAZ;,:)?#4>I=?WLO-N+:8[CZ>]=57ACUZ=?
M?NK]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]UAE;T.!]=)O_K:3[N%P2>%.FW;R''IEJ?\ -G_??VE]
M[C\^F^F=V"ZF-[ _C_$V]T/$_;UL"IITVO\ H;_@K?[T?>NK'X_SZ:)/HW^O
M_P 3[]T[U"=M,E[$_M_0?ZY/^VX]^Z]TV1EIC./TVB)]7IMQS>U_?NO=(S?L
M2M18Y3)%Z::6Y+V'^<IR>?\ 8>_=>Z"]E#S(E[VA4W'TX8CZCVVH.D@>O7NJ
MS?YPT9J/@#\CHA]*?I'MUQ]>"^SJ[^ER?K^?=E% /7K8Z^3!N]2FZ,\I^HRE
M6/\ K*WNW51TG/?NM]>]^Z]U[W[KW7O?NO=>]^Z]UFB4&_-FYX_PX_Q]^Z]T
MJ=A[6J]];SV?LG'1.^2W?N?![9H#%&)Y35YS)TV,IA'3M-3K*_FJ193)&&/&
MH?4>Z]U]6G^2U\8X?C7\&.J(JW%_9;CWWUOL"HS=1+1O0U%55[<BS-*DLL7\
M6RT+-X\@?T&,+J_M?44>E#UL^0IU;')(\K*\C%F5!&I-N$%[+Q^!?VWJ/KUK
MK"$07LH&H6/^(]^J33/7NN8XX'T'O77NO>_=>Z[!(^GOW7NO$:^#S?\ '^MS
M[]U[K-!"=2E18!U^GT^H/]?=J-4&G7NM<C_A19_+L[C^8_3^P-W]._QO,Y3J
M^B[7R]?M3![7I<Q/ESN+']>T-!0/D:K=&&&.,AV_,RR""?5R"HTW9VF2>O4K
MU4!_(V_E(_-GJ7M-.\MPT._>H&V9F-R8ZFIJ[96(J?ODW/U[5X<UL>4_OD!3
M*/X@8='VTNO^JWN-5S]G6Z4SUMBG;OSJIIA,^^=_9.EBT$J<5@84D\9U-'<U
MLA%T!7Z'@^[=:ZSOWM\G^O6,.=Z1W7V*5)#3R[LQ>#+^'UL2L.WLGI\RU*CZ
MFWB_-^*\17KV1]O3I1?,CMH**C/?$S-8#'*=$E?4]ETE1&LC+>(%5V1$UYG-
MASP?>Z?MZUGTZ5</SKZAI+INJ7%;7J?H*6HS%?6L6:S1#73[:4?NQW8?TM[U
M3-,_M/6\>O2PPGS&Z'W 5$6\<)2(VBTHERLUPXD(.DX6$\&+_>?>R"2#7KW0
MK4G<W4=<D4D.^\4$EC5T=8*]@P90ZGFF7]2M[\ 1Q/7NEIC,_MG-$?P7<%-E
MF)LD<,$T1=M8C509 O+2>G_8^_<1U[I2OB<D(UF>AEAC(U(3H(E6X!8'4" I
M]Z (^?7NH'ADU%6!C(O];-P./I?^OOQ:@KU[KIUEB8+X#*A(#2Z@H53R7TC5
MP@]ZJ33!KU[KD&3D*HD/X%[?Z_)!_'OS9S4CKW6-@RD>533H1?6?6.;VX'TN
M/]Z]VKZ#/7NN+6/,2>=5N5J%)75_CIYMH(M_C;WZH]<>77NIN&CI33Y-I]".
M:B,EFN2+GDD VY/O0_%G'7NHO[2EDIYQ4>LGP*I73SS)J8F]OI_L??L#B<]>
MZ[]1D4>/1<CC4#_3_6]^![1Y]>Z4U-&D<2,6"MH4W(^EU4$?4CZ^[=>Z5%($
MCE4^4&]N--OJR_0W-_I[]U[I8TK$.A0%KL-=C8?4Z;WXO[]U5J4^?2PI.0I\
M9C]*ZN;ZSI_5S:W)]WX*0>/2FU^!OMZ4;_3_ &/_ !!]^3CTE?A^?33F_P#B
MS5O_ "R'_6U/=)?Q=)[G_<23_5Y]!=TM_P  MY?^'EDO^M5/[;C\^BO8/[.^
M_P":Y_P#H:O;G1_UTP)! .DGZ&U[?[#W[K1R.FS&(5CJ0)_+>LF).C3I-H_1
M:Y^G_$^[57TKU4 TP:=.GNO5^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZC.;JY/^I/^]>WR**0.DY-
M<GIGJ#Z6']+6_P!NOO2#%>O=-#@-J!Y!/_$^VCQ/V]>!ID=-K_H;_@K?[T?>
MNKGX_P ^FIN20?ZG_>_?NG>H4I$9+A=1OH^MN+D_XC\>_=>Z;WNM3$BQ:5EE
MBCD]0.M'(#(?S8CW[KW2([$2,+1QB(6$,X"AC:WE@L/]A[T>''KW05%76'R
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M3_K>R/E?F79MWWFWM;?<5EN&5VT@-FBDGB .G5VR2+N-O3Y?ZCT-)</ROT
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MS@#@W^7K*]DC)O<"YYY^BF_^O]/>][LXMJV3>-WA=C<6MM+<(KTTEHXV=0P
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M_3W[/KU[H(,[_+SIII2V'[U^0],NI3:G['Q]&A B46*1X!/29!S_ (\^]T'
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MSZ]UR]UZ]U[W[KW7O?NO=>]^Z]UC8V:,WMZOZV_WG\>TUR[JJZ&(SY=-2S^
M 3)I!Z45&Q:$&Y(LH_K;@?G_ &'L[LX98TMY[Y3]&4!+'(-1C J>-.G8W$FD
MZJ@BO4F,WU7/(N?KR"+>RW=7VY[DK'I\ J 10T^>.EB2K",-IIGJ%44=)5,D
ME;#'.J$LB3)J"7 #6/\ M0 O[CCFOV@]KO<=+*'F+DC;MUBM&9XENH@PC,@
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M:FP>&%2L0I7'WRTU?J$,#UB,4-?]"X!M]1>P\<@]>Z.)BJ6$Y$13U9,BR3)
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MM0_9T<&G?4I70B*MM(1=*\EKV%[?7W[IN1%2@4]2??NFNL$Q]+C\!3_T+[<
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M%XV4D%D$CZB%)! (;ZG3[WZ];].I&6ZVV7NFF"Y7%35%U35;(5\%SJ68_P#
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M\77NN$J,\4KH2LTFDO$+ 2MJ'ZWX!T#D>_:E%2#U[K*RM*(V-0\#K$J:D!)
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M-(K5Y]$4459"*@8'\S3HIOQGGI<925\6398#43YB*-61I-;SU^/,:_LK(!K
M/UL!^?85M??;VLWJ2WV_;^;EEN)9%C5/ NA5F.@"K0 "I(''J]SLMV&9UM*4
M6M:KY?GT<2C6G4R+"JJPTZPJD6'J*\VM_MO<CK##%F*,+7C3HJ6.6-09%I7A
MU-87! _WW/MQ30@GK3"H('35,3=RPT\<B][67^H_P]^/QY'3/3).0SW'(/\
MQ0>[2>77NFZ?]8_X*/\ >S[;ZN/@/V],LBE6.H?T_H?Q[]TX#7(Z:ZE+W(
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M8")1 6T:G)(LB(N+>.3R<</3/4 WSQ^%=ZD+  8_U>O5SG4=)6C!;BH< _\
M 8:3<LU-3I+&*SQT]/3TT<:!JD2R-:%0MR23:Y-_:&XLB7&EQ2G3O*CH]G>:
M5I2<BE?Z(Z&K)8/'U+P5<U/KJ89XYDF\DZ@/"+QG0DJQ^BP_!!_/M#&H4U([
MNCJ^5;@)J& U1^SI0TT$3T\19;DKR=3<V)_H1_3V:Q,2BMY]-*BZ1U'Q*1)'
M5^)- ^^G!&HM<Z8[GDFWMPG '[?MZVF<^?#IV]ZZOU[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1.OBG&4H\J2;_Y1G/]YR&-
M_P"*>]+\(ZV>/1Q?>^M=>]^Z]U[W[KW4.KCU+JO:WXM_BH_K[N#BOI_EZ:<9
MKTP57!(_HH_Z&/N[92O5.F:7_.-_L/\ H4>V>G1\'4&J_2O^Q_WM??NM1^?3
M>X)'']??NG.HN4.K$Y..W+X^L13_ $+02"]O]C[]U[HMM2SB:IB52&@E*W^H
M:Y'('X]M&E03P/7NN<#@QU (U*U/.C6_#%+&Y']/>T!&:8Z]U\P[_A1[LR7"
M_P QWNW<#.6I<K6]0T<'[4JJ&I_C[UH'(E:1DD]41XL"/;G7O.G6OJX 8V-^
M3_O?OW7NN/OW7NO>_=>Z][]U[K[9VTMO[?V;MJAVMM'"8O 83'UM3D/M,-0P
M8RE!JI6FJC]I31PP_N.UVL+L?Z^Z-1@#UOX:BG2I:.GD\4J,/H20$L&O:U[J
M"??M0I0FG6NO N;ZQ:QTIZM5XQ^DBWZ0?Z?CW1@12ISU[KOW7KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO==CZC_ %Q_O?OW7NNW_4?]A_O0]^Z]
MUR4@"Q_K_2_]/?NO=<#;\&X]^Z]UU[]U[KL"_ ]^Z]UXAE!(^OXY_/\ 3CW[
MKW6$R3 $E>!_M7_&_=Z)ZGKW61(7!#,[$.-8!-Q9N1^3[\U0,J.O=8)JNBA4
M^5EO8\F)V/T)_P!0?Q[]1ACKW3+49NAC5O$1J^@98Y$(L1^?'?D'W8*<5/7O
M(])BJS%7,Q",^D\ B5Q_::W!(M]?=@*=;ZS4F)J:PHTA;U,+W9&^C:?RQ_I[
M]7K72DI\.E)ZFC4@?74L1OQ;^S?\GWJH)%#U[UZ?8OMR H2,$#D".W]!>^G^
MONAU*/E7KW7G#(\*J.-?T!TBW!/'^Q]^ )!)_+KW71DDC,A*74M?EAQS:P_/
MOPS0:L]>Z%'84;"&2:0  F=+<'F].P^A)^@][*AUH!45\^M@$^70DP+J>X8\
M,H%N+FY _I]"/=&1Q&VD4 '2-#_NPCCTU)8#_!TL*#2$ D:QLO)!:_H_PO\
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MC_B9%^EO=M-<MQZ\:>7#K@=TH.#%(#_C$!_O<WOV@?/K771W2A^B.#_C$O\
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MZ:K\,A6G6QT'_6]D.^;9!N,-U!,&TL/PTKY'S!'$=#OD7GO=_;_FS:-_Y?\
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MR)^VS"]_UV-R ;&P_'MSR4^O5E?5UD50>6;R,O!:VG_86!M]?>NK @UZP2!
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MC_7CW[MXUZ50Q"$,JX%:YZS_ ,6/^J3_ &R_]'^ZZ4]>GJM_&.L3Y'7^I_\
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M7C_FZV2JL_:3/%/Z2CLBD>JZJ[(I.F_)*GW5EX$#KW7<JF+1KXUMI6W-R?\
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M7W>E.!QU<Q(34]8W %K?X_\ $>]C[:]>\!#P!Z[\=1)8M+!I L!<@V_%^.;
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MT_I_K>_=>ZZN>!<V'T']+_T]^Z]UR9F:VIF;2 JZB3I4?0"_T ]^Z]UO!?\
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MO>Z&O#KW2!RF4DG9H[DKJ8<L3:S*PM=1_3VZ%\^M_(<.F#W;K77O?NO=<E+
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MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KG'(T3K(ALRWL;
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M^5&TH4!+-MO>7'_!=O5A)%@?Z>_=4?@/MZ^PG.%%'@PM[#;N#_5];_P^&_\
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MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NNF<(CD_P"H8?6WXO\
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M84O_ #NL9_U*S/\ ]:??NO=>^PI?^=UC/^I69_\ K3[]U[KWV%+_ ,[K&?\
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MFO\ O8'\1/\ T"_GI_\ <1^_=>Z]_LMG37_>P/XB?^@7\]/_ +B/W[KW7O\
M9;.FO^]@?Q$_] OYZ?\ W$?OW7NO?[+9TU_WL#^(G_H%_/3_ .XC]^Z]U[_9
M;.FO^]@?Q$_] OYZ?_<1^_=>Z]_LMG37_>P/XB?^@7\]/_N(_?NO=>_V6SIK
M_O8'\1/_ $"_GI_]Q'[]U[KW^RV=-?\ >P/XB?\ H%_/3_[B/W[KW7O]ELZ:
6_P"]@?Q$_P#0+^>G_P!Q'[]U[K__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>timage_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 timage_002.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &0      04  DE$_]L
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M/U8<_GVC\;4"P2GRS^SH2!%89E"D>I45^6>F"KWMMS' _<Y*F1$)OY:B)
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M'OW6^D'\H^NNL=Z?'C(9_;^8HL7NCKQ%K-O86F@I2U511&):R.G>FT6-D$I
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M;<OE<[E:TDDE9:V<1W-[GQ1NB_D_C\^_=-ZFZ2L@"/=0 Q%R]@7)N?[9N?\
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M<GG\GW[K8R:'K%[]UKK&T:N;F]_^(!_XW[UKC7#5KU=20.HP O\ 6_UXM?\
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M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UT#?\
MWP_X@GWLBG6@:]8!4QD%@'LI]19?$%7\N3*8^!]21?VV8J<6/[>KZ&ZR&1-!
M>]UTD^CUD@ WL$U7/'XO[99DC&LO@9.?3KVA@=)&>F3+;EV]M^!JO.9O&8:E
M2-II*C*Y"CQ\$<48+22RR5<T(55"DNQ(  )) 'M'+O-A#\;?S7_*W3BP2O\
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M[3<D5+(/M/\ F!Z*SOC^<QUMBDF7:'46]Z](.'R&^<O@MAT3_3]!^ZR<U_\
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MD2*GA4'EY99'15'XNQ4?B_MZUN=RN?\ %X(>/RZ;,L5OB;I 5W9G6V/<BN[
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MW*PRGM-:Y^1/FW1U=OY7%9ZGCKL1DZ#-0M$)5K*"2G>10ZG0'G@F=HV%^"Z
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MOO?YD?%_KH3KN[O?JK%U5.H:3&IO?!Y/,@%G7C X6IR=<W,9&I:9E)! 8D$
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M'X]NM$Y4AQ@@UR.'57)5"P%: ]90"Q(4J1SS&9"X/]%U0K[9CB2+X!3\Q_D
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M_5@'D4Z>/J!S_3WJ&=9(RR9KUL+(<%2/V?Y^D[-ZN5NPN3J725"@DEB58D
MCFWM3;3+)4/V9\_L^5>K$^&*'IHF'J^MP%-B!P00;$>U(>19U14+*3\0I0<?
M4U_ETG>;4=-#GIOD-B3_ *W_ !'M3TWTVU!XU#^U8C_"S:N?]O[<5:&O7OGU
MQH<[D<%.:C&U4M/)XW9T6&*:&I"QS 0544CH#'(KO"XN;K(0;@D>U:RA:5\\
M=-7!JOY]!:N8=<M3R5[)6TM)6I/-@Z/Q">IION@*JG\U#1US1^=8I4 65&2]
MQ8@>UWA,$\3I)TJLQ$4JY;T<F.2KAI<G2T,KM))38_)Q1UM%$TCG462*>-7U
M68$\B]_;+PLN:\>KK.I[0.F,BW'_ !'_ !L^ZH*$CJ\HH ?7J-/^+?7C_B?;
MJUKC_5GIFH&3T3GY?=91;KV(V\Z-43,;&CEJ7"1LSUV FF0Y"F9E!L8K"H^G
M]EQ?GF6O:WF0[9NZV,FHER144IDKZGY= SF?9Q<0M=J0!3AFO54EF6ZNP9@S
M L+<V8VY'' XN/K;WE?(I!#,=6H:OV^7\NHH4**A10 ]=/\ I/\ L/\ >Q[I
MUY_AZP^_=,]>]^Z]U[W[KW7O?NO=<4+K)&R,PE61)(V0Z'21&U1R1NI%F!4%
M3<6-O;2Q1DN]R-:$'M^T?/I0'=9EDC- IZNL^//>&6W?MO9':>*K)\?V'M?*
M4M-F,C3%8IY=X;9&-J(,Z&72%>LAKJ6I<$#5()+CZ^\7N<+2?8^8!=0$!9B6
M4+4:0K9!Q_2'4I;->P[MMLEMI(9=(JW#(/H>MV#XP]VT?R Z4V-V931+3U&:
MH32YFG5XW6FSV,J)*++0C0!Z6DA\B<#TR#W.O+.ZC>]LCDC!4H:FM,T/R]>@
M!NMBVWW)B<AC\O0\/\W1AO8IZ+.O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]_OOI?_ 'KW
M[KW6.218@&;@%@MR0 +@G\D?T]Z90PHW5E4N:+UQ\ZFU@6N?[)7@?ZHEV3C_
M %K^VS'$!4X_;UXHPXCI([H[%V+LFFDK=W;OVQM>AA!,U=N//XK T<0%KEZK
M+55)';D7]7'Y_'LOGW&VLZ FNK[1P_(^O3G@2TJ0?]7Y]%.WQ_,?^%^Q$F.2
M[UV=FI("Z^'9U35;R,KH0'2"7;-+DXY#S_8=A_C[+)N9K=1V+7]O^5>GTLG;
MB0.B@;R_G8?'O'224NP.M^WNQ*Q=2P-'B<+MS'U9-M+0_?9:LKM/UU&2@CMQ
M8&_!=-S4]1X">M<C\OPGI4FWJ/C8#[ ?]CHEG:7\]7LFB%70[3Z_ZBZ\G(8A
MNP-VC<.8IDNA0C;6.KMNS^0 FX\<UR19>"&2'F&]EQII_O/_ $#TK6RM,$U-
M/4FO\NJ[.R?YQ?R(W543I5?('=%%',ID..Z<V>F&$41:1?!'69B;;U2MB#>1
M&G6Q%G9@P5-)!N6[2>.A*@=OX?+/J/XNFI;VTL'$0C!KW?Y/0^G1$=\?-?>.
M]ZF>JW'D^SNP) Y$+]@]F9FJ6+U-((9L?21R2JH+E_&E<J@N; $EF5V_+-VX
M!<_\=_R/UX;_ !D$J/YG_H'H%\C\A-YU)MC\9M3#1L=>FGQ$^;.LW'D(WE7[
MH378 :EC7](X!N2:P;#):C0^:YK_ "_B/ITU)N2W/ZBXIC_+Z#UZ0N4[0[)S
M,34U;O?<?V4CEVQ=)D9<9B""%&K^$XDT%-JXL6$0N !:RCV;0[7"*:Q_A_S]
M%<]U+DJ<?E_FZ1+3278^64.[$S,)9D2742>::"2&$&U@2(^?U-=B23J-;*VB
M$16M/FWGGY^O58[N7P03Q_+U^SKL$D?VD47] EJ/$NHDG3 LRQBYY-D%R;FY
M)/OS7D,1HH_F?\W2>6[D %>/Y?YNNO\ $BS @@J67Z6^JAK?[8#_ (K0R"8^
M*//_ (KY=6B8N@8^?798L;L03_@ . +#@?X#W[ISKKW[KW4Y/T+_ ,%7_>A[
M]U[KE[]U[KWOW7NO>_=>ZD>_=>ZR$K>UG)_JRZ/S;Z:C_3WH404;RZ+HC/*:
M#_)UG8@C638#^R1ZP>.-(O\ [W[>6[MXQI/^7_-TO6UD< D?X/\ /U*I:.IK
M2!0T=56>H"]-#++8DV%](]I9C9H-1;^3=:BV^<FG^;U^WI=XGK+?N:"?8[7R
MDJLRA9'@,4:WL SM)I(47N38\?CV72[G965;G57P^[@WX<^A].C.';K@L%/G
M0>7[./0E8GXT=EY+3))!CL;]+FKJ251;B[.%CU6'U("DV' /LFNO<F!5.G_+
M\_\ A71C^Y'_ -7_ $5T)F'^(F6J/')E]V8^E*%6<8V"OG( (+:%DCIU)X-@
M2HO]2/89N/<GXM/^KC_PKJT>R'6NH>8_U?%T*N#^(VQ5:)LQF=PY1@UV6&H2
M@1OSI91]UQQ_7V'[OW)E"G3_ )/^M71Q'LD?I_A_Z"Z&7!?'GJ+%>/3L^AR3
M17LV6:6K8DJ5NQ#0@G\_3Z^PT_/=[N#BT& _GV_A[O\ ?8]/7HT@V6$L*_Y?
M^@NABPVQMG8E$&+VQ@L>$(T24N.B6:,"PLDDIFM<<&X/!]E]U?7L@KJ_DOR^
M71M%LULH_P"+_P"@NA!I$4,A0>,"RZ(E2*-D N%>.-$!MP1Q]?9)JNC)^HU1
MYX'2J6U@BA+)Q%/7UIZ]*BD4\DLB"PNSE@H"@WN51S^>./K[4_@ITB7!KZ=*
M:FC+>I!(XC75*J0S23QK=0LG@B21BMR!<Z1S[VKA00?3K32&/O'G_P 7T_TH
ME2>. 1+]T4,GC$BI)" 00_E(66(Z;D-$I?\ L@68GV43J_BZU\C7^=>E5L4D
M^/IX2FQV3HZBAJ$HZZAK(Y!/1UE.E1#(5(21JS&Y6GA,K^HJLE1!,-+-R"1[
M5?O:^MXT\$^8_AX?F.E5Q86]Q#I\ZU\_0_,>O1-.W?Y?W6V^$KLWUQ75G56Y
MI09S2X\F39.0JK&]3789I)Y8I69@ U$= 4L/MFOKCD'EGG2Y@94N#Z>0_HCR
MCZ".Y[,,E!Q_V?Z752W9G6F^>F]TU>TNP\+-A\BDS_9U^F4X#/0A8V6OP>8\
M2T\@D65&>&1H98RZAT!-A-NT\U6EQ&*') KAO0_T.@#N.USPN"O U]/*GSZ1
M6D\AU,<A"EH9 RSHIOH9T(MI:QTL"0;'^GL8+)'<1AU_+CZ_['2,120BK_Y.
MN4-PVN/Q%E!4>6(RA5?]5D+JI)M]6#6MQ[+Q\1ZUK(P>E1M;=&=VC6)4X+)2
MT<H/D:-F>6FJBER(JBF,BJ1ZB$TZ;7/UOQ;K8:N.CA===W8C=:+C]PF' YQ#
MI85#^*AJ18 20R>) I)'Z?5_K^_=6KY=#Q&\;+&58NDPO#*@U1R$_0JZD^GZ
M6;_7XX]^Z]7K*P9=:/H:W#(Q\L2FU]:6T>JQ^OO?$:>FVL)+B07,9IIQY>1K
MZ_/K-3S30O%50RZ):0ZJ68QQ3/%+R2&69'#)R++8'Z\\^T\FUPS_ !CC]O\
MD(Z/++=]RVM:1O2GR3Y>H/IU&W'34F;HY<A_#A%N5)%>.HHD--2Y5VU"7[FB
M*"*-@+?N>8W%AH%KL%=[Y.%TXEAX!0/7-2?-QZ]3A[9>^EWRPYVZ_-0S-)P
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M>_#GL2HPF^ZWKFLB%1B.RHT2GF:5_-B]TX&GK<CAIJ2%1Z_OA)/0.  S/41
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M.F^H;_3_ &/_ !!]^Z]T5[Y3]:5&^^OGRF)H'KMP[3E.3HH(U#O78UE:/,4
M!T\"-_.+&^J(<>Y3]JN94Y>WS7,0%DH!7A7/04YGLGN;8Z17'51Q72""&N#:
M[C2W! .M38@_U%O>64/AW:'<E/\ :T(_/J(&A:VUQ-Q)_P O7#W?IGKWOW7N
MO>_=>Z][]U[KHFW)]^Z\!7 ZGXC,U^W\MC<]AZJ6CRV%KZ+*XVIB%S%78^JB
MK:66QMZHY*='0W'(Y]MRVBWT36U>Y@:#UZ66<G@7"N?+^75]/QU^05;CLWU?
M\@]G114F3HZ^'.5F)1V6CAS5!5/CMU81W72_VTI-0%4^H4]2ES<@G%G=()N5
M.<!-*"%UH37&!0]2FMR-QVJ6"/)9' \^((ZW4>I=^X3M+KC9?8FW'C?#;PVY
MB\Y1+&P?[=:NGC^XI6ETH2T4D;Q/<#F.WO(S;]QBW/:HKN(@ZU4X/S_V.HNN
M+5[24P.*%?+H1P;W_P "1_MO9MTSUW[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>ZX2ZO&^@J'",4+DJ@< E=9 /%_KP>/>B:
M"O6CPZTF?YX_STW?VYWOEOCCU]GLSA.H.H,ADL#NF@H*J6B3?V_J:..GSN2S
M $2M]O0M63X^B2-Q<)-(2NOQHOAMO$A\3_5C\^O4H,#J@*-CHC!5D\"&*G"3
MU4)IJ=FU-$&@J(FD!*@D3&0'\@D A"UX+"0FE:U7^?V'TZHQKP]>N:"-!(54
M*7X>47CG+77U+)2_; ?3\JW^O[VMW;S'6R_S/^;I^&61#0<?RX8ZR1F:4*(I
M);@$:_N9(V'^U3S&J@9U) !0:R20=)M</Z[*Z!@"T*C5Q;RQ\O7I1/=RM$%/
MK3R^8].F+*;BP^ AFFS><PM$(A&P:>N/E9RP22-:5 :@$%@-<D80GC4#[*9I
M8K>;0G^7Y^O2/PI6[_3[.G:GJ::KC^YIYUFIY&_9=3 TDD>A'65XH)I@BMK]
M%W)-B;#VM![0>M!V.&\O]7EU(9;6(.I6OI;Z7M]18_Z_O?5NN4?Y_P!A_P 3
M[;D\NG(_/K)[;Z<ZQ/\ 7_8?\2?;J<.FGX]9X/T'_@Q_WH>[]4ZS>_=.IPZ]
M[]U?KWOW3+_%U[W[JO7O?NO=>]^Z]U)BU2,D20RR%K!?&K.2WTM8#VQ)=I:=
MY_U?R/IUY8'D/;TK,7L?<^8?318FJ87Y,B-&H'U/)O[2/S-:$:&/R_%_T!TL
MCVR1A@?ZOV]"GB.@\[5K&V6K$HXY(T?QJ/(\8< B,VGC^GT/T]A&^Y_AB=XE
M_ 2OGY$C_??2R#9I=7<,?EZC^ET*>&Z)VG0",Y%ZG*R*JW#MXHPX U:!KFXN
M#;V%KOW$<,=/#/\ E_X7T([798Q0OZ?/Y?TNA<PNU=OX>(18S%4=-&%4,?"C
MRNP55U-+9>3;GCV%;S<KR]8W(;$AU<%_$:^@]?3H[@VJV2A_S_Y^EC!>VG4W
MC']BX_%O[0 _K_3V&9Q>N:ZOY+T81VMN!0?Y?\_3O +_ *CK/^U*I_Z)_P ?
M=_K)7X'_  ?YND7#CU.@B+-==0B^OED7QD(1^K1J;_;7]Z_4?/\ FZ]D]/,<
M;Q.B2I(DC#5XBC1RK&""[,E0(.?Z*";^UWSZ<KG/2LPN%R&4666GC_:IJ6HK
M7F2DR.3@9*.-IFI_]Q>,RH25@MA]TL,()_<E5+L--@$_+K7J>E%/F:L9/;^%
MQTD6U\='@L2E=/AZZ*MJX*F'(I++N"MJL.<WE8!&+NU-%#8!3I1C9"E-*=4K
MTKX,CM>KHY:"IS>6R-'%7T^0GFW!5S1MF,M1RB:C-#L?'466R4@+HH6JK,MA
MUYNYA%W6\>9%)]1_DZVOQ"OKTKT7;]'1Y&I@CV[*^)2&IJJ>AHTK*T"2QBCJ
MSMK<W;$4 )8 _P 0EHR+\J#Q[73>%3_B^E50*4\^D;_=%ZS!1&NHYHZ*HJ7K
MUD49$XT,:J.JIH*NDJ!!2.JR(O$M.RN;#2"18N9HU[EZWI!QY]/N+K\[#D),
MAG:*7<M6*1<?C&I<]A]F[?QM"BZ4C.W\;L_)0FP^IA$)<V5C8D^]&84(!_EU
M[P6ZGX7#Y&&D3[_)+FI%-4[T^2HL;N';]))-.)Z1Z7!;IH\U31M"RK8Q11ZB
M+D#Z>Z-+VU/6C%FAZ7"44E9/#D<K6U>:KX*2.@IJG(BBCBQV*MY&QF%QF'H\
M31441=0Q%/3(2MT8L&-VUES7JOA @=*;&8W'T5Q1T5+2QRN'F^VIH()9.?4N
MJ*-$Y-CJ\9;CZ\FZ>X?4@^W_ #].1)I->E;2JY;5KNX'I9E+,%&FP-F6Y_%^
M/:8BB]*/+_5Y=*")"A01QE[<65E5PIY;3K9;W-O2/^(]T%R+4>(16N/]6#Z=
M.1,J'4W^K/2CIX]1"WD6PU%7IZQ).+?AZ=4MR>1(3].+'C3;DSX1<_;_ +'3
MQFC\\?M_S=*6E6X":92_I*$1RA.+ZE<Z#P>/P?I[3233,O<./#ATBNI5U((^
M&:_Y.E' LB-K/CCF*:!XHI%BT-QZXIHE5R ;6.I2&-U/'MFVO[BTDUIY?9Z'
MY?/HP2TCGB[_ #^WU^WJNCY4?R^,-V4];V'TA]CLKLN8R5F4VM R4>V-_5"J
MCI2T],2R4=?/IEU3/^Q(7&MJ?2ODE#EGGJ>&8I.<8I@>C'RC^?0,W_88V:,P
M?TJ_\9IQ;JD3,X?-[9S>;VONK"U^V-UX&KDAS>!S,$U'58F8L5\+HT;>6(>)
MBM52K/ X/HD:QME)LF_[;?V0SW?[;^)OZ(].@1<[>]N,?ZN'S/KU'^MF&K2R
MJ5+ *6N.60!FNA_LL;$_T'MD99B.!I_@Z*H]60W7*ZE=+*6%R;7TBY ') O^
M/I<>[=.=28&/C(THEF('C#J+<&[!I)+G_'C_ %O?NO=25&I@Q)L.+7>_UYYU
M6_WCW[KW64V_L@@?XD'G_7 7W[KW77OW7NID7^;7_8_]#'W[KW63W[KW3%N:
M++U&W\Y2X&L.+S55CI(<=DD59:JC)8&>JHH79 \@0,JKJ7GG5^/:>4O6@X=:
MZK_W#L/=E;DY%GI>QLW-+5-!23YC>\^"DRE6\A7728N!ZE1&Y]2:I4L"/2/H
M"Z377'^KCUO'EUPW?UUWUTNVW\EN/!=U=64^;$-3@\E7U%3N/;N4BG19J1D$
MM-3(T$BLICE$TH*D$%KW]H;.ZN!=,AX!CZ>H^71?XE)6SP)_D>C?]([F[!W#
M@ZYNP:,M+1F!L?F1"*<Y595!6H**MAJOKU D&_T'L3DF2,!O3_5_AZ7QRXQT
M/1O<W^MS?F_/YY]O(*(!\AU8\>LGD&G2P:0 W597UI'Q;T@*A;_6F,H]U$?6
MNCV_&7^8C\F/B[/24.TMZ3;HV/#_ )_KW>K5&:VXUS<_PUI9?N* ?U%)+%_M
MO:7Z=_3^?6J#K8Y^+W\W+XW]]#%[=WM7/TIV+7 "+#;NJ1)MC,.+C_<-O=J*
M@I-)XO\ ?)CS];>VVC8<.MT\^K4XJREGIHZV">&:DEA^YBJ8)8YH9:?3K%1%
M+$SJR$6(92;@CVUUJO4?+UL6.Q.4R%2Z0T]#CZVLGF9OVXH:6EDGEE<E> H0
MWX/ ]NP1F29(UXL0/VFG2:\G2VLY;B0T6-&8GR 522?Y=?-]^;?>57\C?E/W
M=VM+4&HQN=WUEZ/;S,_F-+MG +1X;;=/"^B'6CTF,BEU!$ -0_!Y)E3:K?Z5
M:#R_V/F?3K _W$WH[SNS.3Q/_/\ )ZJ/7HJ@ N-7T^O];C^G'LXD)DSZ= 5D
M$<D*/D,4_F>N99O3&KZ%+!(U=K4PAD.F6.1;7 8$AF#"PY]Z:#ZB,T^?^#\N
MD=S?3[=? VQH P]/XCZ@^@ZVQ?Y'7\Q@[BQ'^RI]W[M\NZ<9(LW3>;W%6%*[
M<&WI::H>HV=5U4T;>6NI&Q[2TH+ZF@;0%%EN -\V9A(9D'"O_'O2O67?M'SV
MMS8)ME\W<2NFO 4B!(P@ X$\:5^VO6S73U2U##Q@D69G('H2Q*JI8A3J/UM:
MUK\_2X1>,IQZR!BE65:KU+)Y4?UO?_;>Z:0>X\1PZL3D#KOWKJW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UAF0O'9
M?U!E*F]K$$>J_P#@"3[\  :^O6PQ7(SUHW_,[I;.?&+Y^?(SK"?'PT767;F6
MK?D=TV(0$I?X/O>M6;L?!0NJQK"M#G:^9HX+62%X]/UM[@WW0V<PN-XM^YR
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M>/P/:)KNZDPB_P Q_FZ=&U1Q_B_D?\_2BI(JAV0"%K,>)0R. "+V$2%I"2>
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MKTE8IW/(M_:AT?[&_P"+>Q/"PD /KU!DNS>'>/,34VS,_IF,U_B_S_GUC?\
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M .[-M8BMR?HJL9(VW=Q>&74XIQ3BE:=P^KU^"K\J@_5HP?Q[@7=;<_49^?\
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MUBD?600+<6_WD_\ %??NMJ-(IUP/^-[?0Z?KS_3Z\^ZLV@:O]6<=6&,]6M?
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M^G%Z[$X[145F2HJ(P!WC>JJT1XS(NAFBB4@\A;7'UM8W ]^D-K<VYNC)ID7
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MVMLK<-;#31019VNDRN.JIGA18P^0=*_'0%BL:A]*K<6_/)2R0Q<?\W0_@YF
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M8_O78E1!0"HR<E)M"LIJS?&!I:B*-YHTKL2M1Y/&#J:! P(^A7OUH+W:Y8B
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MGAGA^76[3\2.[J;Y#]$[([' 6GRD]-+A-RT0F281;AP;?8Y%M2L;K.46ICU
M'1.OU%B<A.7=RAO]IA,)[@JALBM0HK6GKU'NZVC6]\X/#-!Y<>C-* %4#Z
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MZ:;>VBFH=U>B];95D\74WV5QQKPITQ*D:WM&@N;D(HBU-:WD?P^/4W NS7/
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M%SK/9\40I-K;+P[Q_K%33S9G+2,5*:A-.E==@3<VF0?X^P3N//\ N]S&T8<
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M;[''MB*6IM;]$F3C66W/UBAFM;U:;KJ$MA[?;I>?[EAUK_#J'KZQGT'1-/S
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M!NL[Q$?Z]OI[Q(WF$26\CG\$FG_CP_R=2]MEP;@!R:U'5D.8::OP5,75)*G
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M8C,?CT5J?WDR 3\!55J@ _[4.?\ 'V#KSW+DN$TEZ_E]G_"AT>IR_8)E(_\
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M%?\ >O\ -T6;=OSQ^/.WFGAPF<S&^*BFXE_N]@*V2F$FH)H%?75$ -RWZT4
M?D6]B.UY.W>9P :$U_@]#_3'17-N=D$)B%&\CW?+U'1=,U_,'WON6<X[J[J"
M%III!! <UD9MQ9&5W8"-H\7@13HI-OTS3"WU&H@*1A8>W$LS#ZP:_P Z>O\
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M-$%7C]JT-9E40&-K/F\LF0JV-XU;USDDJ#]1?W8.ZCM-.K\<'HSZP0H $C5
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M@7=Y;B_OAB@_A\P#^&0>;>G2]V7UIEY<K3Y.HI9\90TU1'4-45 =9*AHRYB
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M<]5.+@!BPN">%HHX_P!)*'UJ3Y])HYIO$!K_ (/3Y=6Z=1_$?XR=$0PP]/\
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MXW2)W RM?Y5ZF2TF7P@XS_Q71NM\%:Q<9F]+B2>GDH,G*4]+Y2@6$M6NP/\
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M4;WAASYR_+RYOTL<M?"E=G!I2FLLP ^0X=39L.YKN,*+( E% XUX >O2W?\
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M0TZ! X=>]ZZWU[W[KW6"5E*<,";CZ$'W[KW4>Y]()-E(L#<@6=9.!_P9 ?\
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MS_P=;HWP _F5]2_-_;5+1T59!L_M[%4Z_P![^MLC/3P5*3-$S');=DFD+UE
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M]@[WQ5?3F#(8W=FRZ_[0??Q&Q622)*64E;(WD++^H^\7>>-N^BW:X4*%67@
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M_3_7_P"*>_5''KW3349M=/$B$DCZ_3C_  )]ZJ3_ *J];H>F&?.VO^XMVO\
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M.B=:@" ;@ EE9&L5(-QP+^\@())(XFMY5$E22:YI7AUQD+F%AIMUBF!+"12
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M=5"A<]-DE0>6#:0/]<"POR>?K[]UNE>/3;+7Q*>7)N3?@V_K^;>_=;ZA5&1
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MC?\ %= _FW;E-DDU/BSU5DW(!_%S^+?\1[RHE3PF5/XE#?X/\_41Z-"4^?\
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MK;J;(5,-!/#&JU%129S>5?C:.98V?]N044(+*#:9#8^VZ$FG5:@9ZV6_C_\
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MXW'MZ90L5'D9I: JI$<N*KI):C%2QD_@0A8S_4H?>;?+F[KNVUQ2C)50,Y/
M=09O5JUON3MP!Q3RX](+V?\ 19U[W[KW7O\ BH'^ O\ U/X_US[]UL GAU"G
MJ*>GCDGJ)XH(8E,DDLDJ1HB7-F9V( O_ &?Z_B_NDA*HQ'$ ].ZM"ZO3J7@L
M7N7=*!]MX&>MIF+1TN7R-72[=Q%3*'*B.ADR:223L&4@%(O40;&WNMW!#)91
MW$CZ&J,9^?IT\@:X7Q5'330UDU0E2E915&+KZ&MJL=D<;5E'J**MI*J2DFBD
MDC #:FCU*P NK _2WM[4CHI3T'5#6M#TX>]=:ZZ6H>EGIYXB5DAFCJ$8&S++
M3NLU.P(Y%G4?3W[KW5H>P]TTV]MJ8K<%*RH\L(CJX;W:*K@*15<3?3U L#_R
M%[W4^O6ZDKI/#^76'>/8.R]AXXY3=N>Q^(IK,8DJ)0:JI*Z@4IZ-6$DGZ3]
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M>+<#Z7/NP:L94>?33C2ZR_PG_#U5!_.6VEC-U_&O;O8S4<39OKW?N&I/XH4
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MXU=(S95I?.U9)UMMEI'F_P".DBKC0C'_ (,I][QUNI)QG]G0_83;^#VSBJ/
M[;PF*P&$QT(IZ#$83&TF+QE% "2(:6AH8((HUY_2J@<^_5/6M(XTZ=B"?JM^
M+&ZW!4 A5(M] ";#Z"_'OU3QZWI'7K'^A_ ^A^@X'OU"<]>J!CKUC_0_[8^_
M4/IUZH]>N7BD;Z7'^&DD_P"]>]CYBO6B?0]28J"9QS<'ZCTGZ?4\6][H#GJN
MJF./3M3XL_VE!!-^;_3Z?T]["XI3JI8GITBH?&?0H%N20I/'Y)//O>FE,]5Z
MFQTKL3;D$?A2?R/Z>[]>ZGT^-U?J7ZG].DW_ ->Q'O7V=>Z?*;#3N0!$K$MP
M2/H#]+BWOU1U[CTL,?M29[/,L8559WDD?1!%&1I:2:0#TZ20Q_J%;^A]NQKK
M4@<?+KS]D+2L>U>/6A[_ #HOE)C/D9\Q,]@MF;CFS?5G4&)H=B;;^W.C&S;B
MHO-+O3,4:@MY5FKZIX8Y3R8J<#@6'L1;=&\4#AO0_P"#J ^?MS_>DPM(FJ13
M3_18\#^75>O0=)/7[TJ6I$9VCPTT42QH)'DJ*^>A2&'2!R6N5 '-S]/8FVMX
MX8@\N33J(.?+@W&U0;/;+6YJE6 R:5K4_P"QU] C^5%\)&^+O2LFZ]XXZEB[
M=[<HL3F\\P<2S;=VZT!K]O;8=F5;2P#(-+5JO^[+*;LO 5YBW"2YO2L;'P](
MQY5S7K(WVOY4CY:V2*9XE6Z<=\@^(KAE!^RN.K::7%R26'T!/ T_Z]P3I/\
M3\>PZ"5&D<#U*/Z>EF([FXG[.E)0X%W9#I!-R.1^;?ZU_P#>?>P">FBP'2RI
M,$RA+H@TZ;EOJ--OI=?>P*&IZH2S<.E%3T44'.E2_P#6U[?ZQ/OVKTQU8)3C
MU-]UZOU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7%E)M;W96 X]592>'7#QG_#_??[#W?6.J>&
M>H,M.FD64MR.+ _@\\+[\05R,]4Z;)Z4EQI&D:1Q:WY//"^]8;+8Z]U EIB;
MW4^D_6W/%Q:Y'TY]Z*>8ZV#3IFJ*0,3>PO?G3=6O_O7^/NG3BG&.DW68L.7]
M*J2.%T\,+6(]^ZL"#PZ2M;A1>^D#T_E3_L;@CCZ'WJG6^D;D,.HU#0+@V_2;
M'CZ_3_'WX_/KW2.KL4 K * 1?^R?]ZM_A[J:\3GKW20J\>06%K$7N;?F]_\
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M^![=&%ITT<FO4^/$RN0=;$?6PN"/J/>M/G_AZV6QPZ=Z?&(@]?)O_:'-N/\
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57NO>_=>Z][]U[KWOW7NO>_=>Z__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>timage_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 timage_003.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &0      04  DE$_]L
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MOSG\5MN@\%$CQM/JR>8H@]G&B,O(;A;'W7NJ'?\ H+V_DX?\];\A?_1%5?\
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MU-UUBL9@6-!+)"S4U7NG<&WJZL21D#0R0XQJ>6(^19[:0WNO=6!_RXOY_O\
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M5T\N2HIL/M+"XQZ7P2H(:N!(T D&OW[KW6_Q[]U[K4"_X6K?]NLN@_\ Q?\
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M<-ANXNUNN\+!MDM45"4T<^0;";ES67Q5)*SK(L\^*\,4 >2M>DT%3[KW1_\
M^>;_ #%>IO@W_+K[@W)F]\;]VMO#Y,]+]W=,_&/L'J9)YZBFWOO/8V;GVMD8
M<MCZNGJL0D=4(*F#)P2$T[1K,CJXC)]U[K1(_P"$UG\WCXN_RT>VOF5V'\T-
MT]GU-5W_ +=ZU3#9[;FUZGL>NK\G@LGGJ[*U.3F:I2?S3MDHI&FD=WFD:1F)
M:Y/NO=?42[![FZMZDZKS?=O:^^=M]9]5[8VY%NS<V]]\9:#;^/QU#*B.):NH
MG<11DF1$5=19Y&6- SLH/NO=:P>^/^%D_P#*@VMV)%M#;NT?EGV5M$5,%/4]
MK;1ZIP^+Q0%0;>>"@W!N?";AE@AN#+KP\,H6YABG8!&]U[K8&^$GSY^*'\Q'
MJ'_3;\2.V,7VALJERTVWMPP+05>W<MALE3J&?'YK#9&"ER6-J"A$D1EIQ%4P
ME:BEEG@=)6]U[HI'S0_G??!?X%?*#8'Q"[_RW:-)W-V7@-B[CVG0;2Z\DW+C
MY:;L7+UV$QGEKUJH8X)'R&/J5D5U'C4*Y.EA[]U[HF78W_"IO^69L/YBTGPX
MPE)W]VWGY>P*/JBL[5ZDZ_QVZ]K)N.NR!Q:XVD=\Y2YS,!<AH@-1CL+502/(
MGVKU*ZV3W7NC*=>_\* /Y?/8?S@A_EYPY+N7:'R8D[6W7TK+MW?G5DVV\?%N
M+:'WJS4<F3:KE@*54M"\='*@>.K:6G,+,DR,?=>ZN?SN<Q.V<)F=R9^OI\5@
MMOXK(9S-92K?QQ4U)B87GJ:B5K&T<,,;NQMP ??NO=4^_P OO^>U\%?YFW<F
M9Z.^*9[MW%N_;6R<EV%N7([HZHJ-JXG'XS&U-+1^2KR,M5)''-45=;3Q01!3
M)*Q8JNB*5T]U[H;?YB'\VWX-_P KW;6"S'RM[5?#;GW=%4S[)ZGV5B7WGNS,
M1TJ3,U12XB!T^VH/) T/WU=44E )RD#50E=5/NO=5(_'/_A7Q_*;[SWS2;&W
MO_LP/QE.5RE!B\-O/O+K[&-M^1\I*L$/W>0VKGMRR8I%D8&>>MI(*&FC/FFK
M%B65H_=>ZV?CN'#OMP[LHJZFRV ;"'<-)D\141Y&&IHV@^YCGI98W,4\4T-G
MC=9"CJ5*M8@^_=>ZH=^//_"F7^4Q\CJOM=,#W)N_KO#]+=1Y3NK?NZNX=A3[
M%QL.'QF;P.WA#2S-/4RU^6K,MN3%04E!3P25-4\A6%'<!3[KW1-Z?_A9'_*<
MF[5&PY=L_+"DV,U::$=W3=38I\$+#5]VV-BW+)NL4!%U!7;[5>NP-&$O(/=>
MZV'NP/F7T!L'XB;D^<J[Q3?'QNVWU//W:=\]=PKN<5VVZ>F%8U?C8A)":H_;
M$N(]2R7!33Y!H]^Z]U\K3I_^:%UK1_\ "A%OYDO='8W;F]?CEA?EI\AM\[+S
M&XDR&\LYC=@;KFW?'L_#T.,K*N6:AHL90YC'PPXR&9(*&+5%"BJEO?NO=?00
M^6/S9_EB_/'^2MVK\L?D)2]L[H_ES[ZKMGX_?5/BL)D=I[FJ)-G=H83!X[P4
MF/K8<A"L6]J+&EBE4NNF1V8&)F5O=>ZP_P#"?;)?RN<G\6>WYOY4&W^U-N]%
MQ]_Y.+?U)VS-EIZU]V#;NWC424QS-=750I3ASAQ995B\@?2NO63[KW5A?SD_
MF+_#O^7)UM2]G_+KN7!]9XG,U$M%M+;J4]1N/<&>J*<QK)#A,#CXZC)Y#P&:
M'[B9*<4U(KH]7/!&P?W[KW5 6V/^%FG\JC.]@#:>9Z\^8>R]IRU\]%#VCGNK
M=NU^,1*=7/W=50XK>&1ST=+,R!8A#B:BH.N,S4\'[GC]U[K9L^/'R0Z+^674
MVU^\_CCVAM/M[JG>,$DN#WCL_(BO@:2G.FHI*F,A*BAR%))^W4T=3##54T@,
M<\4;@K[]U[JLS^8%_/J_E_?RSN\,7\>_E#F^U\9V+F.O,#V?0P;*ZTFW?1MB
MMQUN3H*9S515,068U.)K T92ZA5;D,/?NO=%J^=/_"HS^5_\'>S,_P!,U.=[
M0^1_9VS\Y5[;WQA/CIMO&;DH,)7XR22*LHZ_.9G,X/%2U='/%)#/!15%9+!4
M PSK$ZR:/=>ZL!_EL?S<?A=_-7V3N3=7Q8WGN [AV+_"_P#2'U-V-@DVENK
MC-H6I9:ZAAJJ^BJ*2=EEC2KH,E64AFBEB$_D0K[]U[JS3W[KW19OFK-TO3_#
M;Y:3_)"ES5=\=X/C+WS-WU1;;:=,C-LN/:N5;=,5 :62&J%;)@Q7+ 89DE$I
M7QNKV8>Z]U0Q_P )VLQ_)1RFXOE>/Y1>U>[MMY2'"]-GOANW:C.SQS4\D^Y?
M[N"A_C>2K[.D@S?E\(3AD\A;]NWNO='9[9_GZ?R].D_G93?RZ^P-R]GXOY&5
M/:W5/3?ACZZDFP,67[E7#/A6FS1JE@BH3'GJ!JBH9 L"F0N/VS[]U[HC7R6_
MX5V?RG_C]V-4]=[3D[X^3@Q.2GQ^?WQ\?=EX7)[>B-(RK+]CD]Q;CVZN9O<F
M*6BCFHY@I*UFDJ6]U[J[?X(?S!OBO_,BZ53O?XH=A?WVVA39>?;>YL3D\9-M
MW-8+*4R+(^-S6+J )J.I,+QRQL#)!/"Z34\TL3!_?NO='5]^Z]UKL_\ "JW_
M +<>_*[_ ,.CXX_^_'VK[]U[KY9NRMG]E=)]<]"?.;9E4ZKB_E!O#9^UJHX:
M6HIL7N7X]T.P]X8^6LJED$1.2_O.A@ISXG=<;5NCR /X?=>Z^Q9\K/G1MK8O
M\IOM[^8'L*NHZO#U7PSKN]NKZA<C]I%/7;_VU'5;7A^X'JC-1E,EC8;A?(&:
MRJ9++[]U[KXQN9ZCS6%Z)ZX[YGJD?;W9/;7=74>+HA2LC1UO26'V#F:^4S:R
ML@F@[ QJA @,?B+%F$JA?=>Z^Q9_)]_[<J_!?_Q2/K[_ -T'OW7NM"O_ (1R
M?]O=LI_XJ7W1_P"[3:WOW7NOJC>_=>ZH!_X5'?\ ;BCYS?\ ELW_ +^+K[W[
MKW6J/_PEU_E ? /^97T5\I]Z_,3IW+=F;CZR[9V5M;9M=C>T-T;!%+19G#RU
M=1$T. R^-AJ"\Z*P>5'=?TJP7CW[KW1G/^%$G_"=;X"_"WX%;C^9/P\Q>].E
M]R].;PV%C=V;$RF^,MV7B=RXWLG,X_;X17S]=6Y'%Y/&UE=3U44\-8U/) M7
M3S4CR2T]31^Z]U8#_P (O^^^QNR?@-WWT[O3/9#/[8Z [\IZ'K 9*J^Y;&8K
ML/$0Y&HP]-= R4,&5@KJN-3(VF2NF50B*B^_=>ZM/_F*_P#"AW^6W_+3WSD^
MHNW-[[W[3[PP<-#+N'IOH';=)O;+XHY-()8(\Q59#)X7!8NH:FJ(JDTU1ETK
M/MV65:=A)$)/=>Z)%\>_^%@G\J+NG>V-V3OK'_(OXV',9&BQM#O7N/K_ !-7
MMY7R$B0Q&LKML;@W#5X^-9'O+/48V.D@C_=EJ50.4]U[J]KYE?/3X\?!;XQ5
MWR_[KSF:KNC:"IV1#_>7KG%)OAYXNQ*F"EQ-72103HM71U4E53D2Q2,/'(L@
MNEV'NO=?+;_D.?S0NM?A9_,PW7\S?G9V-VYO>DWCTAV-LW<?8-2F0[>W)D<S
MN6JP+TDN0J*VK>OJ[T^,D1IY:EV4)&OTM;W7NM\;^<%\@/Y1_P @_P"6-\6O
MD9_,.PW<6Z?AEW=VOU#V3TI#L.DR^"SIS^]MD[MR. J,A38>OI*NG@.VI<]Y
M8I*AHTF>(.ID"%?=>Z.]_)AK/A!7_P O+IFJ_ETXG?6$^)$F:[5'6^-['DKY
M<LE0FZLP,Z9VR=365Q1\\,DT7EG;]LKH"QZ /=>Z0'\R+^>Q_+T_E=Y:#9'R
M [$W!NSN:LQ#9RDZ+Z9P46^-RI3,(3!+D5FK,?B<&E6LRO3#)Y6D>IC622F2
M98W(]U[HI'PG_P"%3W\K'YG=C[9Z??</:_QL[(WMN"FVMLO&?(G:%#@<7E:_
M($BEIJ?<&"R^?P]$]4VF*+^)U6/$M2RTT/DDDA$ONO=7R_(#N_8WQIZ/[;^0
MG9TN4@ZZZ4Z\W9V?OF?"8XY>L3%;*HIJ^O>FI0Z&HF2F@D*1AP7("CDCW[KW
M5,W57_"F'^4KVKT[WCWI%W9NG86P^A,AUQA-SGLC8%7M[)93)=K0[BGPV+VU
MBH7K*[/9":':V8DEBIX3]O%%YIBD.J1/=>Z*=TY_PL&_E/\ :G;E+UEN'&_)
M/I3;^5S$.&PW<7:W7>%@VR6J*A*:.?(-A-RYK+XJDE9UD6>?%>&* /)6O2:"
MI]U[J^#YI?.SX_\ P,^-.5^6O>N5S\O2V'KMF453G-@X4;RG<;^JH*/&5%/3
MQ3Q?<4T\U3!ZXW:R.'L4N1[KW7RUOY#G\T+K7X6?S,-U_,WYV=C=N;WI-X](
M=C;-W'V#4ID.WMR9',[EJL"])+D*BMJWKZN]/C)$:>6I=E"1K]+6]U[KZ?>]
MOYF/PWZN^$^POY@G:_:L'6/QK[-V'L[?^Q\_O'&3TV4R,._\=_%<1CJ/"TRU
M5?69NMHPS)0T\4LPT2,P"12.ONO=4!;D_P"%H_\ *XPFZJS#8CIGYL;PVY12
MRP#>."ZWV=0Q56@/IEHJ+*;\Q]:U.Y\=C4Q4LHNUX1I ?W7NM@;X&?S*/AU_
M,JZXRW9?Q'[8I-_8_;.0CQ.]-KY+&5.UL_@ZBH\A@3*X>NCBJZ>*K2)WIZA5
MDIJA5<0S.T<JI[KW1[??NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7R0O\ A+M68W%_SW?C;3]IXW<<V_:RA^3>+PM3F9YJ2JH-
MT'8.ZWKYLPM3-#/)-+CHLY2/',DLGWE3$6B$B^6+W7NOK>^_=>ZAC(4#5[XH
M5U&<I'1Q9"3&BI0U"T\[O&D[0ZO((7DCD57*Z2RLH-P0/=>ZUGO^%8GS+[$^
M)G\K2OVMU5E*S;^Z_E;VO@OCKE]R8W()055!MK+XC-9K<9IKQRR.V4H\.F)E
MT",I39&>19XY4B63W7NJK?\ A+;_ "1_A7W/\**?YS_*_IK8WR-WOW+O/?VW
M.M]K]FXD;HP&WMO]?91L-.W\$J7DQE;F,CF<77R/5U-)(\%(L$%+X1+5M4^Z
M]U7'_P *H?Y4_0_\M_M'XR?+?X38.3H7;_<&Y=SXG<&QMCYVJP]-M_=O70QV
M5Q&<VJB-]SAONX9:AY(Z:LCAHZFC@EHXH3,]O=>ZN4_F9?+7-?.;_A(EC?E#
MNFNCR>].QMH_&O']@Y2&ADQJ56Y>M^U\)M7<E2L$@!1:C.X3(2#3>,AKQ%HB
MA/NO=5]?\)#_ .5E\/\ Y3]7?)+Y;?*+I/8GR"R^T>U<?T=UQLWMO;='OG;>
M-3'X;'YS+Y!\#D%J,;D,A6?Q?'1)+644HI8X'%,5:HG/OW7NJ^?^%9_P*^.'
MPI^<?3N?^,?7>T^F]F?(#H[^]>YNJ]@[?CVU@J'.[.R]7C*C(8JAII$H,;39
M/'G&*]#24-/3QU%-/5C7+72Z/=>ZW2/YOO7_ ,C/E!_PGR[.P/1L>Z-S=R[U
M^,?Q[WYFL+M*6LDRV=QN&J-K[@W=CJ..D$M;7SY+"TN41J)-;Y!&>B*RBH,;
M^Z]UHQ?R4?YPGP9_EN;4WMU7\O/Y9VQ.]<[GMT;AR%=\C,3MG [LWY3TE:,5
M =JU>)WE3_;C%4\M!/,4H\_C(/,L0GQT]2TM=[]U[K8?_E]=1?\ "8SYP?S!
M<!\F/B9V=V+T1\H$W?L/L+JGXEKDI/BWAL7G=H4OW%]IX>AQ]-1Y2IJGHII\
MABL7NBMHRB2J,?'1S2BH]U[HV/\ PL6^4F_NCOY;6PNG.OMP56W'^4_=]#L+
ML&IQ\M125%7M3:&+K<SDL:D\#1B.&OR<>#CJE:0BHH_N*5XY(9YM/NO=46?R
M-N]O^$S7QW^$6"E_F'5/2V_/F-V/G=^UO:F)[P^)6]_D"-O8^CR]?C]OXW"5
M,&QMP;>HDGP=-1Y%ZC'5/W?GKGCJ:@/3I!3^Z]U7YT[\DOB[\/O^%%74?<7\
MK+L$[K^'._\ Y"=4;0V]BL50;JV+"=M?("/%8/>>UJW'[JQ6&R#4V*RV1RDV
M-CGIJBEC%+B:E)C/3CP>Z]U9/_PM@^3F\\[\JOB[\/J>LK*7K;KKHY._\C0Q
MUA6"NW%V=FL[@HI9Z;Q -)B,5MRU/,9GL,E5QJD?J:7W7NMGWX&_\)^OY8_5
MOP=Z>ZN[7^(_1'>O8NZ>IMK93MSN+L#8--N#<&2SFZL=#4Y2IQ68J_/EL!21
MU,\B446/K:?[>%(R"9M<C>Z]UH'8SXM8KX4?\*6.@OBWMW.5VX=I=/\ \U+X
MB8'8M?E*B2KJH]O9'?6T<EMZBJ9I7D>:HQF$K:"CDDN%=X&=$1"J+[KW6VK_
M ,+8?^W<WQC_ /%U]M_^\+OGW[KW1_\ _A*E_P!N/?BC_P"'1\CO_?C[J]^Z
M]UJ/_P#"D3_N(UZL_P#+)_\ W/I??NO=68?\+:_E)O[ [<^&_P /=M;@JL3L
M'L#_ $@]W]IX:BEJ*4Y6;9\^.Q>UX:ID9(9Z&CFJ,Y4&G?RJU4M)4,L<E- [
M>Z]T&_\ +?\ D)_PDLZ5^ W2W57R?GZ*[!^1.[>I]LYGY);H[4^''8W9^XZ/
M=NZZ&&JSN+QFYTV!D#C*? UDTF/I9,%DHJ9DI5J8III)7J9O=>ZKD_X3X_(3
M9?Q>_P"%!.0Z=^)O85;V-\.ODMOCO7I7:61UYO!Q9;9]/%E]Q["RM9CL_08J
MO_CF*.+QT$KU>-CGB^XR<-.[153//[KW5BO_  N1_P"/T_EM?^&O\JO_ '+Z
M_P#?NO=7&?R+?Y)O\N:A_E??&7L;N/XE]'_(#MCY*]1;>[G["W_WCUQB>SJ]
M#V;3#(4-!AI,K!6C 4>-Q<]'!&,>::1Y$>JF8U,LA'NO=:DGPTZ.V]\'O^%5
MFP?C]TY6UM+L3J[YR[^Z^V+%4S5$L])MK>6-S%/!B9JB:JJ*FL>BP>6-!)4R
MSEZOQM42HIF:)?=>ZOT_X6O?*O?FP/CQ\2_B+M:JK<9M#Y%;S[$[([2J::J6
M!:ZDZ*.WQAL/-&$9IZ63*[@&0D!DC5*C&T3!92;P^Z]T=#^13_(]_ETP_P L
M/XS=H=X_%7IGY!]N?)'K#!=V;XWUW/L.AW]5PIV-"*_&XS$#))5)AZ/'8J6C
MB'V8A>:825,I,DI"^Z]T[?";_A,-UU\$_P"8[D?G;TE\M.P=I[)P^_=U9GK7
MXWX'9,=/1TFV][T]5!D=IY[<$^9GGSV(C6LT4*G%02TPI*.:HFKJJ+SCW7NM
M1_\ X4'_ "/PGRE_GY9?J[Y-]D9?:OQ)^/W;?27Q[RE?BZ7)Y%=K[-UX.J[!
MS5-C:2GK*JIRIJ:_.U,CT>-EJ:F.FHJ:*.J%-3!O=>ZMV^=O?O\ PD8[B^"7
M;_1GQQR7Q\ZP[OPW4>YS\=NPMG_#CM+8^X%W=M_'23;<CS6[TZY_C&4HJ_)P
M4M/D),I75@>GFFEDO)ZQ[KW0H_\ ")7Y0;YW1U?\Q_B)N*OKLILGJ?<'7G<W
M6HK<E)5C&'M 9/'9_'4L,K,*:AFJL-CZQ(H=,0JJBNG9/-4N[^Z]UKM_-W<V
M[_Y<_P#/P^2_>'SK^(6V?F/MJL^1/>/9."ZI^0DE:VW-X;6[,FR,FU,CC*ZO
MQ^3Q5=2X?%5^-BIXJC"Y7'4,E(V/-%'44<+TGNO=73=O?S$O^$P7\WK%=>[.
M^4'3/97\OCL';V^MMS4_:>R>GMO;/JZVC05$9P5=NS:&-W('VQ43UA-0<IAJ
M84; U-/-1WEJ5]U[K=J^ /2'QL^._P 1>E^K/A_O*KW]\:<1MN3+=0;KG[,D
M[=AJ\5N>HFR2RT&=DGJ$J<?)/53/!'#(*>!6\-/'%"B1)[KW1QO?NO=?+N_X
M4M]X]L_/O^=_LO\ E^4&Y6V_UWU)OCHCXU]6X^HJUK\='N/Y!Q;<J\WN:JIH
MA$15-69ZBH)$:I<BEQ,)5H))IHU]U[K=*VC_ ,)R/Y/VVOCA2?'.N^'?7>Z(
M!M8X'+=R9RGEEW_5ULZ.9\TN[A+_ !>BKI*J1YXXJ:ICHH/1314JT<24X]U[
MK1U_E1;UWU_)S_X47S_#G';_ ,IDNJ=X?)O+_"G?-+)//6P;BQ>^\F^.V#D:
M^EI$AIUS--E:[ 5'G^UTT;35\"LE+/4%O=>ZN*_X6;?%;XX]<_'_ *.^2&Q>
ME^OMJ]]=O?*7^%=G]MX;;\-)GL]30;0RS1P9/( >>JBC-#1Z%=B$$,:J $ ]
M^Z]U9)_PEQ^$7Q$_X; ^#/S,_P!ESZE_V:W_ )R9_P"<@?[GTO\ >K_F878.
MU?\ B[:/N?\ CV_]QOZ_^ G[/Z./?NO=;4?OW7NM0+_A:M_VZRZ#_P#%_P#J
MS_WW7:OOW7NAZ_X2$_\ ;G#:7_BPO>O_ +ET7OW7NK:?YP,^+I_Y4?\ ,EDS
M"EJ1O@W\HX(0',?^556R\S%0FX=/I6O3FU_5]"K Z3[KW6DS_P (AUKC\K/F
MZ\:L<:OQ[V"M6]GL)WW(33@D?M@F-:JU_4;'3P']^Z]U49VQ\EOCG\T/^% F
M_.XOYH79&1QOPXH/DUVMM_=U:F+W-N"GHMD=*)G*;96V8,;M^CR.X(:#+5&*
MPM%6B@H8Y#+D*VOD^V>6>>/W7NK:_P"=5WM_PF)^1WP7WGB_@%D^@NL_F#UY
M/L_-],+U)\0M_P#0ISL=)E*.'-X;,Y"/KW$XNO-5@)LE)32Y6HXKX:755PHT
MC^_=>ZO5_P"$?OR@WSWO_*[S'5N_*^NS,GQ6[PW+U+LG+Y+)29.8[:S>/QVX
ML;0NTS/*L>*J<KD:2F35XH:&.DIH D<"HONO=:Q_P"_[C#]]_P#C2?\ F5?]
M"]J^_=>ZW%?Y\/\ +"^!7SDV;UGW)\]_F9V#\2-C="46X<)M?+P=E;5V9M62
MIWQ-2M-+5T6X\/625^:G:DI(*<4M?%(T:F)89&8,/=>ZH ^8_P [/^$FW6OQ
M"[*^-70OQDZY[TW]0]59WJO878/5'Q17$[IBS2XN;%T&X9>S-V8[ 9BMGH:[
MQ5DV13*US53(9HDK5<!_=>Z"7_A$!G\E3_(SYX;7BEMB,QTIU)GZZ#4WJJ=M
MYW)4]*]@P0Z(LK6"Y0L-7I*@L&]U[HG?\SO9M7_)(_X4B;*^4>TL=-ANH]W]
MP[4^76&2DQU541-MON*MK<;V5B*6[$--Y9=VPPP0N5IX*FC58E3QQGW7NK]O
M^%DOS4Q>Q_@-T7\6=EYZBK,A\Q.Q:#?&:^V1ZM*G973"T69$B2H5CB%7N6NV
MK+ SD^6.FJ!&A*L\?NO=6#_\)[/BSC_Y<O\ ):V1V!NK$FBWWVULC=_S7[82
MHAJXIM.Z,/'782CEBE$E13M1;/QF#BF@C@4)5FJ=8C+)(\GNO=:!'\L/O_X+
M=[_S1>P/EG_.^[$ARO6^X<7V/W-DUW3LO=G9F*W'OW,Y3%Q8C!U^)VSC,]DC
M@J''UN3J::DFA7&QPXNEQ\S-3LE)-[KW5@W_  H-[:_X3Y?(?HOK+?G\J_,]
M-;*^2VS>R<=BMX[#Z@^,>]OCMC,YLW,8ZO6KGDI:G8VW]L39;%Y:'#O'))+!
M424LM;^Y-((XF]U[J\[%_P S#O&K_P"$@F;^3$F=S[]Z8?J=OB&_8";EJ5RK
M+4;WINLH]QG*!SD%S<>UZN.I-49C4MDD^X\H9_*/=>ZKW_X2(_RJ_B3\JNOO
MD=\OOE'T[L7O^JV5V70]&=:;![7VU1[WVY0/28B@SF8RE1A,@E1C\E75"9;&
MP0-5T<B4R1S-"/),S1^Z]TA/^%=O\K'XQ_$1_C-\K/BMU)L?HK!]K;AW?U+V
MIUYUGMR#9^WWRF*HX<K@\ICL10I#C<9/-1Q9>&JCIJ:&*7PTT@C\@F=_=>ZV
MEO\ A+C_ -N*/@S_ .7,_P#OXNP??NO=7_>_=>Z^6Y_PLV_[>Q]=?^*4=0_^
M]7OWW[KW6]C_ #*?^W'7S)_\9N]K?^\!4^_=>ZT1O^$EO\M_XT_.KY0_(CL3
MY1=<X3N+9OQEZ_V'6;7ZRWE2)E<!69SM.MR<%/79C'2-X<M#CZ'"9!8J2HAE
MI&EJ%FFC:2"#W[KW1N?^%@G\M[XC?%?%?$'Y$?&#I7K/X]9+L#/=B]3]C;(Z
M@V-1; P653"TE!E<-DTQ.*%'B:"OH=>5AGEAQHEKXZFG\\P%!$K^Z]U=1M7I
MWJ?Y+?\ "3W9NZN^.N=H]I9_HS^5CWQOSJ#);QQ*9J3;N=ZLZ_W108#,XHSE
M_M<GBZ:@IEIYTL\06T>E3;W[KW6O1_PD*^&7Q2^8G:?S>Q?RF^/W5G?F-V+U
M_P!*9#9U#VAM.FW5%C9\[D=PQUDM(E2K+#)4QTU.LA4781J#]/?NO=6"?\+8
M?DUO;:>TOA=\,-H9NHP76^]*???<O96W\=+44@R3;'EQN(VI35+(R0ST%#)/
MFY_MW\JFI2DJ&6.2E@=O=>Z#[^6_\A/^$EG2OP&Z6ZJ^3\_178/R)W;U/MG,
M_)+=':GPX[&[/W'1[MW70PU6=Q>,W.FP,@<93X&LFDQ]+)@LE%3,E*M3%--)
M*]3-[KW5<G_"?'Y";+^+W_"@G(=._$WL*M[&^'7R6WQWKTKM+(Z\W@XLML^G
MBR^X]A96LQV?H,57_P <Q1Q>.@E>KQL<\7W&3AIW:*J9Y_=>Z=O^%FW_ &]C
MZZ_\4HZA_P#>KW[[]U[K<C^#G_"=_P#EB_'7K'XC[NJOCEA-U?(WI!^K.X6[
MQS&X\S+E:S>^WZ:FK9,G40+E'QDM%'E-4U-CVI9**F9()88Q40QSCW7NM5+_
M (5H_%G=?PP_F3_'G^97TC1U&WO]-U1M+>-3N6CQU164N.[0^-D^+:EK)W=I
M**FDR>&@V]/!3A8352X[)U.B5Q52^_=>ZOE_GM_S8MIS_P#"?[:G=G5U2V-W
M!_,SZVV%UCLO#547DGQ^-[6Q)R&^Z6K6GJ)8HY<;A*?+X>:U7*D=94Q@&= =
M7NO=)G_A'G\%5^/_ ,!MW?+G=F'J:'L7YG[O%;@VR-%4T$\&R.J)Z[&8)5BJ
M&"!,IE9L]D$GB@1:NCFH)-<T:0,ONO=:?7;'R6^.?S0_X4";\[B_FA=D9'&_
M#B@^37:VW]W5J8O<VX*>BV1THF<IME;9@QNWZ/([@AH,M48K"T5:*"ACD,N0
MK:^3[9Y9YX_=>ZMK_G5=[?\ "8GY'?!?>>+^ 63Z"ZS^8/7D^S\WTPO4GQ"W
M_P!"G.QTF4HX<WALSD(^O<3BZ\U6 FR4E-+E:CBOAI=57"C2/[]U[JZW_A)I
M\H-\][_RA^Q^K=^5]=F9/BMV1V+U+LG+Y+)29.8[:S>$H]Q8VA=IF>58\54Y
M7(TE,FKQ0T,=)30!(X%1?=>ZTU/^$V?P/Z4_F"?S.=H]7_(?;IWKU'UEU=OO
MO7<^PYJEZ2DSDFS*C%X['8[)-%+#/)C?XIFJ.>HA1[5*0&FF#4TTP]^Z]ULW
M_P#"K[^5;\&^F/Y?&R_DY\<OCCTO\;^R^JN[=D;/K:CI+K+&=;4N>P/85-7T
ME5C\M182/&T555P5\&,JZ>OJ*6IJ85@J:9"J5TKI[KW1]O\ A+/M3:W??\B3
M;?3G<6W,/V'U?D.T?D1UWEMC[GI?XGCJW"YK,MDJO'55-(3'+25%5DZUI(B
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MXYJR>7;%7AJW$;GKZ411*Z08N:IH,E5'QI%'CZ6JGD"B!0/=>ZI)_D$?*/\
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M*[&>>EK<K1[8HY)JW*U5' E,E=F\O62U.7SF0$$:)]U7UU1/I&GR:>/?NO=
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M,%+55KM).]/B<5FZ6FQD4SL28: 4L"'_ #44=VO[KW5WW^C#KQ^M8NG*S9V
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M30PF*+1[KW0U_.?^5Q\$_P"91_HN_P!G5Z,_TT?Z%_[[?Z-/^,F[QZZ_AO\
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M]T_\])G_ /S\5'_7SWZ@Z]4]>_O7NG_GI,__ .?BH_Z^>_4'7JGKW]Z]T_\
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MH_Z^>_4'7JGKW]Z]T_\ /29__P _%1_U\]^H.O5/7O[U[I_YZ3/_ /GXJ/\
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M_P#\_%1_U\]^H.O5/7O[U[I_YZ3/_P#GXJ/^OGOU!UZIZ]_>O=/_ #TF?_\
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MS_\ Y^*C_KY[]0=>J>O?WKW3_P ])G__ #\5'_7SWZ@Z]4]>_O7NG_GI,_\
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M]T_\])G_ /S\5'_7SWZ@Z]4]>_O7NG_GI,__ .?BH_Z^>_4'7JGKW]Z]T_\
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MH_Z^>_4'7JGKW]Z]T_\ /29__P _%1_U\]^H.O5/7O[U[I_YZ3/_ /GXJ/\
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M_P#\_%1_U\]^H.O5/7O[U[I_YZ3/_P#GXJ/^OGOU!UZIZ]_>O=/_ #TF?_\
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MS_\ Y^*C_KY[]0=>J>O?WKW3_P ])G__ #\5'_7SWZ@Z]4]>_O7NG_GI,_\
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M]T_\])G_ /S\5'_7SWZ@Z]4]>_O7NG_GI,__ .?BH_Z^>_4'7JGKW]Z]T_\
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MH_Z^>_4'7JGKW]Z]T_\ /29__P _%1_U\]^H.O5/7O[U[I_YZ3/_ /GXJ/\
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MI#/(#H587+75+>70LTU$$YH!\Z$_Y.AIR'R5-SY??10ND>F,RR.]3IC5D0T
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M$F?9OOB#/]\D,<V/2?6*A:>19$E$T0<-"^<6O$UU::^=*5_V.CF7VUVY^<U
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MGM#X:8'Y6X/>6"W7M^"M^3F[<'D=G[<S,E7C:ZH*XV>I='&4K)J3[I((J:.
MT@J%8SC](:N!'$JM"'!!'>:@''E\^LNN5)=TW^YN;/?I-N>)XY*;?&\<L\-)
M$'<$![%#::EBP?2<<>K*?YLL6ZMT=_\ \NG&[7W%D-I[NWKELQMO%[GPL?\
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M;]1+BZ_:>V*3'T68W1D4FA0/1SB0O2P$F/R::B-&60+[67$S2K'&N&D )IQ
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M43332)%##%V+AY&=I" JJHK"69B0  +D\#W3ZB/^)?\ >A_GZ5'8+Y14VTX
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M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T?&E_P" U/\
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M_P J_CQ@\MEY8H.T>NQ2[#[5Q/B--(N0QD02#(>$JFB++4\8FLJA$G%1 O\
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M=7Q<^-F^=TMO?>?0G4&Z=WR3Q5,^Y,]UYBLI6320-J22>>:E=ZAU;D-(6/\
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MNO=5B;G^5_<GRGW!DNKO@CBHZ/;&/KI,3OOY6;SQ4D6#QP2WEAVW3S1'^*9
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M&,=5TUZ.)MK:^VMF86AVWM#;V$VMM[%PK3XW!;=Q4&%HZ=%^B0TU-''#&O\
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MYNCQ61JL-AIZ[^%QU=53PN]/2O4F.84Z5$P1#+X7\8;7H:VD^Z]U6S_HJ_F
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MCLGL'<N_^W=J3=C;CW3N/?\ ELAN'*)A\=*N5SV3E66ND*T>/HWBI(0B)%#
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ML=7I6US(3_L=5" =';IZ>GI((:6D@AI::GC2&GIZ>)88T2,65410%55 L
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MPG_-,B@*/&0GAC[.MA>C^P004L$--30Q4]-3Q1P4]/!&(4C2$!41$4!515
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MY]\TU!5K60[2WK\K*JIQ+O%*LL:SQ8_(XZKJ(D*Z3%+6/'(A99DD!]^Z]UL
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MD;$W3L2HW!N?:L.Z</4XA]Q[,R[8+*T7W('^44-6@8PU$9 *DHR'E71T+*?
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M26K]];)Q6<QNV,IO':N-W+F9Q38?;U?N&DHZZKD*L_CIJ229:B=]*,=*1L;
MFU@?>Z=:KTJ?>NM]%O\ D-V9WQU]3;5INA_C\W>N9W'-F(<H\^_Z'8=)AEQX
MI33RU3UT96J6K,TP5%J(2OA8ZFN![LH!XFG6B:=%H;!_S1^RCJR&]OC=\;\3
M, J1;6P-7V;FH5>Q/E&26JQ$LB7(!CF13:VG^V;=H]3U7)Z.MTWLS?.P.O\
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MUU'+MN:\%155+K!52 O1^6G*3/[KW5WGR9^#WQ"^9G]R?]FK^.G5'?W^C?\
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MZAP2[:ZPV+M?8F$#"26AVUAX<8)I  OEJ9(U$M5.5 !EF=Y" +L;>Z$UX]6
MIT(/O76^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[HC7S._F4_![^7YMO\ O#\LOD5U]U95
MU-#5Y#!;'J<G_'-T99*((7_A.V<>M5FZ]5:6%6ECHC!&TD?EEC#@^_=>ZTNO
MF_\ \+'NY^U=R1=*_P K/XXUF%R>Z\]2;/VKVEV[M\]@;KRU9FYZB@HJ?;&Q
ML3)444.1K:F7'-1?=U>5>9W:F?%B5T8>Z]T=_P#D#_#K^<9L7^93NSYH?S4Q
MV#E*OO3X2=V[/VK6]E]F8S<^5Q-71;\ZJK8\9)M['ULL&UZ:MHX)YZ>CI:2"
M&-:>19X::4QQR>Z]UNE^_=>Z][]U[KWOW7N@(^-WQFZ1^(W5=!TI\>=D_P"C
M[K+%[BWGNNAVS_>3+[KT5_866K,YF*C[W.5^2R#?>92OJY]#59CBU^.!(X52
M-?=>Z'?W[KW5$G\K#_MXE_/E_P#%Q^B/_?9XGW[KW5[?OW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NHE?D*#%TDU?DZVDQU#3(9*BMKZE*2*
M-5^K/)(RHH']20/?NO=% [%_F"_#SK(SP9WO39^8R,$A@_A.Q99>P:@RJ2#"
M?X-%6PQ2!@582RQA6]+%6X]W$9/EU4L!T#I^=G;_ &/JA^-WPG[OWU!,P2DW
M9VBU+TWAW#7M/!45K5$=7%]#I^X@?206T&RFWA@<2/\ #UK57@.O'8G\S;MG
M4=U]R=(?&7!5+#_<=U=M"7LC,)$U[QSSY=C2I*!;]REKTNP) 0<'U5'D3UZA
M/4NB_EF=2[EJX,Q\A.R^[_DMFHIQ4@=E]BUU/CHG%_\ @)0X^6GDIHN6_;^]
M= IT@!;@Z\0^6.O:/7HY76_1/3'3\*P]7]6[$V*WB\,E9MS;-+CJN5;!?\HK
M%C^[J&*@ M+,[$?4^Z%B>/5@*="O[UUOKWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z"/N_L?<_577N1WAL_JO=O<NX*>NQ>/H-C;+:..KF;*SK LSNZRM
M%20,ZM/*D$IBCO*Z"))'3:BO6B:=$B_N)_,5^1)+]@=B;/\ AUU]6H-6TNJ@
M-Z[O>)UYCJLV9!344USZ9Z&LC9/H]/=+O>JKPS_@ZK0GY=' ^/GQXV;\<-I9
M3:FS\UO?<;;@STVZMR[AW]N>7<^0R&2JH(*:6LFD98H$EEAI8%;Q01A@BZ@Q
M%_=6;5U8"G0\^Z];Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NM;G^
M9#_PF)^ OSTWIN+O/:]/G?CW\C-P9-=P9W=6VJNLW%M?<=931A4CW/MALA12
MFDG\<:3O@\S@ZUH]16J$FEU]U[H,.W/C5L3X'_#G%_'[9?\ +CV_\?Z6D^4_
MP!W=E_D!\9H9>\MLY;!=+=_=:;@RN<WGN2LI*7L3"5-)M3;U7E<@V>QE3B:(
MI+3Q;BKY%66;W7NMB/:?R5Z)W_O/9.Q.O^U-B;^SO8G6V].V]H_W(W=C=U05
MFW]@UVVL=D<E%+0U4WDIDJ]VX1%D16C8S6+J=(;W7NAR]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW5$G\K#_MXE_/E_P#%Q^B/_?9XGW[KW5[?OW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[H.=\]P]3=8QF7L;LW8.Q%TAE7=V[J#;[M< @)'53Q/(Q!%@JDFXL#
M?WL GK5:=$\W%_,]^)V/R,N"V5N#>W<^YXP^C;/4'7V2W/4RE"JV@EJ(J&AG
M!+* T=8R7(!8$B]_"/V?;U76.D\ORN^9?9#+'TM\%MR[?QM0K-!NSY ;TI=@
M+$&!TO-@V$->Z&Z&T-6[&Y 4 %Q[2!Q/[.O:B> Z['3G\Q_L_2_8ORBZNZ,Q
MD[2-4X#HCKE]RS:'  C&1SC0UE-(!JLT57(%)O>2PMZJCRK]O7J$]2J#^6+T
M=FJJ#*=X;Z[S^1V7BD^X\O;/:60J::.4WN::GQ[4,L,9O^AZJ4?5;E3I]^\0
M^5!]G7M'1O>N_CWT9U*L/^C7J/KW9E1" %R6#VK1TM:UK &2N\1K)FX'+SL?
M\?="Q/'JP '0Q>]=;Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M*A\@OFAT?\;\OCMI;VR&Y,WV-G,;#EMM]9[&VM5;ES.1@JI)H8GIT58J)1+/
M3S1IYJV+4R.%OH:UU0MU4M3HO![8_F$_($&/J+I;:WQ8V16!A#O[OJJ.<W$T
M4BJ5FI=N0Q,*&J0&_AKJ*:)C8>86:VZ*O'/V=:J3U8]MVDS%!M_!4.X<K#G<
M_18?&4F<S=-0#%1UE93P(E35QTHDF%,E1,'D6+ROXPP36UKEOJ_3Q[]U[KWO
MW7NO>_=>Z][]U[HGOSJSWS.V?\;NQ]\?!#%=.;O^0.R=LYC=.UNL>Y]D9?=]
M#NJ3#1><8&BFQ&[]H28S)UR1RQTL\U3/ U0T22I&A:4>Z]T"7P<^<X^2W\MO
MKSYG]A[WZRVYNNMZEJ=P=T/@=D9/!X?9^[MITO@W7MRJP%?N2OS+3;>S]/74
M?V\N:AJJI4ATK"\RCW[KW1@?AED?E]G^B]G[J^:[]-8[NC=>(H=P979/2_7.
M:Z^H]OKDP\T>*KQFMY;REK<I30/3I5M#610152SQ1&HB$<[>Z]T:[W[KW7O?
MNO= GWWN+NO!;*HZ3X];0V;NOM7=.Y<3MG!5'961R.*VSAH*A9JK(9W/R8FE
MJ\E+28_'TE3]O20+"V1R+T..:MQT=6^0I?=>ZK4^*_R[^<FS?G;G/Y>_\P#:
M/1^Z]Q;RZ-S7R0^-GR7^,> R^S,!G,'LO)8O$;FP.Y=MY[.9[(XC/8C(YBC:
M">"N>CJ:.2(-IJ22_NO=6#?,/Y&XKXA?%?Y!?*'.;9R^\\3T)U-O7M*NVK@7
M2*JKTVA12U?VT<DG[<(E,8#RM=8H]4A#!;'W7NBKYSY8]N]6[F^ $FX]Q=1]
MX[3^=O;&/ZH@@ZQVM6;-J,-_&NN=T;^I]TX.:;<.X%S>VZ.+:C05T<R)*(\C
M#71UT:PBAJ/=>Z$SL?Y:[@S/R@_V2KXV8';FZNZ,!UY0]J]X=A;PG:MVOUI@
MMR22TVWCF<;0UM'E\]N/<]3!4-C,+3U>/62BIJROJLK11Q4Z5GNO='0VS1;@
MQ^$H:3=.<H]R9^,5#9'-8_"?W<@F::61U$-%]S6&GCBC9(U5JN9R$#/(S$GW
M[KW0 =A]Y._>>T/BSUQ4TQ[6W+L++=N[VSE13"O@VELW%5L6*CRDD#$1568S
MV8F^QPU+(PB)I\EDIUJ(,4]!6^Z]T]?*OO;_ &63X[]L]]_W6_OM_HNVK/N;
M^ZG\<_NW]]X98HO!]]]G7_;7\M]?V<OTMHYN/=>Z,%[]U[I!=HYS=VVNO-X[
MAV)BMN9K=>%V[E\IAL=NW,U6!QTDU!!)*OW531T.0J5C73<JE,6>VC7'?R+[
MKW1-_P"59\LM]_.C^7_\;_EIV7A-L[:WKW=MK<^ZLSM[9T%1!C*(4^X<Q04M
M+2BKJ*JI9(**CIT9Y)V:1PTA"ZM*^Z]U8&[I$CR2.L<<:L\DCL$5507))/
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M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T$>]^_\
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M[KWOW7NO>_=>ZB5]6N/H:VO:&HJ5HJ2IJVIZ1!)+(*9&<I$I90TCZ;*"P!)
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MOW7NO>_=>Z][]U[KWOW7NJINE#_,!^+6#W9D.X\;AOEYT[GNYNV-T;;P?5F
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M)_\ JOW[KW7O].72G_/X.K?_ $8&)_\ JOW[KW7O].72G_/X.K?_ $8&)_\
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M7_H*._D4?]YS?^RS=Q?_ &OO?NO=>_Z"COY%'_><W_LLW<7_ -K[W[KW7O\
MH*._D4?]YS?^RS=Q?_:^]^Z]U[_H*._D4?\ ><W_ ++-W%_]K[W[KW35D?\
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MN=K,;GNP=T97'Y:HARHW!%D#!4TM#3*:=JAH%9-:H'Y]^Z]U9I_T"J?R//\
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MU[JT/_0;TI_SY_JW_P!%_B?_ *D]^Z]U1OV[U1U;%_PH7^'6 BZUV!%@JO\
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MF3W%D/+7UTDM5/Y,IEZZ1=<AT(RQK9$4#W7NC*>_=>Z+7VK\1^ANZN^?C/\
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MSMO X'#8^$U%15UN8P&0IZ6F@C'+S3SR1HBCEF8 ?7W[KW17?Y1O6'8/2O\
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M#XJ?%"AS&.^,OQPZ1Z"I=Q2K-N$=1]98?8,F0:.V@UTV-I*>:L\=@$\TCA
M%L ![]U[K#W]\-_B7\K&VZ_R9^-/1??TNT9S/MB?M_JW"]@R4.K66CII,I1U
M+Q02%V,D(;Q2$W=&(!'NO=#]@\'A=LX;$[<VWA\7M[;V!QM%A\%@<'CXL314
M5'C8UAIJ6DI8$C@IJ:GA1$CBC141%"JH4 >_=>Z=/?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=$:W'_+!_EI[QW#GMW;N_EX_!
MG=6[-U9K*;CW/N?<?Q+V#G,CDLCG)Y*JMKZ^MJMORU-96UE3+++//+*\LLKM
M)(S,Q)]U[H?^D_CE\>OC3M[*[1^./0_3/Q_VGG,T^X\WMCI/J_!]58ZLR,D$
M-*U?546"H:"FJ*UJ:FIXC/)$TIBBCC+:44#W7NE5N;JSK'>NZM@;ZWEUSL/=
MN]^J,CF<OU;O'<VT,?GLKMJKW'2&@R%5@,A54\M7AJBOH6:GJ)*2:%YX"896
M:,Z??NO=:K7SR_GC?R\]J?S)^_OY7G\UCXG=?;VZ"ZNW!T]6]8=\;FV#2=S8
MS'3]A;"VMNRH?<VW:ZCJ\ACO#D<K-3Q9+#+4NT+4\-5010QU-:_NO=;-?QGJ
M_C;6]'==R_$-^G6^.G\"A_T81]!1XB#:<=!*3($Q,6""XR&+R.Y=(D4K(7\B
MB35[]U[H=O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW0
M?]K]5]>]X]:;ZZ>[9VIB=\]:=E[7S&S-\;0SD)GI<AC<]"T%533 %7 >-S9T
M971K/&RNJL/=>ZJ<PG\E#JZJ?K[9?=/R\^;_ ,F/C-U#N?9N[.KOB1W;VQB,
MELNBJ.MZB*JVU39J;$;<P^YMWXO;LL%/]E0YO/UU+(L,/\1CR#Q*_OW7NCE?
M,#X)]7?+]^K=UY3=O9G2G>70N6SV<Z'^1O16X:?:6[]JS;II!196DI:BKHLC
MCLAA,Q!'3ID<57XZIH:U8(?+#KBC=/=>Z;OB+\".O?BGE^U>P\CV3V]\D^_N
M\WPL';?R(^16>QVZ-S97';8CDBQ.WZ>/%8O#87#[9Q(GJ6I<;08J" 23S33>
M:9R_OW7NB=U7\CCH8T=7U+A?D=\O=J_"#*[NJ=YYS^7SMSLS%T?6%4V0R<F6
MJ]OH'P$F[:'8];62:Y]NTFYX,:PUQ+&E/(\)]U[JZ+'8Z@Q&/H<3BJ*EQV+Q
M='2X[&X^A@6EA@IZ)%BAAAB0!(XHHU5450 J@   >_=>ZF>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z*_W_\ "7X=_*S);;S/
MR9^+?0'?V9V?'-3[6R_;W4N#[ JZ"&I<22TU-4Y.BJ9HJ2:15:2G#^&1E5GC
M8J"/=>Z,3@,!@=JX3%;:VOA,1MO;F"H*7%8/ 8#&PX>BHZ6B01PTU)2TZ1P4
M]/"BA4CCC5$4 * ![]U[HM>U/@M\+-B=S9#Y%;*^)WQUVEWQE&J)*[M_;G3F
M PVXGDJU1)IOXK3T$=6D\Z1H)95E$D@%G9@3?W7NEWWS\9OCM\I-J4VQODCT
M=U1WMM"BKDR>/V]VQL/&;[I::IC*$5%+'DJ:H%+.?&H,D6AF4:&)4D'W7NEU
MUQUIUUT]LG;W6G4NP]F]8]=;1H1C-K;$Z_VS1;/P^-IPS/X*'&X^&GHZ6(N[
ML5CA4%F9C=F)/NO=+;W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=%D^6NS/E/OOJ5\#\/.ZM@=!]Q'<F%K(]_\ 976@[9QBXRG$WWU&V'^Z
MHR\U26A\<HJ4,14GU E&]U[JK_\ V6/_ (4!_P#>T?X<?^D''_[)_?NO=>_V
M6/\ X4!_][1_AQ_Z0<?_ +)_?NO=>_V6/_A0'_WM'^''_I!Q_P#LG]^Z]U[_
M &6/_A0'_P![1_AQ_P"D''_[)_?NO=>_V6/_ (4!_P#>T?X<?^D''_[)_?NO
M=>_V6/\ X4!_][1_AQ_Z0<?_ +)_?NO=>_V6/_A0'_WM'^''_I!Q_P#LG]^Z
M]U[_ &6/_A0'_P![1_AQ_P"D''_[)_?NO=>_V6/_ (4!_P#>T?X<?^D''_[)
M_?NO=>_V6/\ X4!_][1_AQ_Z0<?_ +)_?NO=>_V6/_A0'_WM'^''_I!Q_P#L
MG]^Z]U[_ &6/_A0'_P![1_AQ_P"D''_[)_?NO=>_V6/_ (4!_P#>T?X<?^D'
M'_[)_?NO=>_V6/\ X4!_][1_AQ_Z0<?_ +)_?NO=>_V6/_A0'_WM'^''_I!Q
M_P#LG]^Z]U[_ &6/_A0'_P![1_AQ_P"D''_[)_?NO=>_V6/_ (4!_P#>T?X<
M?^D''_[)_?NO=>_V6/\ X4!_][1_AQ_Z0<?_ +)_?NO=>_V6/_A0'_WM'^''
M_I!Q_P#LG]^Z]U[_ &6/_A0'_P![1_AQ_P"D''_[)_?NO=>_V6/_ (4!_P#>
MT?X<?^D''_[)_?NO=>_V6/\ X4!_][1_AQ_Z0<?_ +)_?NO=>_V6/_A0'_WM
M'^''_I!Q_P#LG]^Z]U[_ &6/_A0'_P![1_AQ_P"D''_[)_?NO=>_V6/_ (4!
M_P#>T?X<?^D''_[)_?NO=>_V6/\ X4!_][1_AQ_Z0<?_ +)_?NO=>_V6/_A0
M'_WM'^''_I!Q_P#LG]^Z]U[_ &6/_A0'_P![1_AQ_P"D''_[)_?NO=>_V6/_
M (4!_P#>T?X<?^D''_[)_?NO=>_V6/\ X4!_][1_AQ_Z0<?_ +)_?NO=>_V6
M/_A0'_WM'^''_I!Q_P#LG]^Z]U[_ &6/_A0'_P![1_AQ_P"D''_[)_?NO=?-
MI_GZ[8^0.S?YM/RPVW\I>TMF]T][XW_03_?KLSK_ &'_ *,L1DOO.M-FSXS[
M3!_=5GV/V>&EQ]++_E+^::"2H]/ETK[KW5T__";?^7Y_//Q6_-O=Y?'GL',?
M#/XA;GR]#G=\UW?>"J<_@-[4GC,;RX;KJHEI*G-U,D4,$<>6%1AHQ#;[7,2&
M(T[>Z]U],6 3+#"M3)%+4+%&)Y8(33HS@#4R1L\K(I:Y"F1R!P6:US[KW67W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW52E;_)2^!N[OG[W#_,?[AZR
MB[S[_P"T,IUKDL#0=II!N+;6U'ZNVSMS;=!/A<"T(HILB?[N4]9][7I5ST\\
MC?9FF"W;W7NK:41(T2.-%CCC541$4*%"BP  X  ^@]^Z]UR]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW5%'\XCYQ?+?X-;T^!$'0.Y>GZO ?+_P":?5WQ3W3B.T>K:[=$V(IN
MQY8XAEL96X[<F&U34H2<F*HIIE=G0AD"%7]U[HS_ /,?^<>;^ G173-10#:V
M^^^/DM\E^G/B-TE/OF.7;.WDW-W;DY8(LUN$4#&2#![=Q4%=6U$:5,#59IHZ
M3[NE:J^YB]U[IB^3=#_,P^/?Q^[#[FZ+[NZL^3W9/7NQMU;RRO2/:71]+L.C
MSW\&Q=14/1[4R^ S=!48*MBJD$U+'EOXW'51(*"::"6;^)1^Z]T+GRG^?'4?
MP/\ @I5_-'Y*Y7(/MK;/7>Q\I4XK;U#%/E=P9_>-/2QX_"X>D!AA:NRN1J J
MZFBIJ6'RU=3)!1TT\T?NO=)CXZT'\P;O;KO;G<'R'[%VK\3,[OG&8C=>$^,W
M4G7^+W]5;4I,I303QX;>&[MRG*+N3-QLT@K),3A\%3PD_;Q+(\1JI/=>Z<.O
MNQOF91?+W/?'+NA^I9.LZOXXYWL_J'N[KS;]5@JO<&4PFZ,9B\K2Y/;F3R66
M&.J]M8[*843FGR<U)6R9-*I%I R4-+[KW1'OY:OSD^9GRG_F"?S1_B[W1O'I
M,];?R^NT>K=D[2K^N^GLAM7+[CI^TYMU3T\F5J:_=>:I:9Z&AVXD4OVU&GGG
MF:9# BB$^Z]TY?ST_G9\N/Y>'57QI[4^,VX.FJB3O;Y@]5_%?,;=[AZNR&]:
M>@3L_$;@KH\S238K<NWIVDHYL PDIY6=9EG 22$QW?W7NC,_S1^^ODE\+?Y>
MWR%^4G4>_P#8&7[.Z%V$F]X:/L+JR3.83+?;Y&ABJ*6:BQV>Q%92^2EFG2&2
M/)MX9"DLD=2J-%)[KW4KX<[K^:_R:^(GQ7^2.<^0?2>U\U\@_CAT?W?E]M8K
MXPUU;2XZJ[7VQB\]44----V()9:>DEKWBC=P'9$#,+D^_=>Z?]Q[M^;NR?B!
M\G-R[JWYT^/DGT32]Y9S9N]*7I',879.XJ':^'.X=JRRX.KW)49(4\V/GI*3
M*2T6Y)EBR,5=%#(33- /=>Z*G_(S_F?=M?S#^G.ZMH_+'9FT>I_FQ\7.V\CU
M[WKU=M3'SX"GCQ^=5JS;6;I,?5Y3+U,=#7P+6TBSBOG@JI:"2KII#3U$/OW7
MNK+OF-\AU^+/QO[0[II-O3;VW9M["PXGK'KNCJ(Z:IW-N[=U1%BMJ[<I6D9%
M6;,YZLH*8N3IACDDGD(CB=A[KW5;'\BOYH_+7^9'\#L/\NOD9N?J/ [A[!WI
MV9MG:.U>GNLZW;E%C*+9-:,3%45KY?/YR>OKY*ZDKYCHD@@\$D$1C,B/(_NO
M=,/P-^;WS ^1'\S7^9A\.>T]W=._Z*_@AG>D:;:&8V3U-6[=SF?A[>I:W)B/
M+5%9N7*T<1HZ2B,#/3441DD?S*(U'B'NO=#A\K_YB6^,/\RNLOY9WPNVAM#L
M3YB]@=>Y3N?L[>?8QJ:G9?4FPJ)FI(MU;FH<?68[);DR5=E)**FH=OT.3H9Y
M14PU-77T-//2-5>Z]T:RJZR^8NV<!/F-K_)[:O8^_8(8*EMK=I=*8W [6KG@
M.J:CI&VW4T&X,&*M=4<-5497-_9L4FDI*]4>";W7NG3X/]L]M=W_ !AZX[([
MYVOA=C=TY:K[!PW:.QMNU@R-%@\YLG<^:P>1PD%0/^!"XBIQKTAE/KD:%G?U
MLWOW7N@F[MQO\QS>WR7R^UOCAW!\9NBOCIMKH_K7.R;J[=^-V>^0^=S&]=SY
MW>,&7QU+#C.R>OZ/'XO%8+%[;F+223S//7MI!3_-^Z]U53\4?EK_ #8_D]\\
M?YB'PD_V9SX4;(_V0G)=(X__ $F_[(7NO<O]Z_\ 3'C*[(Z_X+_I]Q_\"_AW
MV7CM_%LA]QKUW@TZ6]U[HR_?O??\S3XL? /^8+WYVYOKXT9WNCXF9??F[>F]
MP;3Z'S>!VGO/9FW]G;0S])-DL!6;WK\MC,F<O7[FQ\S4^YIH8VIHF"RA&\GN
MO=&]^ ?:WR#^4_P&^.'R*[!W]LC"]L?(?H;K/MV1MI=;-!@\-5;[Q2Y/[6#&
MU>8J:RLIHA5TZ.),JLC>)BDD?DNONO=5H_R3?YN'R1^9'='R?^(?SRVAU=UU
M\F.HJ3;';'49ZSP%=L_&;RZZW.%I?XYC:/)YO.5%4M'6&AEEFCJ@J)E(:2:*
M*JHZI1[KW5_';'9VS^E>L.P>WNP,DF'V3UGL[<6^-TY%K$QT6V:66KJ/&MP9
M9G2(K%&MVED9(T!9@#[KW5$7\DO^81\Y/YF,?S8W=\A*7JSH7%_'WY+;A^/^
MT.H]G]<U-1G\54[<2>IR$&Y\Q7;AR5!D:S'K4X^D)HL?21O4TU7,;Q30QQ>Z
M]U)^"/S5^>WR[^<O\U7XI9_MCX][.VS\ .V>I]D[#W1A_C?E,C7YV@[5.\)T
M;+QS]A)3QU>.I]NTD;24ZI'42233"&G4I"GNO=6DX6A^9FS.].L(=[=H]4=J
M=#;MQ>]MO;OH=J_'_+[%S^)SU)1-D\)D6RJ;NS^-CP$]/0Y.EJ!48^!A72XZ
M**J9JH0^_=>Z.9[]U[HG&X._ZCLCY*;G^(G3N8J<7N;J[86UNQ_D5V71XN+)
M#:E'V-)51[5P&-^\AJ,=+NW<46/R5<JU%-40X[&4PJJFFD>OQZ2>Z]T<?W[K
MW7O?NO=>]^Z]T57KGK3Y0X#Y3?(7LKL/Y'8;?7QDWWMWK''] _':CZMH=N5>
MR:[;M&T6XJVJW-%(U?G3G*TM.JS@)"C)#&D8@U3^Z]T:KW[KW7O?NO=>]^Z]
MTCNP^P=E=3;#WGVAV3N?#;+Z^Z]VQG-Y[UW=N&NCQE#C<7MNFDJZZMJZB4K'
M%!34\4CNS$  >_=>ZX=;[XQG9W7>PNRL+2UU#A^PME[6WQB:+*)''4PTV[*&
M"O@BJ%BDEB6>.*H19 DKH'!TNPL3[KW2T]^Z]T2'._(K-]"_)WK+H3NNMAR>
MP/E#7;IQWQM[;>*EQ+T^Z]LTLV7K.N-Q11F&*2MK,+#65^V\C! /OJ>@R..R
M*1Y&DI*S.>Z]T=[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]UK'?\*0/^/N_DE_\ C8OXM_\ N2_OW7NKA/YC
M7P Z2_F5_&+<7QE[NFRF%HZ[-XO>G7&_]MO'%F=J[LVQ%5#%;BPSR>G[VCBJ
M:V*1+KYZ.HJJ9G1)F=?=>ZUJ3\X?YO\ _(._@'7W\S38A_F)_P N*DJ<%LK"
M_-SK:-JC=FW:#(.^-H:7=4-8[2U=056E1HLV+U<M2D--NC(U-Z4>Z]TIO^%$
MW:>T>[ML?R#<_P!79+;^XOA_W1\\ND]]?Q_%ZH:":CJQ@$VQX<;]M% :9\!E
M]R:DDK*5Z<)X!!())7I?=>ZW'??NO=1GHJ.2L@R+TE,^0I::KHJ6N>!&FCAK
MW@DGACE(UI%,]-3M(H8*[11E@2BV]U[K4O\ Y45;WC1_SC_^%&?^AG;75&X?
M)\A?BQ_>3_2=O?+[-\.BD['^S^Q_A6W\[]SY+U7F\O@\>F+1Y=;^/W7NFG_A
M3)D/D;5_&W^7]'V_M'I/ ;:7^;'\4WH:SK?L3.[NKFKA@=^B**6FRFU\)3I2
M&G-2S2K5O()%B41,KN\?NO=6U_S_ +_MS5_,'_\ $"Y#_P!V6.]^Z]T%W\N[
M'?S%)_Y57P8'3>[OAGCYIOY?7QE'57^D/K_>N2:!I.N,)_ _XX^/W)3QU#1$
MTOWIIH8U<B0PH@*J/=>Z-)LB'M6G_DX;1@[UBRT'=\'\L[ 0]QPYY(8ZY-U1
M]61+N%:U:<"G6K7+BL$PB'C$FH)Z;>_=>ZI$^3;-_*P_FC?R[/YEN+JAMSXP
M_P P3K;K/X+?-V%'\-%%N=L!3R["W540))!%]Y''C:435LR5#TV,Q&3CC"&O
M8GW7NKMNW?-\C_F"^SHS+/U)\#^N<OVGO QSLM/D>V.Y<%DL=M7&N:?(IY6V
M7L:JSF5K*.MQDD)J-S;:R%-**FAO'[KW5=G_  DW_P"W*'07_B2_D+_[V.5]
M^Z]TE_Y4?_;^/_A0_P#^''\)/_>9SOOW7N@?_DZ5>=W%_P * _\ A05N'L:&
MFAW]C-T=/[6VXHG;(2?W7QM1D:+$,L\L%')&LF#Q>V&DA%,\<;%8UJ)TA2>?
MW7NMM'W[KW4:DHJ.@B>"AI*:B@DJ:VM>&D@2F1ILE-)45$Q5 H,M142RRR-;
M4\CL[$LQ)]U[J3[]U[K6._E1_P#;^/\ X4/_ /AQ_"3_ -YG.^_=>ZLG_G=?
M]NB?YB__ (J7W!_[JYO?NO=*/^3=_P!NG/Y;W_BE'QN_]Y3&>_=>ZUU?F_MC
M<7PKZ>_E,_SQ>J*2JAJ_B56;;Z*^8U!B5TMG^GNY]PU.+GBJH8I*9LA-BLCE
M:F+'1S32119')T=887-$MO=>ZV(^^=TX7Y<=N_%/XX;"RT.X^HL]0;3^<7>V
M>Q%66I:S9/7]925W7.$::FR-)51KO??0QF016I:FBR&%VSG\?6((ZI5D]U[J
MKS_A-_\ \?=_.T_\;%_*3_W)3W[KW0"_RLJ?Y$3_ ,X__A1=_H$R_2^*T?(7
MXM_WK_TO;=SF?\FJD[&^Q_AW\%RF-\6FU9Y_-Y-5X?'HTOJ]U[J]#XOT'SAI
M?FC\P9OE/DNL,MU14]&_#0?'>KZ<V]D]O8:.:#)=N#>5/6KF:_(U\VXTJVPT
ME2Z3K2#&S89(HQ4+6._NO=6-^_=>ZUO/^$X_8F=[[VW_ #7_ )(;TK)<COCL
M_P#FW_(G UU741JCPX?KW;>RH-NXQ2G'V^(QM:*2!26*Q1+=W8EC[KW2^^4U
M)W=%_/&^"/6VU_E!W7MCK3N3XL?,3<6Y>OZ;-0U.'H:S9@Q%/!DL-B1%#AXL
MU%194T]+79#&Y*2E5'D5))JF>1O=>Z 9^K.T?BA_/"ZD^*G1?RO^3=%T!\V/
MAOVQV/VQLOMKN#/_ "%J,7GNJ\NI_CFSLGO7*9FHV[F,E2N*628)400PO-XZ
M7R"A>@]U[H3^E>M=Z_"/^>/M'XV]8_(GY&[Z^,OR?^ ?8O<.Y^G?D%W7N?Y"
MC$[SZCW;C<=%N'"YS>67S67HI,ACLGX9Z=)Q'(1(]0:D"A3'^Z]U[X%;Y[CR
MG\]'^=-T-N_OGN+L'8/3?5/PGI.IZ#?&Z8LW'MP=G;/AW'E7P^.^TBP5%)+E
M<K/)^WB )%C@CJ%G2%1[]U[H+_Y>?5'9?R>^4/\ .JZ-[M^6_P KMW=1=9_,
MO";#P.+H^YLIL_<'\*J-OM54N&@W5@YL;E<)M_'+4R+#083^%&=R9<A45K/(
M']U[I)?RTM^=K[X^#_\ .Q^-F_>\^_MW47P.^8_SYZ%^/W;U;WCNC';]Q^WN
MN<=D'P$4^\:'*4V?JJG$5(FEII)<@XCU11*@BI8$3W7NC%[5W_VAOC_A,:.\
ML_W%W5_IQPO\J3?G>5%W7A^Y-S;;W@VZ]E==Y;-4&:J=SX[*TN;K*M<E30S3
M>>ND2I(M4+*IM[]U[HJ?S<VX/D?_ ,)2-C]J]V[J[/W_ -B8#^7[T+W,^[<G
MW!NNCJ\MN6JPF$$N3W0U'F:9=XM+)5SSO!G5R-,]45JVA-5'',GNO='%WOV+
MB_Y<'\M/XFY'IC<O;E7V3\P.PO@+\;]KU?:?R-W5WO6T.5^0+X7&Y.HV=!VG
MNS-XK$5F-VY_'JW'XRE>CPT=330SUE+]C33:?=>ZA_+WXY_.:@W5\9>ZOY:_
M6'R2ZY[JZL[AVQ_ISPGR/^6^.W#M'L'K4T=>,]A<[13]D;WCR.Y)ZY<4:'(R
MXN*II4:KECKXI%BC?W7NL'_"H#(UVQ?Y5&X>_P#;28Z'LKXM?)?XG_(+J#.U
MU$*Q\5N7:N]\7CJ+(4QNKQ3I3Y>LB9D=6:"::+4!(??NO=7\;.W F[=H[5W5
M' U,FYMMX/<"4SVO&,S2Q5(0V+"Z"2Q]1^GU/OW7NE'[]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z+U6_+?XKXW=,FQ\C\D^AZ
M'>4.53!3;7K.VL#35Z5TCB):-Z5Z\3+5&4A!$4$FLA-.HV]DK\R;=')X375N
M'KIT&:,-JX4IJK7Y<>I3M_8WG2\LAN46P;R]H8S,+E-LO6A,(&HR!Q"5*4%=
M8.FF:TST*V]>P=A];;<J-X=A[UVGL3:=(85J=S;PW#2;;H(VJ?\ -*U7630T
MX:4\(ODNYX4$^S&[O8;!#+/(D:#BSLJ+GYL0.@3R]RON?-MVMAM5I<WERU=-
MO:P2W$S!>)$<2NU!YFE!Y])?K;OCI#N63)0]1]P=8]G3X9(I<O3[ WUC-W24
MJ3FR/41T%3.\*.>%9U"L;@$D'VGL=XM-TJ+::*4KQ$<B.1]NDFG1US=[:<Q\
M@"-M]VO<-O$I(B-[9W%JLA'$(9HT#$>8%2//H5_9CT".O>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>ZUT?YZOQW^97R@WU_+@7XP?$3L+N_"_%
M3YS=6_*SL_<F*[2ZQV%3OB.L9X)'Q>*@W9OK UU7E:])JCP^2E@ID,%I9U$B
M'W[KW5A_SCQ_S.W/C/A9V%\0.N<%7=@=8?+N@["[8ZO[=W]2;$I*S8\G7/9F
MW<UCJW+X>/<]+#65-5G,2<>T,=7''7M1RSZ(HI]'NO= C\ZMY?)3Y:?#SY ?
M$?K?X%=VXKM3Y+]/]C]#2YON;<G7^#V3M%NR,-D,2^Z<MG\9N_/3Y"@PSS)5
MTJ8?$9')33"EM10-YC3^Z]TAOD#_ "2.K/D#_*,Z<_EB[@[$RN/W'\>^O>MH
MNF?D'!B8YZ_#;VZRH6AIMPQ4A976@KI9Z^GJJ2*IBF_AU7+#!50U"0U,?NO=
M"%\6?E)_,3ZUVE@NE/G5\!NV=\]N[&P--@ZGY+_%#>NQ^R]@[Z;"TM,J9:*#
M<&Z]J;LV[D\D[LL]-D=NQ4_W$<TRU$5/)$B^Z]T?_9&0[GW)7UO9>_\ 9N7V
M'AZ3!I2[(Z&QVY,1FLTTF2$,E77[IKJ6N.WCEX2OVU+04.=J\;2QBHJ7R-?/
M54ZX[W7NJ0?Y3_QU^:G17\RO^;W\@>^_ASV)U3U'\[NV^GMY=-[KK.V.KMY&
MEH>JYMXTDASM!M_?>3R5'-74NX:.J1(*.J$82:%F,BIY/=>Z>_\ A0[\8OF'
M\RNGOB3U=\3/BYO#N[*]-_.3I[Y/;SS-+V=U[UY0+ANKL+N.CFHJ8[KW?A*N
M?(5E1N"-8@*01+]O,9) K1,_NO=&H_F];)^2/RI_EA_(WH7HGXK=H[P[H[_Z
MVI-EX/8=;OSK7:S8BHR=;0SSRYG)Y+?=/AQ#10PS:_L:^N:20*D2LC&1?=>Z
M2OP:[A^8?QM^$_Q)^.W8G\J3YIU_8/0'QGZ1Z2W57;+[?^,F7PU7D.I]LXW
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MS,+_ /5OOW[XM/\ ?\/_ #D3_H+KW^M9S/\ ]&?=/^Y?=_\ 6GKW^S#] ?\
M/\NGO_1F87_ZM]^_?%I_O^'_ )R)_P!!=>_UK.9_^C/NG_<ON_\ K3U[_9A^
M@/\ G^73W_HS,+_]6^_?OBT_W_#_ ,Y$_P"@NO?ZUG,__1GW3_N7W?\ UIZ]
M_LP_0'_/\NGO_1F87_ZM]^_?%I_O^'_G(G_077O]:SF?_HS[I_W+[O\ ZT]>
M_P!F'Z _Y_ET]_Z,S"__ %;[]^^+3_?\/_.1/^@NO?ZUG,__ $9]T_[E]W_U
MIZ]_LP_0'_/\NGO_ $9F%_\ JWW[]\6G^_X?^<B?]!=>_P!:SF?_ *,^Z?\
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M_N7W?_6GKW^S#] ?\_RZ>_\ 1F87_P"K??OWQ:?[_A_YR)_T%U[_ %K.9_\
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M_P!&?=/^Y?=_]:>O?[,/T!_S_+I[_P!&9A?_ *M]^_?%I_O^'_G(G_077O\
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MS,+_ /5OOW[XM/\ ?\/_ #D3_H+KW^M9S/\ ]&?=/^Y?=_\ 6GKW^S#] ?\
M/\NGO_1F87_ZM]^_?%I_O^'_ )R)_P!!=>_UK.9_^C/NG_<ON_\ K3U[_9A^
M@/\ G^73W_HS,+_]6^_?OBT_W_#_ ,Y$_P"@NO?ZUG,__1GW3_N7W?\ UIZ]
M_LP_0'_/\NGO_1F87_ZM]^_?%I_O^'_G(G_077O]:SF?_HS[I_W+[O\ ZT]>
M_P!F'Z _Y_ET]_Z,S"__ %;[]^^+3_?\/_.1/^@NO?ZUG,__ $9]T_[E]W_U
MIZ]_LP_0'_/\NGO_ $9F%_\ JWW[]\6G^_X?^<B?]!=>_P!:SF?_ *,^Z?\
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MS,+_ /5OOW[XM/\ ?\/_ #D3_H+KW^M9S/\ ]&?=/^Y?=_\ 6GKW^S#] ?\
M/\NGO_1F87_ZM]^_?%I_O^'_ )R)_P!!=>_UK.9_^C/NG_<ON_\ K3U[_9A^
M@/\ G^73W_HS,+_]6^_?OBT_W_#_ ,Y$_P"@NO?ZUG,__1GW3_N7W?\ UIZ]
M_LP_0'_/\NGO_1F87_ZM]^_?%I_O^'_G(G_077O]:SF?_HS[I_W+[O\ ZT]>
M_P!F'Z _Y_ET]_Z,S"__ %;[]^^+3_?\/_.1/^@NO?ZUG,__ $9]T_[E]W_U
MIZ]_LP_0'_/\NGO_ $9F%_\ JWW[]\6G^_X?^<B?]!=>_P!:SF?_ *,^Z?\
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MO_1F87_ZM]^_?%I_O^'_ )R)_P!!=>_UK.9_^C/NG_<ON_\ K3U[_9A^@/\
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M6<S_ /1GW3_N7W?_ %IZ]_LP_0'_ #_+I[_T9F%_^K??OWQ:?[_A_P"<B?\
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M]^^+3_?\/_.1/^@NO?ZUG,__ $9]T_[E]W_UIZ]_LP_0'_/\NGO_ $9F%_\
MJWW[]\6G^_X?^<B?]!=>_P!:SF?_ *,^Z?\ <ON_^M/7O]F'Z _Y_ET]_P"C
M,PO_ -6^_?OBT_W_  _\Y$_Z"Z]_K6<S_P#1GW3_ +E]W_UIZ]_LP_0'_/\
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M+_\ 5OOW[XM/]_P_\Y$_Z"Z]_K6<S_\ 1GW3_N7W?_6GKW^S#] ?\_RZ>_\
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M+_\ 5OOW[XM/]_P_\Y$_Z"Z]_K6<S_\ 1GW3_N7W?_6GKW^S#] ?\_RZ>_\
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MX+CW-_Z:7=_^RM^O?\-L_ O_ +Q/Z6_] ^'W[^J.V?\ *-%_O/7O^"X]S?\
MII=W_P"RM^O?\-L_ O\ [Q/Z6_\ 0/A]^_JCMG_*-%_O/7O^"X]S?^FEW?\
M[*WZ]_PVS\"_^\3^EO\ T#X??OZH[9_RC1?[SU[_ (+CW-_Z:7=_^RM^O?\
M#;/P+_[Q/Z6_] ^'W[^J.V?\HT7^\]>_X+CW-_Z:7=_^RM^O?\-L_ O_ +Q/
MZ6_] ^'W[^J.V?\ *-%_O/7O^"X]S?\ II=W_P"RM^O?\-L_ O\ [Q/Z6_\
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M_ O_ +Q/Z6_] ^'W[^J.V?\ *-%_O/7O^"X]S?\ II=W_P"RM^O?\-L_ O\
M[Q/Z6_\ 0/A]^_JCMG_*-%_O/7O^"X]S?^FEW?\ [*WZ]_PVS\"_^\3^EO\
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MW[^J.V?\HT7^\]>_X+CW-_Z:7=_^RM^O?\-L_ O_ +Q/Z6_] ^'W[^J.V?\
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MX+CW-_Z:7=_^RM^O?\-L_ O_ +Q/Z6_] ^'W[^J.V?\ *-%_O/7O^"X]S?\
MII=W_P"RM^O?\-L_ O\ [Q/Z6_\ 0/A]^_JCMG_*-%_O/7O^"X]S?^FEW?\
M[*WZ]_PVS\"_^\3^EO\ T#X??OZH[9_RC1?[SU[_ (+CW-_Z:7=_^RM^O?\
M#;/P+_[Q/Z6_] ^'W[^J.V?\HT7^\]>_X+CW-_Z:7=_^RM^O?\-L_ O_ +Q/
MZ6_] ^'W[^J.V?\ *-%_O/7O^"X]S?\ II=W_P"RM^O?\-L_ O\ [Q/Z6_\
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M_ O_ +Q/Z6_] ^'W[^J.V?\ *-%_O/7O^"X]S?\ II=W_P"RM^O?\-L_ O\
M[Q/Z6_\ 0/A]^_JCMG_*-%_O/7O^"X]S?^FEW?\ [*WZ]_PVS\"_^\3^EO\
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MW[^J.V?\HT7^\]>_X+CW-_Z:7=_^RM^O?\-L_ O_ +Q/Z6_] ^'W[^J.V?\
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MX+CW-_Z:7=_^RM^O?\-L_ O_ +Q/Z6_] ^'W[^J.V?\ *-%_O/7O^"X]S?\
MII=W_P"RM^O?\-L_ O\ [Q/Z6_\ 0/A]^_JCMG_*-%_O/7O^"X]S?^FEW?\
M[*WZ]_PVS\"_^\3^EO\ T#X??OZH[9_RC1?[SU[_ (+CW-_Z:7=_^RM^O?\
M#;/P+_[Q/Z6_] ^'W[^J.V?\HT7^\]>_X+CW-_Z:7=_^RM^O?\-L_ O_ +Q/
MZ6_] ^'W[^J.V?\ *-%_O/7O^"X]S?\ II=W_P"RM^O?\-L_ O\ [Q/Z6_\
M0/A]^_JCMG_*-%_O/7O^"X]S?^FEW?\ [*WZ]_PVS\"_^\3^EO\ T#X??OZH
M[9_RC1?[SU[_ (+CW-_Z:7=_^RM^O?\ #;/P+_[Q/Z6_] ^'W[^J.V?\HT7^
M\]>_X+CW-_Z:7=_^RM^O?\-L_ O_ +Q/Z6_] ^'W[^J.V?\ *-%_O/7O^"X]
MS?\ II=W_P"RM^O?\-L_ O\ [Q/Z6_\ 0/A]^_JCMG_*-%_O/7O^"X]S?^FE
MW?\ [*WZ]_PVS\"_^\3^EO\ T#X??OZH[9_RC1?[SU[_ (+CW-_Z:7=_^RM^
MO?\ #;/P+_[Q/Z6_] ^'W[^J.V?\HT7^\]>_X+CW-_Z:7=_^RM^O?\-L_ O_
M +Q/Z6_] ^'W[^J.V?\ *-%_O/7O^"X]S?\ II=W_P"RM^O?\-L_ O\ [Q/Z
M6_\ 0/A]^_JCMG_*-%_O/7O^"X]S?^FEW?\ [*WZ]_PVS\"_^\3^EO\ T#X?
M?OZH[9_RC1?[SU[_ (+CW-_Z:7=_^RM^O?\ #;/P+_[Q/Z6_] ^'W[^J.V?\
MHT7^\]>_X+CW-_Z:7=_^RM^O?\-L_ O_ +Q/Z6_] ^'W[^J.V?\ *-%_O/7O
M^"X]S?\ II=W_P"RM^O?\-L_ O\ [Q/Z6_\ 0/A]^_JCMG_*-%_O/7O^"X]S
M?^FEW?\ [*WZ]_PVS\"_^\3^EO\ T#X??OZH[9_RC1?[SU[_ (+CW-_Z:7=_
M^RM^O?\ #;/P+_[Q/Z6_] ^'W[^J.V?\HT7^\]>_X+CW-_Z:7=_^RM^CL001
M4T$--!&L4%/%'!#$O 5(@%51_@  /8B TB@ZQXDD:5B[&I8DD^I)J3T&/>&Q
M\MV7T_V3U_@JC'4F9WCL[.[>QE3EI9(*6.;)P-%&T[PPSRK$&8:BD+L!]%/T
M]W4Z37IMA4=.>-VID:3JN@V/+-1'+TO7]+M26HCED:F^YAQRT;.KF)93!Y02
M&,(;3SH!]/O0QUXYZ)EL[XS=S]-X#J/=W6.6Z_K>U=D=;U'6'8>V<U55BX+<
M.,6OGR-(::N2CBK*6OHIYF,<STH#AA$Y2)&$M]0-:\*UZU2G0G8OK7OGMK*Y
MBH^0.9VSM/KVNV9NC9D74/6F3J,I'6_WL@>EJ,AF<C5T\8EGIX&)I(XHBD4F
MB:\;K(LNB0.'[>O4)X])?:FT_FCUQM^AZFVS5]*;GVMMW'1;?V=VINFIR=!D
M*;&4$;PT8K\130R155?24ZP(NB812%%\TCEGD'B0<Y^SKV>DULKXE]E[:ZMZ
MWV-E-S[0S.:V=\LMO]ZYC-FKK(4K,3B:\U<P51C[KEIU-_ 5%.')'W6D!CLL
M*D_*G\NO:>CE=N;3R._NJ.SMBX>:BILOO3KW>FT\749*22&FCJ=QXVIHX'J'
MBCFE2!)9E+E(78*"51C93130UZV<]3NM]NUVT.N]A;2R<M)-DMK[+VMMW(S4
M$CRP//A*&"FF:%Y(XI&B:2)BA:)&*V+(IN!XYZ\,=8NR>O,!VKLO,["W34[F
MI=OY\44>4?:.[\GL6N>*CJ(J@P)D\/5T61@AJ/$(IUBJ4\T#R0O=)&!1WUDF
MXQ-#(6"M2NAWC:@(--2%6 -*&AR*C@>A+RES5=<E;A%N=DMNT\.LQBZM;>\A
M#.C)J,-U%-$S+JU(60Z'"NM&4'JOWHWX>];0]H]AY*;XI?[+*.INSL _4':'
M6';=?BJ_>>+QR4]5--FEQ5?%-7459+&4JJ?)B=9HZF2!A]S%/,X,VCEB!;B5
MOI/I?!E7P98IF#3H*$E]# D$CN#UJ"1Q!/63_N-[\[O)LUC"O,G]8/WEM\PW
M3;MQVR&6':;AR\:K;?4PLL<D:D&*2V\,HT:N#X;(@L[]C[K#SHC6[=B_([:/
MR&['[8ZEVCUUNO$[[V=LC;B+N_=U1@W@?;"R&5O#!32,^MI"!^ZO%CS]/;@(
M(H?7JIK6O37B?B-NK<'5G<5+V1NW#TW</<F]:#LN3-[1II/X7@LKMEHY<+'1
M+.J5%3#2O%IG>0!I(Y&11K7SR:U4(]!UZG2AR-5\W]WX2'84FU^K.M*^K1L;
MN+NG#[UFS^F!2JRU6&P9H(YZ:MFCUF'[BH=$9KDQ,JL/"@]>O9Z>.T.H^U\#
MV)M?O7H^NP&X]_8S8L76N_=L[ZE7$P;EQ<,ZU,-5]U1P1Q4F7IZJ\GD$:1M'
M:(:8T\$O@V*'KU//H/-P=8_*'MSMKI+L??>+Z^V-M'K#L!<RG7>&W))N2K6"
M6%Q/D:G)FDIX:FI],,,,$4**%,DC:2;>_5 ! Z]D]#QTAU?N?K_>GR#SV?\
MX=]CV7VK+O#;7V56:E_LWHH( :A2B"*7R(WI!;@7O[T34#K8&3U,Z ZWW)UO
M3=P1;D%"&WMW_P!J=D83[&J^Z'\-W?5QS49E]*^.?0IUISI/&H^_,:_L'7@*
M=</C+UKN3J?JV/:&Z_X?_%UWAO[-G^&U1K(O!N/,5E;3>LHGK,$R:AI]+7%S
M;WYC7]@Z\!3I2]O]!],=_P")Q.![IZVVIV9AL%D9,OA\9NW&+E(:>JEB:%IX
MD?A93$[)J^NDD?D^RZ_VNWW10MQ&L@4U 85 /"O0[Y#]S>8/;">2ZY>O[G;Y
M9HQ%+):R&)WC#!]+$<5U &GJ!T7_ /X;9^!?_>)_2W_H'P^RO^J.V?\ *-%_
MO/4H?\%Q[F_]-+N__96_7O\ AMGX%_\ >)_2W_H'P^_?U1VS_E&B_P!YZ]_P
M7'N;_P!-+N__ &5OU[_AMGX%_P#>)_2W_H'P^_?U1VS_ )1HO]YZ]_P7'N;_
M --+N_\ V5OU[_AMGX%_]XG]+?\ H'P^_?U1VS_E&B_WGKW_  7'N;_TTN[_
M /96_7O^&V?@7_WB?TM_Z!\/OW]4=L_Y1HO]YZ]_P7'N;_TTN[_]E;]([^9]
M\]*+^73\6ZKOA=C0]D;NW#V-UYTSUCL_)[HI]B8JIW)VE6_98Q\]GZM7I<%@
MJ73-/65LJ%8HH]/#.& CZQUZ+#\?OG%_,IQOROZ=^.?S8^!>S,3U[\@ME;PW
M9L3Y1?#??>Y>^-G;>JMIT]-4IB=\35.V*2'!)D(IPM-DILA#23U$E-!2I5>2
M:6F]U[JQ#MOYJ_#WH/L#:O5'>'RE^/G4'9N]Q1MM'8'97;^ V3F,@,C,M-3-
M38_(U]/52)55+"*!O%IFEO'$6<$#W7NA>W'VKU=L[.]?[7W=V1L':NYNV<K6
M8+JO;NX]X8[!UVYJ['4CY"HH]OTE5415&9JH*".2IDBHXYI$@5IF41J6'NO=
M,=/WYT55[Q[1ZZI.ZNI:KL'H["XG<G=6Q:?L?#S9G9^.S]",I0U^Z<8M8:W;
M]%6XTBK@GKX((IJ8B>-FB]?OW7ND1UO\Q_B1W'N++;1ZC^3_ ,?>T=S8'K_&
M]KYG!]=]P[?WI44NU\NL34NXIH\;D*DQX2=*BG9*T_Y.5FA;R:98RWNO=8.D
MOFA\0ODKN'=VTOCS\H>@.\=T["5I-Z;<ZG[<P._ZW%QK,]/YZVEQ==4S04QG
M1XQ,R"(N"H<GCW[KW7+JSYG?$3O'L?>'3W3/R?Z"[6[7Z^ER$.]NM^O.V\%N
M_.8ML14-25@K<905T]9#]G5(T-1JAM!-^U+H<A3[KW0H[7[?ZEWOOCL?K'9?
M:/76[^R>G9=L0=N=>[7WMC,_G-JOO>FEK,*FX\325,M?@WR]'!//1"MIX350
MQR2P>1$9A[KW5;W\S?Y]=Z?#;>OPHZK^/'2'77=_9GS,[LW!TIMS%]F]D5O5
MV-H*O&8M<G!539&AQ&;D$3JLJ.OV+$>EE/!4^Z]T$72_\T;Y+;.^</5'P/\
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M4->]/A5ECAG96JY(E;Q2@&\4@7W7NL73'S#^)WR+V?N[L'H3Y+=$]Q[&Z_\
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BZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
